{"title": "PDF", "author": "PDF", "url": "https://www.aam.org.ar/descarga-archivos/41-4completa.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "N\u00ba4\nVOL 41\n2009REVISTA ARGENTINA DE\nMICROBIOLOG\u00cdA\nPUBLICACI\u00d3N \nDE LA\nASOCIACI\u00d3N ARGENTINA\nDE\nMICROBIOL OG\u00cdAPUBLICACION DE LA ASOCIACION ARGENTINA DE MICROBIOLOGIA\nSecretar\u00eda:  De\u00e1n Funes 472, C1214AAD Buenos Aires; Tel/FAX: 54-11-4932-8858, 54-11-4932-8948; E-mail: info@aam.org.ar, http://www.aam.org. ar\nSUSCRIPCI\u00d3N (cuatro n\u00fameros anuales)\nSocios AAM U$ 100\nArgentina no socios U$ 200\nAm\u00e9rica Latina U$S100\nOtros pa\u00edses U$S150\nLos pagos pueden hacerse por giros a la orden de Asociaci\u00f3n Argentina de Microbiolog\u00eda.\nPersoner\u00eda Jur\u00eddica 000908.\nRegistro Nacional de la Propiedad Intelectual N\u00ba 269649.\nI.S.S.N. 0325-7541\nCorreo\nArgentino\nSuc. 4 - BFranqueo Pagado\nConcesi\u00f3n N\u00ba 4195\nTarifa Reducida\nConcesi\u00f3n N\u00ba 628DIRECTORA\nSilvia Carla Predari\nSECRETARIO DE REDACCI\u00d3N\nGerardo A. Leotta\nCOMIT\u00c9 EDITOR\nAlicia I. Arechavala\nDaniel Grasso\nAna M. Jar\nClaudia I. Menghi\nElsa C. Mercado\nH\u00e9ctor R. Morbidoni\nVilma Savy\nASESORES CIENT\u00cdFICOSAparece en Biological Abstracts, Chemical Abstracts, Veterinary Bulletin, Index Veterinario, EMBASE (Excerpta Medica)\nMedline (Index Medicus), Tropical Diseases Bulletin, Abstracts on Hygiene and Communicable Diseases, Literatura Latinoa-mericana en Ciencias de la Salud (LILACS), Peri\u00f3dica, LATINDEX, SciELO y Science Citation Index Expanded.\nC. Bantar\nJ.C. Bas\u00edlico\nM.I. Berr\u00eda\nH.M. Bianchini\nN. Binsztein\nM.M. Bracco\nR.A. Cacchione\nR. Campos\nG. CarballalJ.J. Cazzulo\nC. Coto\nM. D\u2019Aquino\nR. de Torres\nJ.E. Gonz\u00e1lez\nS. Gonz\u00e1lez Ayala\nA.H. Frade\nN. Leardini\nH. LopardoW.P. Mac Cormack\nD. Masih\nE. Massouh\nM.A.M. de Asconegui\nR. Negroni\nF. Nicola\nT. Orduna\nJ.L. Parada\nA.P. de Ruiz Holgado\nASESORES EN EL EXTERIORH.R. Rodr\u00edguez\nA. Schudel\nL. Scolaro\nR. Soloaga\nD. SordelliH. Terzolo\nG. Vaamonde\nM. Weissenbacher\nJ. Arbiza (Uruguay)\nE. Garc\u00eda L\u00f3pez (Espa\u00f1a)\nM. Gottschalk (Canad\u00e1)\nR. Guerrero (Espa\u00f1a)M.J. Mendes Giannini (Brasil)\nM. Philipp (EE.UU)\nJ. Pont\u00f3n (Espa\u00f1a)\nF. Queiroz Telles (Brasil)\nA. Restrepo (Colombia)G. San Blas (Venezuela)\nG. Schmunis (EE.UU)\nA. Steinb\u00fcchel (Alemania)\nM. Tolmasky (EE.UU)\nJ. Vila Estape (Espa\u00f1a)XII CONGRESO ARGENTINO\nDE MICROBIOLOG\u00cdA\n24 al 27 de octubre de 2010\nPalais Rouge\nJer\u00f3nimo Salguero 1433/49 (C1177AFA)\nCiudad Aut\u00f3noma de Buenos Aires, Argentina\nPresidente: Ricardo Negroni\nVicepresidentes: Isabel Bogado\nJorge Reinheimer\nMarta Tokumoto\nSecretarias Generales: Alicia Arechavala\nMar\u00eda Alejandra Picconi\nProsecretaria: Cristina Iovannitti\nTesorera: Adriana De Paulis\nProtesorera: Paula Gagetti\nSecretaria de Relaciones Institucionales: Daniela Centr\u00f3n\nSecretaria T\u00e9cnica: Adriana S\u00facari\nComisi\u00f3n T\u00e9cnica: Manuel G\u00f3mez Carrillo, Cecilia Quiroga y\nSoledad Ram\u00edrez\nSecretarios Cient\u00edficos: Liliana Guelfand\nHoracio Salom\u00f3n\nComisi\u00f3n Cient\u00edfica: Carlos Vay\nRepresentantes de las Divisiones en el Comit\u00e9 Cient\u00edfico y Comit\u00e9 Organizador\nDivisi\u00f3n Agr\u00edcola y Ambiental: In\u00e9s Garc\u00eda y Susana V\u00e1zquez\nDivisi\u00f3n DAMYC: Virginia Fern\u00e1ndez Pinto y Guillermo Guir\u00edn\nDivisi\u00f3n SADEBAC: Mirta Litterio y Magdalena Pennini\nDivisi\u00f3n SAV: Viviana Mbayed y Victoria Preciado\nVocales: Marina Bottiglieri (Filial  C\u00f3rdoba)\nPerla Hermida Lucena  (Filial Rosario)\n Luis Merino  (Filial NEA)\nAna Paris de Baeza  (Filial Sur)\nFrancisco Salamone  (Filial Santa Fe)\nAlejandro Sturniolo  (Filial Cuyo)\nA\u00edda Su\u00e1rez  (Filial NOA)\nPara m\u00e1s informaci\u00f3n y/o sugerencias puede contactarnos a\ninfo@aam.org.arXxxx 1 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2008) 40: --- XXX\nVOLUMEN 41  N\u00ba 4 \u25cf\u25cf\u25cf\u25cf\u25cf OCTUBRE-DICIEMBRE DE 2009\n* En ingl\u00e9s\u00cdNDICE\nEDITORIAL\nTransferencia e intercambio de conocimiento a trav\u00e9s de reuniones cient\u00edficas. Cerca del coraz\u00f3n\nde los amigos, lejos de las arcas del EstadoH.R. Morbidoni\nMICROBIOLOG\u00cdA B\u00c1SICA\n*Amplificaci\u00f3n del genoma completo del subtipo 2 del virus de la influenza equina\nG.H. Sguazza, N.A. Fuentealba, M.A. Tizzano, C.M. Galosi, M.R. Pecoraro\nMICROBIOLOG\u00cdA CL\u00cdNICA Y ENFERMEDADES INFECCIOSAS\nBrote de micoplasmosis cl\u00ednica por \nMycoplasma ovis en ovinos de Salta, Argentina. Diagn\u00f3stico\ncl\u00ednico, microbiol\u00f3gico y molecularD.H. Aguirre, C. Thompson, R.D. Neumann, A.O. Salatin,  A.B. Gaido, S. Torioni de Echaide\n*Mycobacterium bovis  en Argentina: aislamientos de gatos tipificados por spoligotyping\nM.J. Zum\u00e1rraga, M. Mart\u00ednez Vivot, D. Marticorena, A. Bernardelli, R. Fas\u00e1n, R. Iachini, A.A. Cataldi\n*Echinococcus granulosus : comparaci\u00f3n biol\u00f3gica de aislados de bovinos de regiones end\u00e9mi-\ncas de Argentina y Espa\u00f1aM.V. Andresiuk, F. Ponce Gordo, C. Cuesta Bandera, M.C. Elissondo, M. Dopchiz, G. Denegri\nAGENTES ANTIMICROBIANOS\n*Actividad antibacteriana y antioxidante del aceite esencial extra\u00eddo de \nArtemisia echegarayi  Hieron.\n(Asteraceae)A. Laciar, M.L. Vaca Ruiz, R. Carrizo Flores, J.R. Saad\nMICROBIOLOG\u00cdA DE ALIMENTOS\n*El t\u00e9 de tilo como veh\u00edculo potencial de esporas de \nClostridium botulinum en la transmisi\u00f3n del\nbotulismo infantil\nM.I. Bianco, C. L\u00faquez, L.I.T. de Jong, R.A. Fern\u00e1ndez\nModelo de contaminaci\u00f3n cruzada por Escherichia coli  verocitotoxig\u00e9nica durante la elaboraci\u00f3n\nde hamburguesas caseras y evaluaci\u00f3n cuantitativa de riesgosM.L. Signorini, L.S. Frizzo\nMICROBIOLOG\u00cdA INDUSTRIAL Y AMBIENTAL\n*Evoluci\u00f3n del contenido de ocratoxina A en vinos tintos argentinos durante el proceso de\nvinificaci\u00f3n a escala pilotoM.L. Ponsone, M.L. Chiotta, M. Combina, A.M. Dalcero, S.N. Chulze\nART\u00cdCULO ESPECIAL\nToxinas de \nClostridium perfringens\nW.E. Morris, M.E. Fern\u00e1ndez-Miyakawa\nIM\u00c1GENES MICROBIOL\u00d3GICAS\n*Efecto citop\u00e1tico en c\u00e9lulas BHK 21 (C13) inoculadas con Leptospira  interrogans  serovar Pomona\naislada de un aborto porcinoB. Brihuega, A. Venzano, O. Zabal, D. Funes, C. Auteri, G. Romero, L. Samartino\n*Consorcio bacteriano degradador de hidrocarburos aislado de suelos de Ant\u00e1rtida\nL.A.M. Ruberto, S.C. V\u00e1zquez, W.P. Mac Cormack\n\u00cdndice general del volumen 41\n\u00cdndice de temas\n\u00cdndice de autores\nAgradecimiento a revisoresFe de erratasInstrucciones para los autores203\n207\n212\n215\n218\n226\n232\n237\n245\n251\n261\n262\n263\n269\n271\n2722722732 Revista Argentina de Microbiolog\u00eda (2008) 40: ---\nVOLUMEN 41 N\u00ba 4 \u25cf\u25cf\u25cf\u25cf\u25cf OCTOBER-DECEMBER 2009\n* In EnglishINDEX\nEDITORIAL\nExchange of scientific information through scientific meetings: close to our friend\u00b4s hearts, far\naway from the purse of the StateH.R. Morbidoni\nGENERAL MICROBIOLOGY\n*Complete genome amplification of Equine influenza virus subtype 2\nG.H. Sguazza, N.A. Fuentealba, M.A. Tizzano, C.M. Galosi, M.R. Pecoraro\nCLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES\nClinical mycoplasmosis outbreak due to \nMycoplasma ovis  in sheep from Salta, Argentina. Clinical,\nmicrobiological and molecular diagnosisD.H. Aguirre, C. Thompson, R.D. Neumann, A.O. Salatin,  A.B. Gaido, S. Torioni de Echaide\n*Mycobacterium bovis  in Argentina: isolates from cats typified by spoligotyping\nM.J. Zum\u00e1rraga, M. Mart\u00ednez Vivot, D. Marticorena, A. Bernardelli, R. Fas\u00e1n, R. Iachini, A.A. Cataldi\n*Echinococcus granulosus : biological comparison of cattle isolates from endemic regions of Ar-\ngentina and SpainM.V. Andresiuk, F. Ponce Gordo, C. Cuesta Bandera, M.C. Elissondo, M. Dopchiz, G. Denegri\nANTIMICROBIAL AGENTS\n*Antibacterial and antioxidant activities of essential oil of \nArtemisia echegarayi Hieron. (Asteraceae)\nA. Laciar, M.L. Vaca Ruiz, R. Carrizo Flores, J.R. Saad\nFOOD MICROBIOLOGY\n*Linden flower ( Tilia spp.) as vehicle of Clostridium botulinum spores in the transmission of infant\nbotulismM.I. Bianco, C. L\u00faquez, L.I.T. de Jong, R.A. Fern\u00e1ndez\nQuantitative risk model for verocytotoxigenic \nEscherichia coli  cross-contamination during\nhamburger preparationM.L. Signorini, L.S. Frizzo\nINDUSTRIAL AND ENVIRONMENTAL MICROBIOLOGY\n*Fate of ochratoxin A content in Argentinean red wine during a pilot scale vinification\nM.L. Ponsone, M. Combina, A.M. Dalcero, S.N. Chulze\nSPECIAL ARTICLES\nToxins of \nClostridium perfringens\nW.E. Morris, M.E. Fern\u00e1ndez-Miyakawa\nMICROBIOLOGICAL IMAGES\n*Cytopathic effect in BHK 21 (C13) cells inoculated with Leptospira  interrogans  serovar Pomona\nisolated from a porcine abortionB. Brihuega, A. Venzano, O. Zabal, D. Funes, C. Auteri, G. Romero, L. Samartino\n*Bacterial hydrocarbon-degrading consortium from Antarctic soils\nL.A.M. Ruberto, S.C. V\u00e1zquez, W.P. Mac Cormack\nGeneral Index of volume 41\nSubject index\nIndex by authorAcknowledgement to reviewers\nErrata\nInstructions to authors203\n207\n212\n215\n218\n226\n232\n237\n245\n251\n261\n262\n263\n269271272272273Editorial 203 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 203-206 EDITORIAL\nTransferencia e intercambio de conocimiento a trav\u00e9s de\nreuniones cient\u00edficas: cerca del coraz\u00f3n de los amigos,\nlejos de las arcas del Estado\nAl poseedor de las riquezas no le hace dichoso el tenerlas, sino el\ngastarlas, y no el gastarlas como quiera, sino el saberlas gastar.\nMiguel de Cervantes\nMycobacterium  tuberculosis , la bacteria causante de la tuberculosis humana, es uno de los pat\u00f3genos\nm\u00e1s efectivos de la naturaleza, ya que una persona se puede infectar por la inhalaci\u00f3n de 1 a 5 bacilos.\nSin embargo, el sistema inmune puede r\u00e1pidamente controlar a este pat\u00f3geno e impedir la enfermedad.\nA\u00fan con este escenario, se estima que un tercio de la poblaci\u00f3n mundial est\u00e1 infectada, y que por a\u00f1o 10millones de personas enferman y 2 millones mueren a causa de esta bacteria (3). La incidencia de esta\npatolog\u00eda en la salud humana fue potenciada por los altos n\u00fameros de casos de enfermos infectados por\nvih que desarrollan Sida. Dado el efecto devastador del Sida sobre el sistema inmune, el bacilo tubercu-loso encuentra un hu\u00e9sped en el cual no existen barreras para su control y contenci\u00f3n. El tratamiento de\nla tuberculosis es extremadamente prolongado: requiere el empleo de cinco drogas durante dos meses,\nseguido por la administraci\u00f3n de dos drogas por espacio de cuatro meses; en otras palabras, m\u00faltiplestomas de numerosos medicamentos. Este hecho supone una gran dificultad en la adhesi\u00f3n al tratamien-\nto por parte del paciente, a lo que se suman otras circunstancias como la lejan\u00eda de los centros de salud,\nlos efectos secundarios de una o m\u00e1s drogas y, a\u00fan m\u00e1s grave, casos en los que el paciente comienzaa notar una mejor\u00eda f\u00edsica como resultado de los f\u00e1rmacos y suspende el tratamiento.\nEntre las estrategias implementadas por la Organizaci\u00f3n Mundial de la Salud se destaca aquella\nconocida como tratamiento acortado estrictamente supervisado o TAES, consistente en la observaci\u00f3ndirecta del cumplimiento del tratamiento (ingesti\u00f3n de los f\u00e1rmacos) a cargo de una persona entrenada\nperteneciente al sistema formal de salud o un voluntario debidamente capacitado para ese fin. El TAES\nest\u00e1 basado en cinco principios clave (5): intervenci\u00f3n organizada y sostenida, identificaci\u00f3n de casosen forma temprana y precisa, quimioterapia eficaz y f\u00e1cil de ser administrada, manejo eficaz de los\nmedicamentos y monitoreos basados en los resultados. Estos principios se cumplen a trav\u00e9s de los\ncomponentes del TAES como lo son el compromiso gubernamental para asegurar acciones de luchaantituberculosa completas y sostenidas, la detecci\u00f3n de casos en pacientes sintom\u00e1ticos mediante t\u00e9c-\nnicas microsc\u00f3picas, el tratamiento normalizado de corta duraci\u00f3n durante 6-8 meses, el suministro\nregular de f\u00e1rmacos antituberculosos, un sistema de comunicaci\u00f3n y registro normalizado para evaluarla detecci\u00f3n de casos y el resultado del tratamiento instaurado para cada paciente.\nEstas normas, junto con un plan de inversi\u00f3n de organismos oficiales nacionales y de organizaciones\nfilantr\u00f3picas, tienen como objetivo disminuir sensiblemente el n\u00famero de casos de tuberculosis y demuertes producidas por esta enfermedad en el mundo para el a\u00f1o 2015 (3). Al presente, los resultados\nfueron dispares, mientras la detecci\u00f3n y el tratamiento de nuevos casos ha funcionado eficientemente,\nya que se lleg\u00f3 a valores cercanos a los establecidos como metas, otros componentes como el avanceen la implementaci\u00f3n y planificaci\u00f3n en algunas regiones de \u00c1frica y Asia y, fundamentalmente, las\ndificultades en el tratamiento de las formas resistentes a las drogas han quedado lejos de los prop\u00f3sitos.\nDesde el punto de vista financiero, los fondos disponibles en el a\u00f1o 2008 fueron de 3.300 millones deUS$ para 90 pa\u00edses que concentran el 91% del total de casos de tuberculosis. Sin embargo, hubo204 Revista Argentina de Microbiolog\u00eda (2009) 41: 203-206\ndiferencias sustanciales entre los fondos requeridos y los percibidos por pa\u00edses donde las actividades de\nprogramas TB/vih y el manejo de casos de tuberculosis multirresistente (MDR-TB) requieren m\u00e1s dinero.\nEl progreso en la detecci\u00f3n de casos comenz\u00f3 a declinar en t\u00e9rminos globales en 2006, sobre todo\nen China e India, y sigue siendo bajo en \u00c1frica; esto indica la perentoria necesidad de acelerar losavances en el control global de la tuberculosis si se quiere alcanzar las metas propuestas en un lapso\nrazonable. Sin embargo, una de las razones que impide la concreci\u00f3n de estos objetivos es la diferencia\nen asignaci\u00f3n y uso de fondos en Asia y Europa.\nEn Argentina, durante el a\u00f1o 2007 se notificaron 10.683 casos de tuberculosis (tasa 27,14/100.000\nhabitantes), mientras que 805 personas fallecieron debido a esta enfermedad (tasa 2,07/100.000 habi-\ntantes) durante el a\u00f1o 2006. Aunque las cifras no son necesariamente alarmantes para el lector, llev\u00f3m\u00e1s de 15 a\u00f1os reducir a casi la mitad (60/100.000 habitantes en 1990 contra 31/100.000 habitantes en\n2007) la incidencia de esta enfermedad en nuestro pa\u00eds. Al mismo tiempo, datos locales de Santa Fe\nrevelan la aparici\u00f3n de casos de tuberculosis en los cuales las cepas aisladas fueron resistentes am\u00faltiples drogas (MDR-TB), definidas como resistentes a las drogas pilares del tratamiento antituberculoso\n(drogas de primera l\u00ednea), isoniacida y rifampicina. Lo preocupante de esta situaci\u00f3n no es la\nmultirresistencia en s\u00ed, sino la detecci\u00f3n en pacientes no tratados previamente, ni encuadrados en lo quese denomina factores de riesgo (institucionalizaci\u00f3n, contacto con familiar enfermo, tratamiento previo\nabandonado, uso de drogas, entre otros). En definitiva, la batalla sigue y requiere medidas m\u00e1s r\u00e1pidas\nde detecci\u00f3n y control.\nSiendo esta una revista cuya tem\u00e1tica se enfoca en la microbiolog\u00eda, a esta altura del presente art\u00edcu-\nlo editorial el lector posiblemente se pregunte el porqu\u00e9 de un comentario sobre planes mundiales para\nel control de la tuberculosis. Hablemos entonces de microbiolog\u00eda\u2026\nRecordemos que \nM. tuberculosis  tarda 30 d\u00edas en formar colonias en medios s\u00f3lidos, por lo que su\ndetecci\u00f3n se hace mediante microscop\u00eda \u00f3ptica, y que la sensibilidad de este procedimiento depende\ndel n\u00famero de bacilos presentes en la muestra. La otra opci\u00f3n es sembrar la muestra e incubarla hasta\n60 d\u00edas, antes de poder informarla como bacteriol\u00f3gicamente negativa. La determinaci\u00f3n de la sensibi-\nlidad a drogas de los aislamientos cl\u00ednicos de M. tuberculosis  requiere, de la misma manera, tiempos\nlargos. Los avances metodol\u00f3gicos hicieron posible la detecci\u00f3n y determinaci\u00f3n de la sensibilidad a\ndrogas en plazos m\u00e1s cortos, de alrededor de 12 d\u00edas, gracias al empleo de equipos especiales automa-\ntizados o semiautomatizados (2, 4). Sin embargo son costosos y, por consiguiente, no est\u00e1n disponiblesen todas las unidades de diagn\u00f3stico, sino s\u00f3lo en los centros de referencia que, al concentrar muestras\nde distintas procedencias, justifican la inversi\u00f3n.\nUno de los temas que requieren la atenci\u00f3n m\u00e1s urgente es el de la detecci\u00f3n de cepas MDR. M\u00e1s\na\u00fan, recientemente se han informado cepas resistentes a drogas de primera y de segunda l\u00ednea (1). En\nconsecuencia, la escasa cantidad de opciones terap\u00e9uticas frente a estas cepas deja pocas posibilida-\ndes de tratamiento. En este contexto, los dos objetivos fundamentales en la lucha contra la tuberculosisson la detecci\u00f3n precoz de la enfermedad y la determinaci\u00f3n de la sensibilidad a drogas lo m\u00e1s r\u00e1pido\nposible.\nLa Sociedad Latinoamericana y del Caribe de Tuberculosis y otras Micobacteriosis (SLAMTB) fue\nfundada en Buenos Aires en setiembre de 2005. Esta instituci\u00f3n es producto de 10 a\u00f1os de intensa\ncooperaci\u00f3n e intercambio expresados inicialmente a trav\u00e9s de la Red Latinoamericana y del Caribe de\nTuberculosis (RELACTB) y luego a trav\u00e9s del proyecto de colaboraci\u00f3n financiado por la Uni\u00f3n Europeadenominado \nImproved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America .\nSon parte de esa instituci\u00f3n 50 investigadores de 10 pa\u00edses de la regi\u00f3n, as\u00ed como varios procedentes\nde 4 pa\u00edses de Europa. Como sociedad abierta ha generado a lo largo de los \u00faltimos a\u00f1os colaboracio-nes que han sido utilizadas en la implementaci\u00f3n de pasos concretos para el diagn\u00f3stico de la tubercu-\nlosis humana y animal, y que contin\u00faan teniendo un alto impacto social y econ\u00f3mico en  varios pa\u00edses.Editorial 205\nHasta el momento, esta sociedad ha funcionado como sat\u00e9lite de las reuniones anuales o peri\u00f3dicas\nde la Sociedad Latinoamericana de Microbiolog\u00eda (ALAM); sin embargo, debido a la especificidad de sus\nobjetivos y a su crecimiento, ha comenzado su actividad en forma independiente. Por ello, luego de tres\nreuniones previas (Puc\u00f3n, Chile, 2006; Brasilia, Brasil, 2007 y Bogot\u00e1, Colombia, 2008) lleg\u00f3 la hora deorganizar nuestra primera reuni\u00f3n independiente en 2009. Esto constituy\u00f3 un gran desaf\u00edo log\u00edstico y\necon\u00f3mico, en el cual fuimos apoyados por la buena voluntad de muchos investigadores de gran pres-\ntigio internacional, deseosos de incrementar sus colaboraciones con nosotros.\n La IV Reuni\u00f3n de la SLAMTB tuvo lugar del 5 al 8 de octubre de este a\u00f1o en Rosario, y cubri\u00f3 desde\naspectos b\u00e1sicos como la patogenicidad de las micobacterias, la epidemiolog\u00eda de la distribuci\u00f3n de\ncepas y su nivel de resistencia a drogas hasta la tem\u00e1tica de las nuevas herramientas de diagn\u00f3stico ylas drogas para el tratamiento, entre otros t\u00f3picos. Adem\u00e1s de los asistentes nacionales, se hicieron\npresentes m\u00e1s de 40 disertantes extranjeros y 80 participantes de Latinoam\u00e9rica, por lo que esta re-\nuni\u00f3n se posicion\u00f3 como un evento cient\u00edfico de relevancia internacional, con un total de m\u00e1s de 250asistentes. Es importante destacar que contamos con la presencia de miembros de los servicios de\ndiagn\u00f3stico microbiol\u00f3gico de los hospitales de nuestro pa\u00eds, en especial de Rosario y Buenos Aires, los\ncuales tuvieron acceso a esta oportunidad \u00fanica de participar, aprender y debatir el uso de nuevast\u00e9cnicas de diagn\u00f3stico y de determinaci\u00f3n de la sensibilidad a drogas.\nCon ese fin decidimos que no hubiera costo de inscripci\u00f3n ni de asociaci\u00f3n, de modo que fue una\nreuni\u00f3n de libre acceso. Aunque entendimos las dificultades econ\u00f3micas presentes en nuestro pa\u00eds,explicitamos ante distintos sectores p\u00fablicos y privados la naturaleza del evento y su gran repercusi\u00f3n\ncient\u00edfica y p\u00fablica. Si bien este evento increment\u00f3 la transferencia de conocimiento, nos dej\u00f3 en una\nposici\u00f3n financiera vulnerable al no contar con fondos propios.\nSabemos que la baja contribuci\u00f3n de los organismos estatales afect\u00f3 no s\u00f3lo a esta reuni\u00f3n, ya que\nmuchas otras recibieron fondos insuficientes (del orden de hasta $5.000) o escasos (por debajo de\n$15.000) (6), girados en su gran mayor\u00eda con posterioridad al cierre del evento cient\u00edfico.\nA pesar de la falta de aportes econ\u00f3micos de los sectores estatales de salud p\u00fablica, a los cuales iba\ndirigida la informaci\u00f3n, la reuni\u00f3n fue un \u00e9xito acad\u00e9mico y cient\u00edfico que gener\u00f3 elogios por parte detodos los participantes, y se llev\u00f3 a cabo con s\u00f3lo $ 15.000 aportados por el CONICET y algunas contri-\nbuciones realizadas por un pu\u00f1ado de empresas locales.\nEn particular, una de las consecuencias del bajo presupuesto asignado a nuestra reuni\u00f3n fue que\nvarios estudiantes y profesionales no tuvieron cabida, ya que no se pudo cubrir el costo de salones de la\nsuficiente capacidad f\u00edsica. Sin embargo, entre los puntos que deben destacarse se encuentran la asis-\ntencia de profesionales de los programas de tuberculosis de distintas provincias argentinas y de pa\u00edsesvecinos como Paraguay y Bolivia, as\u00ed como la generosa actitud de investigadores miembros del progra-\nma CYTED \u2013Programa Iberoamericano de Ciencia y Tecnolog\u00eda para el Desarrollo\u2013 del Instituto Pasteur\nde Francia, y de las Universidades de Alabama en Birmingham, de California San Francisco y de Pittsburgh,EE.UU., que pagaron con fondos propios la mayor\u00eda de sus gastos de viaje y estad\u00eda.\nEl mayor m\u00e9rito de esta reuni\u00f3n radica en haber transferido informaci\u00f3n relevante para el diagn\u00f3stico\nde tuberculosis a personal que, caso contrario, no hubiera tenido acceso a ella, ya que una reuni\u00f3nsimilar en Europa o Estados Unidos tiene un costo promedio de inscripci\u00f3n de 400 USD. Quiz\u00e1s haya-\nmos pecado de ingenuos al pensar que obtendr\u00edamos mayor ayuda de organismos estatales o de insti-\ntuciones de naturaleza filantr\u00f3pica.\nDesde este lugar y como Presidente del Comit\u00e9 Organizador de la IV Reuni\u00f3n de la SLAMTB, quiero\nagradecer a todos aquellos que con su ayuda hicieron posible el objetivo de difundir el conocimiento y\nestimular las interacciones entre los distintos grupos de ciencia b\u00e1sica y de diagn\u00f3stico. Sin embargo,cabe citar una de las frases dichas por el Dr. Manuel Carrillo: \u201c\nSolo sirven las conquistas cient\u00edficas\nsobre la salud si \u00e9stas son accesibles al pueblo \u201d (7). Al respecto, quisiera agregar que para que esto206 Revista Argentina de Microbiolog\u00eda (2009) 41: 203-206\nsuceda, primero deben hallar su camino desde el laboratorio donde se desarrollaron las t\u00e9cnicas (las\n\u201cconquistas\u201d) hasta los servicios que masificar\u00e1n su uso en pos del bienestar de la comunidad. S\u00f3lo un\napoyo econ\u00f3mico adecuado por parte del Estado a las reuniones cient\u00edficas permitir\u00e1 que las innovacio-\nnes tecnol\u00f3gicas y cient\u00edficas puedan ser aprovechadas para mejorar la salud y la calidad de vida de laspersonas.\nH\u00c9CTOR RICARDO MORBIDONI\nC\u00e1tedra de Microbiolog\u00eda, Virolog\u00eda y Parasitolog\u00eda\nFacultad de Ciencias M\u00e9dicas\nUniversidad Nacional de Rosario, Argentina.\nE-mail: morbiatny@yahoo.com\n1. Abubakar I, Moore J, Drobniewski F, Kruijshaar M, Brown\nT, Yates M, et al  Extensively drug-resistant tuberculosis in\nthe UK: 1995 to 2007. Thorax 2009; 64: 512-5.\n2. Lin SY, Desmond E, Bonato D, Gross W, Siddiqi SJ.\nMulticenter evaluation of Bactec MGIT 960 system forsecond-line drug susceptibility testing of \nMycobacterium tu-\nberculosis  complex. J Clin Microbiol 2009; 47: 3630-4.\n3. Organizaci\u00f3n Mundial de la Salud 2009. Global tuberculosis\ncontrol: epidemiology, strategy, financing. WHO report 2009.\n4. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner\nTH, McClatchy JK, et al. Evaluation of the BACTECradiometric method for recovery of mycobacteria and drug\nsusceptibility testing of Mycobacterium tuberculosis from\nacid-fast smear-positive specimens. J Clin Microbiol 1983;18: 689-96.\n5. Smith, I. En Frieden, T, editor. Tuberculosis: detecci\u00f3n de\ncasos, tratamiento y vigilancia: preguntas y respuestas: (Pu-blicaci\u00f3n Cient\u00edfica y T\u00e9cnica No. 617. OPS) Kurt Toman.2\u00aa ed. Washington, D.C., 2006.\n6. http://www.agencia.gov.ar/IMG/pdf/RC_listado_\nreuniones_financiadas.pdf\n7. http:///www.lagazeta.com.ar/carrillo.htmGenome amplification of Influenza virus 207 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 207-211 INFORME BREVE\nComplete genome amplification of Equine\ninfluenza virus subtype 2\nG. H. SGUAZZA1*, N. A. FUENTEALBA1, 2, M. A. TIZZANO1, 3, C. M. GALOSI1, 3, M. R. PECORARO1.\n1C\u00e1tedra de Virolog\u00eda, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata;\n2Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET); 3Comisi\u00f3n de Investigaciones Cient\u00edficas de la\nProvincia de Buenos Aires (CIC), Argentina.\n*Correspondence. E-mail: sguazza@fcv.unlp.edu.ar\nABSTRACT\nThis work reports a method for rapid amplification of the complete genome of equine influenza virus subtype 2 (H3N8).\nA ThermoScriptTM reverse transcriptase instead of the avian myeloblastosis virus reverse transcriptase or Moloney\nmurine leukemia virus reverse transcriptase was used. This enzyme has demonstrated higher thermal stability and isdescribed as suitable to make long cDNA with a complex secondary structure. The product obtained by this methodcan be cloned, used in later sequencing reactions or nested-PCR with the purpose of achieving a rapid diagnosis andcharacterization of the equine influenza virus type A. This detection assay might be a valuable tool for diagnosis andscreening of field samples as well as for conducting molecular studies.\nKey words:  Equine influenza virus, genome, diagnosis, RT-PCR\nRESUMEN\nAmplificaci\u00f3n del genoma completo del subtipo 2 del virus de la influenza equina. En este trabajo comunicamos\nun m\u00e9todo r\u00e1pido que permite la amplificaci\u00f3n del genoma completo del subtipo 2 (H3N8) del virus de la influenzaequina. Se utiliz\u00f3 la enzima transcriptasa reversa ThermoScript\nTM en lugar de la transcriptasa reversa del virus de la\nmieloblastosis aviar o la transcriptasa reversa del virus de la leucemia murina de Moloney. Esta enzima ha demostradotener una alta estabilidad t\u00e9rmica y la capacidad de hacer largas copias de ADN con una estructura secundariacompleja. El producto obtenido por esta t\u00e9cnica puede ser clonado y utilizado posteriormente en reacciones desecuenciaci\u00f3n o de PCR anidada con la finalidad de lograr un diagn\u00f3stico r\u00e1pido y la caracterizaci\u00f3n del virus de lainfluenza equina tipo A. Este ensayo de detecci\u00f3n puede llegar a ser una valiosa herramienta para el diagn\u00f3stico y elan\u00e1lisis de muestras de campo, as\u00ed como para la realizaci\u00f3n de estudios moleculares.\nPalabras clave: Virus de la influenza equina, Genoma, Diagn\u00f3stico, RT-PCR\nC\u00e1tedra de Virolog\u00eda, Facultad de Ciencias Veterinarias, Universidad Na-\ncional de La Plata 60 & 118, La Plata, CP 1900, Buenos Aires, ArgentinaTelephone and fax number: 54 221 4257980Influenza viruses belong to the Orthomyxoviridae family\nand are classified into three great types: A, B, and C,according to antigenic differences in their nucleoprotein(NP) and matrix (M) proteins. Influenza viruses types Band C are predominantly human pathogens that have alsobeen isolated from seals and pigs, respectively. On theother hand influenza viruses type A have been isolatedfrom many species including humans, pigs, horses, mar-ine mammals and a wide range of domestic and wild birds(10). Influenza viruses type A can be further subdiv-ided in different serologically differentiated subtypesaccording to the structure and composition of two antigenicglycoproteins located in the surface of the virion: haemag-glutinin (HA) involved in binding of the virus to host cellsand neuraminidase (NA) implicated in release of virusfrom infected cells. At present, 16 HA and 9 NA subtypes\nhave been identified among influenza A viruses. All thesesubtypes are found in avian species. However, only twoequine influenza virus subtypes have been associatedwith the disease in horses, the H7N7 subtype (equi-1)and the H3N8 subtype (equi-2). The H7N7 subtype wasfirst isolated from horses in Czechoslovakia in 1956 (pro-totype strain: A/equine1/Prague/56); later it was isolatedin many countries of Europe and America. Although thissubtype has not been isolated since 1980, it may still cir-culate in subclinical form and persist at very low levels insome parts of the world (10). The H3N8 subtype of equineinfluenza virus was first isolated in 1963 during an out-break of this disease in Miami (prototype strain: A/equine2/Miami/63) and can be found in different parts of the world,except in Australia, New Zealand, and Iceland. Recentstudies of the H3N8 subtype of equine influenza viruseshave demonstrated that these strains have diverged intotwo distinct evolutionary lineages (2).208 Revista Argentina de Microbiolog\u00eda (2009) 41: 207-211\nThe genome of equine influenza A virus contains eight\nlinear segments of negative stranded RNA (about 13.6kb). Six segments code for single proteins: the three viralpolymerases (PA, PB1 and PB2), HA, NA and NP. Theother two segments codify two proteins, one segment formatrix 1 and 2 (M1 and M2) and the other segment fornon-structural protein 1 (NS1) and nuclear export protein(NEP) (5).\nThe analysis of virion RNA from influenza A strains\nindicates that all eight RNA segments contain a commonsequence of 13 nucleotides at the 3' terminus and an-other common sequence of 12 nucleotides at the 5' ter-minus (3, 9). No homologies can be found among seg-ments. On these bases, the aim of this work was to de-velop a rapid method that allows the genetic characteriz-ation of the whole genome of influenza virus using a proce-dure of reverse transcription followed by the amplificationof all viral segments through polymerase chain reaction(RT-PCR).\nThe standard method for diagnosis of influenza is the\nisolation of influenza virus particles using embryonatedchicken eggs or Madin-Darby canine kidney cells (MDCK).This system has the disadvantage of requiring 4-6 daysfor completion. The complete genome amplification byRT-PCR reported in this paper followed by subsequentamplicon sequencing is a more versatile method becauseit allows obtaining more detailed information about circul-ating strains and it will help in the virus surveillance.To amplify the influenza virus genome, two primers\nbased on the highly conserved non-coding sequences atthe 5\u00b4 and 3\u00b4 end present in all viral genomic segments ofinfluenza A virus were used, according to the consensussequence regions previously reported (3, 9) and widelyused to amplify the complete genome of human and avianinfluenza A virus (4) and equine influenza A virus subtype1 (1). To confirm the presence of those conserved regionsin the genome of equine influenza subtype 2, 50 differentsequences of all segments from the viral genome retrievedfrom the GenBank at the National Center of Biotechnol-ogy Information (http://www.ncbi.nlm.nih.gov) were com-pared by multiple alignment using the CLUSTAL X (v1.8)software.\nThe consensus regions were identified as suitable\nsequences for use as primers in RT-PCR, and the oligo-nucleotide primers were subsequently commercially syn-thesized (Integrated DNA Technologies, Coralville, IA,USA). The primers used in this work were a 12-mer primerUFLU-S 5\u00b4AGCAAAAGCAGG 3\u00b4 and a 13-mer primerUFLU-AS 5\u00b4AGTAGAAACAAGG 3\u00b4 (Fig. 1).\nAn equine influenza virus strain, A/Equine-2/La Plata/\n2001 (H3N8), previously isolated in our laboratory duringthe year 2001, was used. The virus was propagated inthe allantoic cavity of 11-day-old embryonated hen\u2019s eggsderived from a healthy flock.\nTotal RNA was extracted using Trizol reagent (GIBCO\nBRL, Gaithersburg, MD, USA). In brief, 500 \u00b5l of allantoic\nFigure 1. Alignment of non-coding terminal regions of the eight segments of Influenza A virus (A/equine-2/Kentucky/5/02. GenBank\naccession numbers AY855340, AY855339, AY855338, AY855341, AY855342, AY855343, AY855344 and AY855345 respectively).The 5\u00b4 terminus of each segment has 12 conserved nucleotides (A), and the 3\u00b4 terminus has 13 conserved nucleotides (B).Genome amplification of Influenza virus 209\nfluid (haemagglutination titre 1:128) were mixed with 500\n\u00b5l of Trizol reagent. The mixture was extracted with 220\u00b5l of chloroform. After centrifugation at 10000 x g for 10minutes, the RNA in the aqueous solution was precipitatedby adding an equal volume of isopropanol. The precipi-tated RNA was collected by centrifugation at 10000 x gfor 20 minutes, washed by 70% ethanol, dissolved in 50\u00b5l of RNAse-free water and measured by spectrophotom-eter (SmartSpec 3000, BIO-RAD, Hercules, CA, USA).RNA extracted from uninfected allantoic fluid was usedas negative control. Total RNA and control RNA (375.06ng/\u00b5l and 225.52 ng/\u00b5l respectively) were used for fol-lowing steps.\nOne microgram of each RNA was used to produce a\nsingle-strand copy of DNA (ssDNA). This reaction wascarried out using the avian myeloblastosis virus (AMV)reverse transcriptase (Promega Corporation, Madison,WI, USA), the Moloney murine leukemia virus (M-MMLV)reverse transcriptase (Promega) and the ThermoScriptRT-PCR System kit (Invitrogen-Life Technologies, Bue-nos Aires, Argentina) under conditions specified by thesuppliers, using a concentration 0.5 \u00b5M of the universalprimer complementary to the conserved 3\u2019 end of allvirus segments (UFLU-S).\nThe single-strand DNA (ssDNA) obtained with AMV,\nM-MLV and RT-ThermoScript was used directly as tem-plate in the PCR reaction whereas the cDNA generatedby RT-ThermoScript was additionally employed for mak-ing a double-strand DNA copy (dsDNA) in agreement withthe supplier\u2019s suggestion.\nThe second chain of DNA was synthesized using 3 \u00b5l\nof ssDNA previously obtained (approximately 100 ng) ina reaction mixture containing: 75 mM Tris-HCl (pH 8.8),20 mM (NH\n4)2SO4, 0.01% Tween 20, 200 \u00b5M of each\ndNTPs, 1.5 mM of MgCl2 and 0.5 \u00b5M of UFLU-AS primer\nin a final volume of 24.5 \u00b5l. The mixture was incubated at95 \u00b0C during 4 minutes, followed by the addition of 0.5 \u00b5l(2.5 U) of Taq DNA polymerase (Fermentas Inc, GlenBurnie, MD, USA) and it was incubated at 65 \u00b0C during20 minutes.\nThe PCR reaction was performed by adding 5 \u00b5l from\nthe ssDNA or dsDNA to a reaction mixture containing afinal concentration of 75 mM Tris-HCl (pH 8.8), 20 mM(NH\n4)2SO4, 0.01% Tween 20, 200 \u00b5M of each one of\ndNTPs, 0.5 \u00b5M of each one of primers (UFLU-S andUFLU-AS), a variable concentration of MgCl\n2 (1, 1.5, 2\nand 2.5 mM) and variable percentages of dimethil sulfoxide(0, 5 and 10% of DMSO) in a final volume of 49.5 \u00b5l.\nThe mixture was heated at 95\u00b0C during 4 minutes and\nincubated with variable annealing temperatures (38, 40,42 and 44 \u00b0C) for 2 minutes, then 0.5 \u00b5l (2.5 U) from TaqDNA polymerase (Fermentas) were added. The amplificationprogram started with 1 cycle at 65 \u00b0C for 10 minutes, fol-lowed by 40 cycles at 92 \u00b0C for 2 minutes, the same an-nealing temperature initially used for 2 minutes, and 65 \u00b0Cfor 10 minutes; the program ended with one cycle at 72 \u00b0C\nfor 10 minutes. The PCR product was run on agarose gel(1.5%) at 50 V during 6 hours, and the gel was stainedwith ethidium bromide and visualized with a UV transillu-minator.\nTo evaluate the efficiency among reverse transcrip-\ntases AMV, M-MLV and ThermoScript, a protocol wasused to amplify the whole genome of equine influenzavirus. Improved results were observed when using dsDNAgenerated by ThermoScript-RT. When the ssDNA templateobtained from AMV, M-MLV and ThermoScript was used,only a few bands could be observed in agarose gel (Fig. 2)corresponding to small size fragments of the genome.\nThe optimum PCR reaction was obtained by adding 5\n\u00b5l from the dsDNA to a reaction mixture containing a finalconcentration of 75 mM Tris-HCl (pH 8.8), 20 mM(NH\n4)2SO4, 0.01% Tween 20, 200 \u00b5M of each  dNTP, 1.5\n\u00b5M of MgCl2, 0.5 \u00b5M of each primer, 10% of DMSO and\n2.5 U of Taq DNA polymerase.\nAn improved PCR amplification was carried out by\nheating the PCR mixture at 95 \u00b0C during 4 minutes, an-\nFigure 2. RT-PCR using ssDNA as template: Lanes 3, 4 and 6:\namplicon obtained from AMV, M-MLV and RT-ThermoScript;Lanes 1, 2 and 7: negative controls (RNA from uninfected allantoicfluid) obtained from AMV, M-MLV and ThermoScript RT,respectively. Lane 5: molecular size marker ( \u03bb EcoRI-HindIII\nMarker - Promega).\n210 Revista Argentina de Microbiolog\u00eda (2009) 41: 207-211\nFigure 3. RT-PCR using dsDNA as template: Lane 1: molecular\nsize marker ( \u03bb EcoRI-HindIII Marker - Promega); Lane 2: RT-\nPCR product.\nnealing at 40 \u00b0C for 2 minutes and then adding 0.5 \u00b5l (2.5\nU) from Taq DNA polymerase (Fermentas). The amplifi-cation program started with 1 cycle at 65 \u00b0C for 10 min-utes, followed by 40 cycles at 92 \u00b0C for 2 minutes, 40 \u00b0Cfor 2 minutes, and 65 \u00b0C for 10 minutes and a final exten-sion at 72 \u00b0C for 10 minutes\nThe eight segments of equine influenza subtype 2 were\namplified simultaneously using primers UFLU-S andUFLU-AS (Fig. 3). No amplified DNA was observed fromthe RNA negative control. Bands corresponding to basicpolymerases (PB2 and PB1, segments 1 and 2 respec-tively) could not be clearly differentiated from each otherbecause they were the same size (2341 bp each). It wasfollowed by a band belonging to the acid polymerase (PA)of 2233 bp, segment 4 (HA) with 1778 bp, segment 5\n(NP) of 1565 bp, segment 6 (NA) with 1413 bp, segment7 (M) of 1027 bp and, at the end, a band belonging tosegment 8 (NS) which showed an increased PCR prod-uct amount probably due to its smaller size.\nIn this study, the amplification conditions for the com-\nplete EIV genome were improved. The data presented inthis paper demonstrate that this method could be a help-ful tool in the surveillance of the equine influenza virusand appropriate for cloning the eight genomic segments,which will facilitate large-scale EIV genome sequencingand greatly ease systematic genetic analyses of thevirus. Adeyefa et al. (1) have described a multiplex RT-PCR method in which 12-mer and 13-mer oligonucleotidescomplementary to the conserved regions were used,resulting in simultaneous amplification of all of the eightRNA segments of Equine Influenza virus subtype 1. Inthis work, a ThermoScript RT instead of AMV or M-MLVRT was used to amplify the full length genome of equineinfluenza virus subtype 2 (H3N8). This enzyme has higherthermal stability and is described as suitable to make longcDNA with complex secondary structure.\nThe product obtained by this method can be cloned\nand used in later sequencing reactions  or nested-PCRwith the purpose of achieving a rapid diagnosis and char-acterization of the equine influenza virus type A (1, 8).\nThis test is much faster than the isolation of the virus\nfrom nasopharyngeal swabs/washings using embryonatedeggs or cell cultures and the possibility of automation willallow handling a large number of clinical samples moreconveniently than with serological tests (7, 8).\nRT-PCR might be useful in detecting inapparent, sub-\nclinical infection in animals that contribute to the spreadof the virus. Accurate identification of infected animalsand inapparent carriers is essential for the control of thisdisease.\nREFERENCES\n1. Adeyefa CA, Quayle K, McCauley JW. A rapid method for\nthe analysis of influenza virus genes: application to thereassortment of equine influenza virus genes. Virus Res1994; 32: 391-9.\n2. Daly JM, Lai AC, Binns MM, Chambers TM, Barrandeguy\nM, Mumford JA. Antigenic and genetic evolution of equineH3N8 influenza A viruses. J Gen Virol 1996; 77: 661-71.\n3. Desselberger U, Racaniello VR, Zazra JJ, Palese P. The 3\u2019\nand 5\u2019-terminal sequences of influenza A, B and C virusRNA segments are highly conserved and show partialinverted complementarity. Gene 1980; 8: 315-28.\n4. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR.\nUniversal primer set for the full-length amplification of allinfluenza A viruses. Arch Virol 2001; 146: 2275-89.\n5. McCauley JW, Mahy BW. Structure and function of the in-\nfluenza virus genome. Biochem J 1983; 211: 281-94.\nGenome amplification of Influenza virus 211\nRecibido: 28/04/09 \u2013 Aceptado: 22/09/096. Oxburgh L, Klingeborn B. Cocirculation of two distinct\nlineages of equine influenza virus subtype H3N8. J ClinMicrobiol 1999; 37: 3005-9.\n7. Oxburgh L, Hagstr\u00f6m A. A PCR based method for the\nidentification of equine influenza virus from clinical samples.Vet Microbiol 1999; 67: 161-74.\n8. Quinlivan M, Cullinane A, Nelly M, Van Maanen K, Heldens\nJ, Arkins S. Comparison of sensitivities of virus isolation,antigen detection, and nucleic acid amplification for detection\nof equine influenza virus. J Clin Microbiol 2004; 42: 759-63.\n9. Skehel JJ, Hay AJ. Nucleotide sequences at the 5' termini\nof influenza virus RNAs and their transcripts. Nucleic AcidsRes 1978; 5: 1207-19.\n10. Webster RG, Bean WJ, Gorman OT, Chambers TM,\nKawaoka Y. Evolution and ecology of influenza A viruses.Microbiol Rev 1992; 56: 152-79.212 Revista Argentina de Microbiolog\u00eda (2009) 41: 212-214 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 212-214 INFORME BREVE\nBrote de micoplasmosis cl\u00ednica por Mycoplasma ovis  en\novinos de Salta, Argentina. Diagn\u00f3stico cl\u00ednico,\nmicrobiol\u00f3gico y molecular\nD. H. AGUIRRE*1, C. THOMPSON2, R. D. NEUMANN1, A. O. SALATIN1, A. B. GAIDO1,\nS. TORIONI de ECHAIDE2\n1Estaci\u00f3n Experimental Agropecuaria Salta, CC 228 (4400) Salta, 2Estaci\u00f3n Experimental Agropecuaria Rafaela,\n(2300) Rafaela, Santa Fe; Instituto Nacional de Tecnolog\u00eda Agropecuaria, Argentina.\n*Correspondencia. E-mail: daguirre@correo.inta.gov.ar\nRESUMEN\nMycoplasma ovis  es un par\u00e1sito obligado de los eritrocitos de los peque\u00f1os rumiantes (ovinos, caprinos), en los que\nproduce anemia cr\u00f3nica o aguda. Su distribuci\u00f3n es mundial, aunque se desconoce la difusi\u00f3n de esta bacteria en laArgentina. Este trabajo describe un brote de micoplasmosis en un reba\u00f1o ovino de la localidad salte\u00f1a de Rosario dela Frontera, ocurrido en enero de 2007. Durante ese brote result\u00f3 afectada la categor\u00eda de ovinos adultos, con unamortalidad del 17,8%. El diagn\u00f3stico en extendidos de sangre (tinci\u00f3n de Giemsa) revel\u00f3 peque\u00f1os cuerpos bas\u00f3filos,caracter\u00edsticos de la infecci\u00f3n por \nM. ovis, en todas las muestras examinadas (n = 11), lo que indica una alta preva-\nlencia de la infecci\u00f3n en la majada. El diagn\u00f3stico molecular (n = 9) confirm\u00f3 los hallazgos mediante la amplificaci\u00f3nde dos fragmentos del gen 16S rRNA. Este representa el tercer registro del microorganismo en la Argentina y elprimero con expresi\u00f3n cl\u00ednica a escala poblacional (reba\u00f1o).\nPalabras clave:\n Mycoplasma ovis , ovinos, brote, Argentina\nABSTRACT\nClinical mycoplasmosis outbreak due to Mycoplasma ovis  in sheep from Salta, Argentina. Clinical,\nmicrobiological and molecular diagnosis. Mycoplasma ovis is an obligatory parasite of the erythrocytes from small\nruminants (sheep, goat), wherein it causes chronic or acute anaemia. This agent shows worldwide distribution. However,its dispersion is still unknown in Argentina. This work describes an outbreak of mycoplasmosis occurred in January2007 in a sheep flock from Rosario de la Frontera, Salta, Argentina. Adult sheep became ill with a mortality rate of17.8%. All blood smears (n = 11) examined by Giemsa stain showed the presence of small basophile bodies characteristicof \nM. ovis infection, indicating a high prevalence of the infection in the flock. The molecular diagnosis (n = 9) confirmed\nthe findings through the amplification of two fragments from the 16S rRNA gene. This is the third report of M. ovis in\nArgentina and the first one concomitant with clinical signs at flock level.\nKey words:  Mycoplasma ovis , sheep, outbreak, Argentina\nMycoplasma ovis , hasta hace poco Eperythrozoon ovis ,\nes una bacteria pleom\u00f3rfica y un par\u00e1sito obligado de loshemat\u00edes de ovinos y caprinos, no cultivable en mediosartificiales. Hoy integra el grupo de micoplasmas conocidocomo hemoplasmas, con rasgos patog\u00e9nicos antes noconsiderados entre los Mollicutes (8, 9). Este agente fuedescrito en 1934 por Neitz \net al. (10) en Sud\u00e1frica, y des-\nde entonces se lo diagnostic\u00f3 en todo el mundo (8, 9). EnArgentina, las \u00fanicas referencias previas de \nM. ovis co-\nrresponden a las regiones Noreste, provincia de Corrien-tes (15), y Noroeste, provincia de Salta (1).\nEsta bacteria se transmite por artr\u00f3podos hema-\nt\u00f3fagos y por f\u00f3mites. Hasta ahora son pocas las espe-cies de vectores comprobadas, que comprenden garra-patas (\nHaemaphysalis plumbeum  y Rhipicephalus bursa )y mosquitos ( Aedes camptorhynchus  y Culex annulirostris )\n(9). Mycoplasma ovis  se puede trasmitir tambi\u00e9n de ma-\nnera artificial por el uso de instrumental com\u00fan en distin-tas pr\u00e1cticas ganaderas, como vacunaciones, esquila oaplicaci\u00f3n de caravanas (2, 8).\nLa infecci\u00f3n por \nM. ovis es generalmente asintom\u00e1tica,\naunque se han descrito cuadros cl\u00ednicos de curso cr\u00f3ni-co y agudo. La forma cr\u00f3nica se caracteriza por anemiamoderada, fatiga y menor producci\u00f3n de carne y lana (3,4). En animales portadores, la anemia puede eventual-mente acentuarse por estr\u00e9s, inmunosupresi\u00f3n o enfer-medades concurrentes (8). La forma aguda cursa confiebre, anemia grave, ictericia, depresi\u00f3n, p\u00e9rdida de pesoy muerte (12, 13). Los ovinos infectados mantienen elagente durante per\u00edodos prolongados (2, 5, 11), aun des-Brote de micoplasmosis cl\u00ednica por Mycoplasma ovis  en ovinos 213\npu\u00e9s de la terapia con antibi\u00f3ticos eficaces (8, 9). Con la\ncoloraci\u00f3n de Giemsa, M. ovis se observa en la superfi-\ncie de los eritrocitos como peque\u00f1os organismos bas\u00f3filoscocoides de 0,5 a 1,0 \u00b5m de di\u00e1metro (9). El gen 16SrRNA ha sido usado como marcador para la caracteriza-ci\u00f3n molecular y en estudios taxon\u00f3micos de \nMycoplasma\nspp. en diferentes hospedadores (6, 8, 9).\nEste trabajo informa sobre los aspectos epidemiol\u00f3-\ngicos, cl\u00ednicos y m\u00e9todos de diagn\u00f3stico empleados enun brote de micoplasmosis ovina ocurrido en cercan\u00edasde Rosario de la Frontera (25\u00b048\u2019S, 64\u00b058\u2019O), Salta, enuna peque\u00f1a majada integrada poco antes por ovinosde origen local diverso. El reba\u00f1o se compon\u00eda de 39animales, 28 adultos y 11 cr\u00edas de hasta dos meses deedad. Alrededor de un mes antes del primer deceso, lamajada hab\u00eda sido vacunada contra clostridiosis ydesparasitada con ivermectina v\u00eda inyectable. El reba\u00f1osoportaba una elevada incidencia de insectos hemat\u00f3-fagos (especies no determinadas) al momento del brote.\nEn enero de 2007 murieron cinco  animales adultos\n(17,8%), uno el d\u00eda 5, otro el 16, dos el 17 y uno el 18. Eld\u00eda 19 se efectuaron las necropsias de dos ovejas muer-tas. Con sangre de una de ellas se realizaron extendidosfinos y gruesos, los que se colorearon con Giemsa al10% y se examinaron al microscopio con objetivo de in-mersi\u00f3n (100X) para detectar la presencia de hemopa-r\u00e1sitos.\nLos d\u00edas 19, 21 y 23 de enero todos los ovinos reci-\nbieron tratamientos con tetraciclina inyectable (Oxiton,Agropharma, Argentina) en dosis de 5 mg/kg. En los d\u00edassiguientes no ocurrieron nuevos decesos. El 26 de enerose realizaron extendidos de sangre perif\u00e9rica (oreja) y seobtuvieron muestras de sangre con anticoagulantes(EDTA, citrato de sodio al 5%) de 10 ovinos adultos delreba\u00f1o. Los extendidos se procesaron y examinaroncomo antes se refiri\u00f3. Las muestras con EDTA se utiliza-ron para determinar el \u00edndice hematocrito mediante lat\u00e9cnica del microhematocrito, mientras que las muestrascitratadas se emplearon para conocer la identidadgen\u00f3mica de \nMycoplasma  spp. por la t\u00e9cnica de la reac-\nci\u00f3n en cadena de la polimerasa (PCR) y el an\u00e1lisis de lasecuencia del producto amplificado.\nPara realizar la PCR se utilizaron los oligonucle\u00f3tidos\n340F y 543R, previamente descritos (9), y otros dise\u00f1a-dos \nad hoc (Myc783F AGTAGTCCACGCCGTAAACGAT\ny Myc764R TCAGTTATATCCCAGGTACTCGCC) a partirde la secuencia del gen 16S rRNA de \nM. ovis de referen-\ncia (AF338268). Los productos amplificados se purifica-\nron (Qiagen\u00ae) y se enviaron a secuenciar. Las secuencias\nresultantes se alinearon mediante el programa inform\u00e1ticoBioedit\n\u00ae y se compararon con la secuencia de referencia\nde M. ovis y de Mycoplasma wenyonii  (AF016546) (9). Los\nan\u00e1lisis filogen\u00e9ticos se realizaron mediante el programaMega 4 utilizando el m\u00e9todo Neighbor-joining (correcci\u00f3nde Kimura-2 par\u00e1metros) (14).Las necropsias mostraron alteraciones similares en\nambas ovejas: anemia, ligera ictericia subcut\u00e1nea, mar-cada ictericia hep\u00e1tica, esplenomegalia, ri\u00f1ones friablesy congesti\u00f3n y edema pulmonares. El estado nutricionalde los animales era \u00f3ptimo, seg\u00fan reflejaban gruesosdep\u00f3sitos adiposos abdominales. En ninguna de las ove-jas se hallaron nematodes abomasales (i.e. \nHaemonchus\ncontortus), a menudo responsables de mortalidad estivo-\noto\u00f1al por anemia en los ovinos de la regi\u00f3n. Tampocose observaron ectopar\u00e1sitos (mel\u00f3fagos, piojos o garra-patas) fijados a la piel o lana de las ovejas.\nLa sangre de una de las ovejas muertas revel\u00f3 al exa-\nmen microsc\u00f3pico m\u00faltiples cuerpos bas\u00f3filos adheridosa los eritrocitos, acordes con las descripciones de \nM. ovis.\nCuerpos id\u00e9nticos se observaron tambi\u00e9n, en menor n\u00fa-mero, en todos los extendidos de sangre obtenidos delos ovinos sobrevivientes (Figura 2). En ning\u00fan caso losextendidos mostraron cambios significativos del cuadrohem\u00e1tico (reticulocitosis, anisocitosis, etc.). La media del\u00edndice de hematocrito de los 10 ovinos muestreados fuede 33,0 (rango 24-37).\nEn nueve de las nueve muestras analizadas se logra-\nron amplificar dos fragmentos del gen 16S rRNA, uno de224 pb con los oligonucle\u00f3tidos Myc340F-Myc543R y otrode 417 pb con los oligonucle\u00f3tidos Myc340F-Myc764R.S\u00f3lo tres secuencias del gen 16S rRNA resultaron legiblese id\u00e9nticas entre s\u00ed y fueron depositadas en el GenBank(N\u00b0 de acceso FJ866785). Ambas mostraron un 98% desimilitud, tanto con la secuencia de \nM. ovis (AF338268)\ncomo con la de M. wenyonii (AF016546). La Figura 1\npresenta un \u00e1rbol filogen\u00e9tico con la relaci\u00f3n entre estas\u00faltimas dos secuencias\n y los tres fragmentos secuen-\nciados. Estos resultados confirman la gran similitud en-tre \nM. ovis y M. wenyonii , previamente observada por\notros autores, tanto inmunol\u00f3gica (7) como filogen\u00e9tica(9). Como \nM. wenyonii  es considerado espec\u00edfico de losFigura 1. \u00c1rbol filogen\u00e9tico obtenido mediante un an\u00e1lisis de\nNeighbor-joining (Kimura-2 par\u00e1metros) a partir del alineamien-to de las secuencias de referencia de \nM. ovis y M. wenyonii .\nAcholeplasma laidlawii  fue usado como grupo externo. En los\nnodos del \u00e1rbol se aclara el valor obtenido en la prueba estad\u00eds-tica de \nbootstrap (1000 repeticiones). El an\u00e1lisis se efectu\u00f3 con\nel programa inform\u00e1tico Mega 4. Entre par\u00e9ntesis se muestra eln\u00famero de acceso a GenBank de cada secuencia. Las nuevassecuencias obtenidas fueron depositadas en el GenBank (N\u00b0 deacceso FJ866785)./c3/c48 /c20\n/c3/c48 /c21\n/c3/c48 /c22\n/c3 /c48 /c17 /c3 /c82/c89 /c76 /c86/c3 /c11/c36/c41/c22 /c22/c27/c21 /c25/c27/c12\n/c3 /c48 /c17/c3 /c90 /c72/c81 /c92 /c82/c81 /c76 /c76 /c3 /c11 /c36 /c41 /c19/c20 /c25/c24 /c23 /c25 /c12\n/c3 /c36 /c17/c3 /c79 /c68 /c76 /c71 /c79/c68 /c90 /c76/c76/c3 /c11 /c48 /c21 /c22 /c28 /c22 /c21 /c127699\n0.005214 Revista Argentina de Microbiolog\u00eda (2009) 41: 212-214\nbovinos (8), la hip\u00f3tesis de una eventual infecci\u00f3n de los\novinos con este agente se estima improbable.\nLos cambios anatomopatol\u00f3gicos sumados a la\nanamnesis y al diagn\u00f3stico microsc\u00f3pico y molecularprueban la acci\u00f3n pat\u00f3gena de \nM. ovis en el caso aqu\u00ed\nreferido. Esta bacteria se diagnostica de rutina por elexamen directo de extendidos de sangre coloreados, sibien la baja parasitemia de las infecciones cr\u00f3nicas pue-de conducir a resultados falso negativos. El diagn\u00f3sticodefinitivo requiere entonces la inoculaci\u00f3n de sangre deanimales sospechosos en ovinos \u2013o caprinos\u2013 esplenec-tomizados, o bien el empleo de t\u00e9cnicas de biolog\u00edamolecular, como la utilizada en esta investigaci\u00f3n (8).\nEs probable que la tasa de mortalidad de este brote\nde micoplasmosis hubiese sido mayor en ausencia delas medidas terap\u00e9uticas aplicadas. La mortalidad secircunscribi\u00f3 a ovinos adultos, como hace poco ocurri\u00f3en un reba\u00f1o de Hungr\u00eda, donde muri\u00f3 el 5,5% de lasovejas adultas (6). La prevalencia de la infecci\u00f3n fue muyelevada, ya que el 100% de los ovinos muestreados (n =11) exhibieron presencia de \nM. ovis. La transmisi\u00f3n pudo\nverse favorecida por la abundancia de insectos hema-t\u00f3fagos o por iatrogenia asociada a medicaciones inyec-tables administradas con anterioridad en el reba\u00f1o.\nEl presente brote result\u00f3 curioso dados los escasos\nprecedentes sobre esta infecci\u00f3n. Aunque se postula quela distribuci\u00f3n de \nM. ovis es amplia en las \u00e1reas del norteargentino con abundancia de vectores (15), la primera\nsospecha de su relevancia pat\u00f3gena a nivel local surgi\u00f3hace poco, tras la muerte de un carnero trasladado deC\u00f3rdoba a Salta (1). Pero ese caso aislado no permiti\u00f3mayores inferencias sobre el origen de la infecci\u00f3n por\nM. ovis y su patogenicidad. Por el contrario, el brote en\novinos nativos de Salta que aqu\u00ed se describe confirma lapresencia regional del agente y aporta evidencia contun-dente de su acci\u00f3n delet\u00e9rea a escala poblacional, la quedesde ahora deber\u00e1 contemplarse para el diagn\u00f3sticonosol\u00f3gico diferencial.\nBIBLIOGRAF\u00cdA\n1. Aguirre D, Cafrune M, Arjona C, Venzano A. Micoplasmosis\n(eperythrozoonosis) ovina en Salta, Argentina. XVII Con-greso Latinoamericano de Parasitolog\u00eda, Resumen 187.Parasitol Latinoam 2005; 60: 173.\n2. Brun-Hansen H, Gronstol H, Waldeland H, Hoff B.\nEperythrozoon ovis  infection in a commercial flock of sheep.\nZentbl Veterinarmed B 1997; 44: 295-9.\n3. Burroughs GW. The significance of Eperythrozoon ovis  in\nill-thrift in sheep in the eastern Cape coastal areas of SouthAfrica. J S Afr Vet Assoc 1988; 59: 195-9.\n4. Daddow KN. \nEperythrozoon ovis  \u2013 a cause of anaemia,\nreduced production and decreased exercise tolerance insheep. Aust Vet J 1979; 55: 605-6.\n5. Daddow KN. The duration of the carrier state of\nEperythrozoon ovis  infection in sheep (letter). Aust Vet J\n1981; 57: 49.\n6. Hornok S, Meli ML, Erdos A, Hajt\u00f3s I, Lutz H, Hofmann-\nLehmann R. Molecular characterization of two differentstrains of haemotropic mycoplasmas from a sheep flockwith fatal haemolytic anaemia and concomitant \nAnaplasma\novis. Vet Microbiol 2009; 136: 372-7.\n7. Kreier JP, Ristic M. Morphologic, antigenic and pathogenic\ncharacteristics of Eperythrozoon ovis  and Eperythrozoon\nwenyoni. Am J Vet Res 1963; 24: 488-500.\n8. Messick JB. Hemotropic mycoplasmas (hemoplasmas): a\nreview and new insights into pathogenic potential. Vet ClinPathol 2004; 33: 2-13.\n9. Neimark H, Hoff B, Ganter M. \nMycoplasma ovis  comb. nov.\n(formerly Eperythrozoon ovis ), an epierythrocytic agent of\nhaemolytic anaemia in sheep and goats. Int J Syst EvolMicrobiol 2004; 54: 365-71.\n10. Neitz WO, Alexander RA, Du Toit PJ. \nEperythrozoon ovis\n(sp. nov.) infection in sheep. Onderstepoort J Vet Sci 1934;3: 263-9.\n11. Overas J. Studies on \nEperythrozoon ovis  \u2013 infection in\nsheep. Acta Vet Scand 1969; Suppl 28: 1-148.\n12. Rouse BT, Johnson RH. Eperythrozoon ovis . Vet Rec 1966;\n79: 223-4.\n13. Sheriff D, Clapp KH, Reid MA. Eperythrozoon ovis  infection\nin South Australia. Aust Vet J 1966; 42: 169-76.\n14. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular\nEvolutionary Genetics Analysis (MEGA) software version4.0. Mol Biol Evol 2007; 24: 1596-9.\n15. Vanzini VR, Somma de Fere GR, Zurbriggen MA, Homse\nAC, Draghi de Ben\u00edtez MG, Rochinotti D, \net al. Hallazgo de\nEperythrozoon ovis  en la provincia de Corrientes (Argenti-\nna). IDIA 1983; 417- 420: 105-7.Figura 2.  Extendido de sangre ovina. Gl\u00f3bulos rojos con pre-\nsencia de formas cocoides sobre su superficie (flechas), com-patibles con \nMycoplasma ovis . Coloraci\u00f3n de Giemsa. 1000 x\nRecibido: 21/04/09 \u2013 Aceptado: 28/07/09\nSpoligotyping of Mycobacterium bovis  isolates from cats 215 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 215-217 ART\u00cdCULO ORIGINAL\nMycobacterium bovis  in Argentina: isolates from cats\ntypified by spoligotyping\nM. J. ZUM\u00c1RRAGA1*, M. MART\u00cdNEZ VIVOT 2, D. MARTICORENA2, A. BERNARDELLI 3,\nR. FAS\u00c1N4, R. IACHINI 5, A. A. CATALDI 1.\n1Instituto de Biotecnolog\u00eda, CICVyA-INTA, Castelar; 2Facultad de Veterinaria, Universidad de Buenos Aires;\n3C\u00e1tedra de Patolog\u00eda de la Universidad Nacional de R\u00edo IV, C\u00f3rdoba; 4LACLIVET, Buenos Aires;\n5Instituto Pasteur, Buenos Aires, Argentina.\n*Correspondence. E-mail: mzumarraga@cnia.inta.gov.ar\nABSTRACT\nIn the present work, 19 Mycobacterium bovis  isolates from different cats were typified by spoligotyping. We detected\nnine spoligotypes. There was only one cluster, which grouped 11 of the isolates (57.9%), showing the main spoligotypefrom cattle from Argentina. The rest of the spoligotypes presented only one isolate each. Five of them were not foundin cattle, and were unique and exclusive of cats. The isolates studied show that tuberculosis of bovine origin in catsconstitutes a potential public health problem in Buenos Aires region. The identification of genotypes from non-naturalhosts could contribute to understand the spread of bovine tuberculosis. This is the first report showing genetic profilesof \nM. bovis isolates in felines from Argentina.\nKey words : tuberculosis, cats, spoligotyping\nRESUMEN\nMycobacterium bovis  en Argentina: aislamientos de gatos tipificados por spoligotyping . En el presente trabajo\nse tipificaron por spoligotyping  19 aislamientos de M. bovis de diferentes gatos. Se detectaron 9 espoligotipos  y un\n\u00fanico agrupamiento o cluster integrado por 11 aislamientos (57,9%) y relacionado con el principal espoligotipo de\nbovinos de Argentina. El resto de los espoligotipos detectados presentaron solamente un aislamiento cada uno; 5 deellos no se encontraron en bovinos y fueron \u00fanicos y exclusivos de gatos. La presencia de estos aislamientos indicaque la tuberculosis bovina en los gatos constituye un potencial problema de salud p\u00fablica en la ciudad de BuenosAires. La identificaci\u00f3n de genotipos de aislamientos de \nM. bovis de hospedadores no convencionales podr\u00eda contri-\nbuir a la mejor comprensi\u00f3n de la diseminaci\u00f3n de la tuberculosis bovina. Este es el primer informe en el que semuestran los perfiles genot\u00edpicos de aislamientos de \nM. bovis obtenidos de felinos de Argentina.\nPalabras clave : tuberculosis, gatos, spoligotyping\nINTRODUCTION\nBovine tuberculosis is a chronic zoonosis that affects\ndifferent wild and domestic animals, causing relevanteconomic losses in livestock. The causative agent is\nMycobacterium bovis,  a member of the Mycobacterium\ntuberculosis  complex, which  also includes Mycobacterium\ntuberculosis , Mycobacterium africanum , Mycobacterium\nmicroti, Mycobacterium canetti , Mycobacterium caprae\nand Mycobacterium pinnipedii  (4). The main host of M.\nbovis is cattle, although several mammalian species can\nalso be infected. In Argentina, the prevalence in cattle isaround 1.2%, estimated by detection of lesions in theslaughterhouse (13). Among domestic animals, cats arethe most susceptible hosts of  bovine tuberculosis (14).\nThe main pathway of tuberculosis infection in felines\nis the digestive route. However, tuberculosis can alsoinfect by the aerogenic pathway and/or injured scratches.\nCats are more susceptible to \nM. bovis than dogs,\nprobably because a common pet owner\u2019s habit is to feedcats only with raw food such as raw lung, liver and other\nviscera (3, 6, 14). The milk of infected animals is a veryimportant source of infection, especially in rural areas,where milk is commercialized without pasteurization. Theevolution of the disease in cats is different from that inbovines, reaching earlier a generalization of the infectionthat leads to the death of the animal. The clinical signs ofthe disease are unspecific and affect several organs orfluids such as lymph nodes, intestines, kidneys, pleura,lungs, liver and/or brain. The confirmation of clinicalsuspicion must be carried out by culture from differentorgans or fluids (7). The National Plan of Control andErradication of Bovine Tuberculosis does not recommendthe use of the tuberculine test in dogs and cats becauseit can give negative false results (10). In Argentina, it ismandatory to report the cases of tuberculosis to sanitaryagents. Nevertheless, the information about the incidenceof bovine tuberculosis in cats in Argentina is incompleteand scarce (6, 11, 14). As an antecedent, 4% of the catsnecropsies at the School of Veterinary Sciences of the216 Revista Argentina de Microbiolog\u00eda (2009) 41: 215-217\nUniversity of Buenos Aires (UBA) presented tuberculosis\n(14).\nThe transmission of bovine tuberculosis can be\nstopped by implementing control programs, feeding petswith balanced food, pasteurizing milk, and cooking meatproducts.\nHowever, in the last years in Argentina, these barriers\nhave not been enough to protect pets from tuberculosis.People who adopt and rear many cats, together with theincrease of immunosuppressing diseases (felineimmunodeficiency virus and feline leukemia virus), haveled to an epidemiological change. Different molecular\nmethods are used to type the \nM. tuberculosis  complex.\nOne of them, called spoligotyping, is a PCR reverse lineblot hybridization method based on the polymorphism ofthe direct repeat (DR) region (8). This method is easy toperform and allows the differentiation of interspecies andintraspecies variability among the \nM. tuberculosis  complex.\nHowever, although the method is not polymorphic enoughto identify close relationships, it can be useful for thedetermination of more distant relationships betweenisolates (15).\nTherefore, in order to gain a deeper insight into tuber-\nculosis in cats, we have typed \nM. bovis isolates from cats\nfrom Buenos Aires city, Argentina, by spoligotyping.\nMATERIALS AND METHODS\nStray cats from Buenos Aires city that had died by unknown\ncauses between 1998 and 2006 were submitted to the School ofVeterinary Sciences of the UBA to be necropsied. Nineteenisolates were obtained from the lymph nodes from all the animalsexcept for one, which was obtained from bronchoalveolar lavage(3) from a pet belonging to a woman that lived with 20 other catsin her house. These cats were fed daily with \u201craw beef lung\u201d (3).Macerated lymph nodes and bronchoalveolar exudate sampleswere cultured in Lowenstein\u2013Jensen and Stonebrink media formycobacteria after decontamination by the Petroff method (4%sodium hydroxide) (5).\nA loopfull of bacteria was suspended in 200\u00b5l of distilled water\ninto a 2-ml screw-cap tube and boiled for 30 min. Aftercentrifugation at 12,000 rpm for 5 min, 5 \u00b5l of supernatant was\nused for PCR (polymerase chain reaction) to performspoligotyping according to the protocol previously described byKamerbeek \net al. (8), and using the spoligotyping kit (Isogen\nBiosolutions B.V., Ocimun Biosolutions Company, Ijsselstein, TheNetherlands). A cluster analysis of the spoligotype patterns wasperformed with the BioNumerics software (Windows NT, version2.5; Applied Maths, Kortrijk, Belgium). The categorical coefficientwas used to calculate the similarity of spoligotype patterns, andthe UPGMA (Unweighted pair-group method with arithmeticaverages) method was applied to calculate a dendrogram.Clusters of isolates were defined as two or more \nM. bovis strains\nwith identical spoligotypes. Each of the different spoligotypeswere allocated a number. \nM. tuberculosis  H37Rv (ATCC 27294)\nand M. bovis Bacillus Calmette-Guerin (BCG) (ATCC 27289)\nwere included as reference strains in each spoligotypingexperiment.\nRESULTS\nNine different spoligotypes were detected among the\n19 M. bovis isolates from cats, eight of which were unique\n(Figure 1). All the strains lacked spacers 3, 9, 16 and 39to 43, characteristic of \nM. bovis isolates. There was only\none cluster that grouped 11 of the isolates (57.9%) andshowed spoligotype Spo 34, identified as SB0140 in theinternational database of the University of Sussex, UnitedKingdom (UK) (http://www.mbovis.org/). This spoligotypeis the most frequent among the 542 \nM. bovis isolates\nanalyzed from Argentina (15, 16), representing 46.9% ofthe total collection. The remaining eight spoligotypes hadonly one isolate each. Five of them (Spo 48, 70, 71, 75and 90) were exclusive of cats because neither bovinenor other host isolates from Argentina had been previouslydetected. The other three spoligotypes (Spo 3, 21 and29) had been found in bovine. In addition Spo 21 wasalso found in human, pig and armadillo isolates and Spo3 was also described in human isolates from Argentina.The spoligotypes not found in the University of Sussexdatabase were included to perform further comparisonsbetween laboratories.Figure 1. Dendrogram showing the relationship between nine M. bovis spoligotypes detected among 19 cat isolates from Buenos\nAires city.  The spoligotypes of reference strains of M. tuberculosis  H37Rv and M. bovis BCG are also included. The numbers at the\ntop of the figure denote the spacers. Spo stands for spoligotype.\nSpoligotyping of Mycobacterium bovis  isolates from cats 217\nDISCUSSION\nSince cats are susceptible to the M. tuberculosis , M.\nbovis and M. avium complex, the isolates must be typed\nto adopt different health management programs. M. bovis\nis mainly transmitted to cats by the gastrointestinal routeafter the ingestion of contaminated food (6, 9, 14). It wasnot possible to know the infection source of the sampledcats, though they had probably been fed daily with \u201crawbovine lung\u201d. Feeding stray cats in this way is an oldcustom of people from our country. This practice couldexplain the probable infection source of these cats.Moreover, the availability of contaminated bovine lungsin the city, suggests a failure in slaughterhouse inspection.The cluster that grouped 57.9% of the isolates from catsshowed the main spoligotype (Spo 34/SB0140) detectedin bovines from Argentina (15, 16). This spoligotype isalso predominant in the United Kingdom and othercountries that had imported cattle from the UK at the endof the nineteenth century (2).  Spoligotypes Spo 3, 21and 29, were identified in a previous epidemiologicalstudy, grouped at 3.3, 20.1 and 2.8% of all the isolates(15, 16).  Spo 21 is the second spoligotype in frequencyin Argentina and Spo 3 may be related to humans because61% of the isolates with this spoligotype were frompulmonary isolates from non-related humans (15, 16). Thepresence of these spoligotypes in \nM. bovis isolates from\ncats, demonstrates the transmission from bovines to cats.\nThe distribution of the different patterns could be due\nto epidemiological factors and the virulence of the strainwithin the population. In low prevalence areas, a highgenetic diversity is found in cattle populations, thusimplying a variety of unrelated ancestor strains (12).Intriguingly, there were five spoligotypes that were uniqueand exclusive of cats, not detected among the cattleisolates  from Argentina, differentiated by one or fewspacers from those detected in bovines. These patternscould correspond to other genotypes from non-sampledbovines. On the other hand, the change of host could exertselective pressure on the mycobacterial genome, thusgiving new related patterns. Other authors have also foundspoligotypes from cats that were not found in isolates fromother animals, thus spoligotyping represents a good toolto detect new types from different host species (1).\nFurther studies will be necessary to confirm the\npresence of \nM. bovis in bovine lungs from butcher\u2018s stores.\nIt is our belief that it is very important to be aware of therisk of the very old custom of feeding cats with raw bovinelung. Thus, we suggest that the best way to decrease theincidence of bovine tuberculosis in cats is feeding themwith balanced food pellets or well cooked food, reducingthe risk of human infections.\nAcknowledgements: we thank H. Gil and R. V. Rocha (Ins-\ntituto de Biotecnolog\u00eda, CICVyA-INTA, Castelar) and L.Dom\u00ednguez (Instituto Pasteur, Buenos Aires) for technical\nassistance. This work was supported by grants from INTA. AC isa researcher from the National Research Council of Argentina(CONICET).\nREFERENCES\n1. Aranaz A, Li\u00e9bana E, Mateos A, Dom\u00ednguez L, Vidal D,\nDomingo M, et al. Spacer oligonucleotide typing of\nMycobacterium bovis  strains from cattle and other animals:\na tool for studying epidemiology of tuberculosis. J ClinMicrobiol 1996; 34: 2734-40.\n2. Cataldi AA, Gioffr\u00e9 A, Sant\u00e1ngelo MP, Alito A, Caimi K,\nBigi F, \net al. El genotipo de Mycobacterium bovis  mayorita-\nrio en la Argentina lo es tambi\u00e9n en las Islas Brit\u00e1nicas: \u00bflatuberculosis bovina provino de Gran Breta\u00f1a?. Rev ArgentMicrobiol 2002; 34: 1-6.\n3. Colmegna I, Ricci BG, Zum\u00e1rraga M, Cataldi AA, Di Lonardo\nMM, Citera G, \net al. Mycobacterium bovis  and septic\nglenohumeral arthritis. Clin Rheumatol 2004; 23: 379-80.\n4. Cousins DV, Bernardelli A, Bastida R, Cataldi A, Quse V,\nDow S, et al. Tuberculosis in seals caused by a novel\nmember of the Mycobacterium tuberculosis  complex:\nMycobacterium pinnipedii  sp. nov. Int J Syst Bacteriol 2003;\n53: 1305-14.\n5. de Kantor IN. Bacteriolog\u00eda de la tuberculosis. Bolet\u00edn\nEpidemiol\u00f3gico N\u00b011. Buenos Aires, CEPANZO OPS/OMS,1988, p. 26-35.\n6. Fern\u00e1ndez F, Morici E. Tuberculosis felina por\nMycobacterium bovis : comunicaci\u00f3n de dos casos. Rev\nArgent Microbiol 1999; 31 Supl 1: 19-20.\n7. Jorge MC, Mendivil M, Fresneda K. Perros y gatos como\nhu\u00e9spedes susceptibles y reservorios epidemiol\u00f3gicos dela tuberculosis. XV Reuni\u00f3n Cient\u00edfico T\u00e9cnica de la Aso-ciaci\u00f3n Argentina de Veterinarios de Laboratorios de Diag-n\u00f3stico, 2004, p. 167-8, Ciudad Aut\u00f3noma de Buenos Ai-res, Argentina.\n8. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van\nSoolingen D, Kuijper S, \net al. Simultaneous detection and\nstrain differentiation of Mycobacterium tuberculosis  for diag-\nnosis and epidemiology. J Clin Microbiol 1997; 35: 907-14.\n9. Kaneene JB, Bruning-Fann CS, Dunn J, Mullaney TP, Berry\nD, Massey JP, et al. Epidemiologic investigation of\nMycobacterium bovis  in a population of cats. Am J Vet Res\n2002; 63: 1507-11.\n10. Kistermann JC, Torres PM. Epidemiolog\u00eda de la tuberculo-\nsis bovina. In: Actualizaci\u00f3n de la tuberculosis bovina, Bue-nos Aires, SENASA, 1999, p. 37-46.\n11. Mart\u00ednez Vivot M, Ritacco V, Reniero A, Barboni A, Guida\nN, Moras EV. Tuberculosis felina: caracterizaci\u00f3nbacteriol\u00f3gica y gen\u00f3mica de los aislamientos en elConurbano bonaerense. In Vet 2001; 3: 179-82.\n12. Michel AL, Hlokwe TM, Coetzee ML, Mar\u00e9 L, Connoway L,\nRutten VP, \net al. High Mycobacterium bovis  genetic diversity\nin a low prevalence setting. Vet Microbiol 2008; 126: 151-9.\n13. Torres P. Situaci\u00f3n de la tuberculosis bovina en la Rep\u00fabli-\nca Argentina. Buenos Aires, SENASA, 2006, p. 1-21.\n14. Underwood S, Pinto MC, Rey Moreno JC, Carfagnini SC.\nTuberculosis felina: casos diagnosticados y consideracio-nes sobre su posible fuente de infecci\u00f3n. Rev ArgentMicrobiol 1999; 31 Supl 1: 17-8.\n15. Zum\u00e1rraga MJ. Epidemiolog\u00eda molecular de la tuberculo-\nsis bovina. Tesis doctoral, FCEyN, UBA, 2007.\n16. Zum\u00e1rraga MJ, Martin C, Samper S, Alito A, Latini O, Bigi\nF, \net al. Usefulness of spoligotyping in molecular epidemiology\nof Mycobacterium bovis -related infections in South America.\nJ Clin Microbiol 1999; 37: 296-303.\nRecibido: 26/05/09 \u2013 Aceptado: 07/09/09218 Revista Argentina de Microbiolog\u00eda (2009) 41: 218-225 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 218-225 ART\u00cdCULO ORIGINAL\nEchinococcus granulosus : biological comparison of cattle\nisolates from endemic regions of Argentina and Spain\nM.V. ANDRESIUK*1,2, F. PONCE GORDO3, C. CUESTA BANDERA3, M. C. ELISSONDO1, 2,\nM. DOPCHIZ1, 2, G. DENEGRI1, 2\n1Laboratorio de Zoonosis Parasitarias. Facultad de Ciencias Exactas y Naturales. Universidad Nacional de Mar del Plata. Funes\n3350 (7600) Mar del Plata, Buenos Aires, Argentina; 2Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET),\nArgentina; 3Departamento de Parasitolog\u00eda, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Espa\u00f1a.\n*Correspondence. E-mail: mandres@mdp.edu.ar\nABSTRACT\nIn the present study we have compared cattle isolates of Echinococcus granulosus  from Argentina and Spain. The aim\nwas to compare and determine if there exist phenotypic and genetic differences within E. granulosus  cattle isolates\nbetween an endemic area of Spain (where the disease is mainly restricted to a sheep-dog cycle) and an endemic areaof Argentina (where cattle are the most abundant intermediate hosts). The Spanish samples were previously identifiedas G1 genotype. The Argentinean samples were also identified as G1, but some variants were found for the cytochromec oxidase-1\n (CO1) and NADH dehydrogenase-1 (ND1) mitochondrial genes. When comparing the cyst features and\nthe morphology of the larval rostellar hooks in both regions, some differences were found. The morphometric analysesof the larval rostellar hooks showed the existence of two distinct clearly separated groups (one corresponding to theArgentinean samples and the other to the Spanish ones). In conclusion, there are some genetic and phenotypicdifferences within \nE. granulosus  cattle isolates from Argentina and Spain. Probably these differences, more important\nfrom an epidemiological point of view, are related to different steps in the disease control in both countries. Furtherstudies involving other epidemiological, morphometric and molecular data, including other types of livestock, wouldcontribute to clarify and expand the present work.\nKey words:  \nEchinococcus granulosus , epidemiology, morphology, genotypes, Argentina, Spain\nRESUMEN\nEchinococcus granulosus : comparaci\u00f3n biol\u00f3gica de aislados de bovinos de regiones end\u00e9micas de Argen-\ntina y Espa\u00f1a.  El objetivo del presente trabajo fue determinar si existen diferencias fenot\u00edpicas y gen\u00e9ticas entre los\naislados de Echinococcus granulosus  de origen bovino provenientes de dos regiones geogr\u00e1ficas donde la hidatidosis\nes end\u00e9mica, una de Espa\u00f1a (donde predomina el ciclo perro-oveja) y una de Argentina (donde el bovino es elhospedador intermediario m\u00e1s importante). Las muestras espa\u00f1olas fueron previamente identificadas comopertenecientes al genotipo G1. Las muestras argentinas tambi\u00e9n  correspond\u00edan al genotipo G1, pero entre ellas seregistraron algunas microvariantes de los genes mitocondriales citocromo c oxidasa-1\n (CO1) y  NADH deshidrogenasa-\n1 (ND1). La comparaci\u00f3n de las caracter\u00edsticas de los quistes y de la morfolog\u00eda de los ganchos rostelares del\nmetacestode mostr\u00f3 ciertas diferencias. En conclusi\u00f3n, existen algunas diferencias gen\u00e9ticas y fenot\u00edpicas entre losaislados de \nE. granulosus  de Argentina y Espa\u00f1a. Probablemente estas diferencias, m\u00e1s importantes desde el punto\nde vista epidemiol\u00f3gico, podr\u00edan estar relacionadas con diferentes etapas en los programas de control de la enfermedaden los dos pa\u00edses. Estudios adicionales que involucren datos epidemiol\u00f3gicos, morfom\u00e9tricos y moleculares provenientesde otros tipos de ganado contribuir\u00e1n a clarificar y ampliar la informaci\u00f3n aportada por este trabajo.\nPalabras clave: \nEchinococcus granulosus , epidemiolog\u00eda, morfolog\u00eda, genotipos, Argentina, Espa\u00f1a\nINTRODUCTION\nEchinococcosis-hydatidosis is a cosmopolitan zoono-\nsis caused by the cestode Echinococcus granulosus. This\nparasite shows great intraspecific variability in relation toits host specificity, epidemiology, morphology, biochem-istry, physiology and genetics (39). Various methodsbased on morphology, physiology, biochemistry and im-munology have been used to characterize the variants orstrains of \nE. granulosus (1, 2, 31, 39). These strains were\nlater identified as genotypes by molecular studies (G1 -G10) (7-9, 24, 35). Recently some authors have proposeda revision of the genus based on phylogenetic studiestending to re-categorize some genotypes to the specieslevel (27, 34, 41). Several studies around the world thathave been carried out to characterize the strains/geno-types of \nE. granulosus from a region or a country, have\ndemonstrated the existence of genetic variation or se-Echinococcus granulosus  from Argentina and Spain 219\nquence heterogeneity in mitochondrial DNA within some\nof the recognized genotypes G1 - G10 (21, 22, 29, 33).Haag \net al. (19) gave the name of \u201chaplotypes\u201d to the\nmitochondrial sequences used to discriminate strains, and\u201cvariants\u201d, to the haplotypes with minor genetic differenceswithin a strain. Since then, different authors have de-scribed these mitochondrial variants or microvariantswithin \nE. granulosus  (5, 6, 10, 32). Among the ten geno-\ntypes that have been described so far, the G1 genotypeis the most widespread around the world infecting sheep,cattle, pig, goat, buffalo and humans. In general, cattlehave been considered a poor suitable host for the G1genotype, although some recent studies have demon-strated that cattle could play a role as a reservoir of theG1 genotype in some areas like Algeria and Tunisia, whichis a serious risk for human health (4, 25, 40).\nAlthough\n E. granulosus  is widespread in the whole\nterritory of Argentina and the hydatid disease is consid-ered endemic in this country, the infection does not havea homogeneous geographical distribution. The contribu-tion of each kind of livestock (cattle, pig, sheep, etc) inthe disease transmission depends on the region: for ex-ample while sheep is the principal host in the Patagonianand Mesopotamian region, cattle is the prevalent one inthe Pampa and northern regions of the country (14). Par-ticularly in the south-eastern region of  Buenos Aires prov-ince (located within the Pampa region), hydatidosis - echi-nococcosis is considered an important human and vet-erinary health problem, being cattle the main livestockinvolved in the transmission of this disease. (3, 14, 15,16, 20)\nIn Spain, \nE. granulosus  infects sheep, cattle, pig, goat\nand humans and several genotypes have been described.However, sheep is the main host involved in the trans-mission of the hydatid disease  (11, 13, 18, 26, 30, 36).\nThe aim of the present study is to compare and deter-\nmine if there exist phenotypic and genetic differencesbetween \nE. granulosus  isolates of cattle origin from an\nendemic central area of Spain (where the disease ismainly restricted to a sheep-dog cycle) and from an en-demic area of Argentina (southern region of Buenos Airesprovince) where cattle are the most abundant intermedi-ate hosts.\nMaterial and methods\nOrigin and processing of samples\nThe hydatid cysts were obtained from liver and lungs of\ninfected cattle. The Spanish samples were collected during theperiod 1990-1996 at slaughterhouses from the endemic centralregion of Spain (Autonomous Community of Madrid, Castilla -La Mancha, Castilla - Le\u00f3n, Extremadura, Arag\u00f3n and Navarra).The Argentine samples were collected between 2003 and 2004at an abattoir located in the south-eastern region of Buenos Ai-res province. Each cyst was processed as an individual isolate.They were opened under sterile conditions, according to Smythand Davies (38). For each cyst, the external appearance andmacroscopical characteristics of the cyst wall, germinalmembrane and hydatid fluid (general aspect, color and\ntransparency, existence of calcified or degenerated areas andcontamination) were recorded. For the purposes of this study,the cysts considered viable were those having  membranes whichdid not appear upset or degenerate, white, without calcified,caseous or degenerated regions, not contaminated and with atransparent hydatid fluid. Those cysts which had protoscoleceswere considered fertile. The vitality of protoscoleces (percentageof alive protoscoleces) was determined by their overall aspect(motility, flame cell activity, presence of calcareous corpuscles)and negative methylene blue staining. Viable and fertile cystswere further processed; germinal membranes were washed threetimes in sterile phosphate buffered saline (PBS) and stored at 4\u00b0C (if to be processed within a short period of time) or at -20 \u00b0Cuntil use. When hydatid sand was present, it was processedaccording to Smyth and Davies (38) and then stored in alcohol70\u00b0-glycerine (1:1) at room temperature (for morphologicalstudies) or in alcohol 70\u00b0 at 4 \u00b0C or PBS at -20 \u00b0C (for geneticanalyses).\nEpidemiological data\nThe number and location of cysts, their size, viability and\nfertility were recorded for each geographical area under study.Comparisons between both regions were made using univariatetechniques for all the recorded variables (Fisher\u2019s Exact Test,Mann Whitney and Student\u2019s t test) (39). Statistical significancewas assessed at \np \u2264 0.05. Mean intensity was calculated as the\nmean number of cysts/infected animals (39).\nMorphological studies\nThe protoscoleces were processed according to Ponce Gor-\ndo and Cuesta Bandera (31). The number, shape and arrange-ment of rostellar hooks were recorded, and 5 variables wereused for statistical analysis: the total number of hooks perrostellum (NUM), the blade length of large (LBL) and small (SBL)hooks, and the total length of large (LTL) and small (STL) hooks.All measurements were made by the same people (M.V.A. andF.P.G. for the Argentinean samples and F.P.G. for the Spanishsamples). Comparisons between and within each region weremade by using univariate and multivariate techniques (PrincipalComponent Analyses) (31).\nDNA analysis and sequencing\nThe identification of the Spanish isolates as belonging to the\nsheep strain/G1 genotype had been previously carried out byusing biochemical and genetic analyses (13, 18, 26, 30, 36, 37).All the Spanish isolates presented 100% homology with thecytochrome c oxidase-1\n (CO1) and NADH dehydrogenase-1\n(ND1) sequences of the G1 genotype originally described byBowles \net al. (7) and Bowles and McManus (9) (GenBank\nAccession Numbers: M84661 and AJ237632).The genotype ofthe Argentinean isolates has been identified by using the samemitochondrial genes, following the same protocols and using thesame PCR conditions as previously described by other authors(7, 9, 26). The gene segment considered was 366bp in lengthfor CO1 (7) and 471bp in length for ND1 (9). The CO1 and ND1fragments were purified using the QIAquick PCR Purification Kit(Qiagen). Their sequences were obtained in an automatic DNA\nsequencer (ABI PRISM Model 377 Perkin Elmer) and comparedwith the ND1 and CO1 sequences of the G1-G10 genotypesavailable at the NCBI database (28).\nRESULTS\nEpidemiological analysis\nA total of 22 cattle were infected with E. granulosus  in\nArgentina and 94 in Spain. The mean intensity of infec-220 Revista Argentina de Microbiolog\u00eda (2009) 41: 218-225\ntion for Argentinean cattle was 18.55 (408 cysts) and 5.61\n(527 cysts) for the Spanish ones. Whereas all Argentineancattle presented viable cysts, only 10.64% (10) of theSpanish cattle presented them. The percentage of cattlewith fertile cysts was clearly higher in Argentina (63.64%)than in Spain (6.38%). Percentage of cattle harboring vi-able and fertile cysts was significantly higher in Argen-tina (\u03c7\n2 = 71.26, p < 0.00000 and \u03c72 = 40.95, p < 0.00000\nrespectively). Percentages of cattle with pulmonary orhepatic cysts were higher in Argentina (95.45% and 31.82)than in Spain (78.72% and 29.79%) but did not show sta-tistically significant differences between both regions ( \u03c7\n2\n= 3.36, p = 0.07 and \u03c72 = 0.03, p = 0.85 respectively).\nOnly 9.09% (2) of Argentinean cattle presented cysts inother locations. Almost all the cysts were located in theliver or lungs, being the latter the preferred organ in bothregions.\nThe total number of cysts, the number of viable and\nfertile cysts and the distribution of cysts by location areshown in Table 1. However, while the mean intensity ofliver infection was similar in Argentinean and Spanishcattle, the mean intensity of lung infection was about fourtimes higher in the Argentinean ones. The mean lung andliver intensity of viable and fertile cysts and the viable-to-total-cysts ratios were clearly higher in the Argentineansamples; however the total fertile-to-viable-cysts ratio was\nhigher in the Spanish samples, although no differenceswere found in this ratio when lung and liver cysts wereconsidered separately (Table 2).\nThe size and the external aspect of the cysts were\nsimilar in both regions. While most of the cysts rangedfrom 3 to 4 cm in diameter for both regions, there weresome up to 25 cm in diameter in the Argentinean sam-ples. In all cases, the color of the germinative membranewas whitish to yellowish and it was usually thin, with amucous aspect, and detached from the cyst wall. Thehydatid sand was whitish in fertile cysts with protoscolecesand brood capsules in the Argentinean and Spanish sam-ples. Few protoscoleces were present in the fertile Span-ish samples with a vitality percentage (alive/not aliveprotoscoleces) not higher than 80%, whereas a greatnumber of protoscoleces was present in the fertileArgentinean samples with a vitality percentage between80 and 100%.\nMorphological studies\nThe appearance of the larval rostellum in isolates from\nArgentina and Spain was similar and consisted of 2 rowsof alternating large and small hooks. The comparisonsbetween the measurements of the different variables for\nTable 1. Characteristics of the different kinds of hydatid cysts (total and per organ) in cattle from Ar-\ngentina and Spain. S.D.: standard deviation\nArgentina Spain p value\nTotal cysts 408 527\nLung % respect to total cysts 93.87 81.21\nResults Mean intensity \u00b1 S.D. 17.41 \u00b1 24.65 4.55 \u00b1 4.23 0.00Per Liver % respect to total cysts 5.64 18.79Organ Mean intensity \u00b1 S.D. 1.05 \u00b1 2.15 1.05 \u00b1 2.28 0.88\nOther % respect to total cysts 0.5 \u2013Locations Mean intensity \u00b1 S.D. 0.09 \u00b1 0.30 \u2013\nTotal Viable cysts 189 13Mean intensity \u00b1 s.d. 8.59 \u00b1 16.22 0.14 \u00b1 0.45 0.00\nLung % respect to total cysts 41.67 1.13\nResults Mean intensity \u00b1 S.D. 7.73 \u00b1 16.16 0.06 \u00b1 0.28 0.00Per Liver % respect to total cysts 4.17 1.33Organ Mean intensity \u00b1 S.D. 0.77 \u00b1 1.85 0.07 \u00b1 0.34 0.00\nOther % respect to total cysts 0.5 \u2013Locations Mean intensity \u00b1 S.D. 0.09 \u00b1 0.30 \u2013\nTotal Fertile cysts 44 8Mean intensity \u00b1 s.d. 2.00 \u00b1 2.88 0.09 \u00b1 0.032 0.00\nLung % respect to total cysts 7.35 0.4\nResults Mean intensity \u00b1 S.D. 1.36 \u00b1 2.36 0.02 \u00b1 0.15 0.00Per Liver % respect to total cysts 3.2 1.14Organ Mean intensity \u00b1 S.D. 0.59 \u00b1 1.60 0.06 \u00b1 0.15 0.13\nOther % respect to total cysts 0.25 \u2013Locations Mean intensity \u00b1 S.D. 0.05 \u00b1 0.21 \u2013Echinococcus granulosus  from Argentina and Spain 221\neach of the groups (Argentina and Spain) were statisti-\ncally analysed by the Student\u2019s t test. All of them but one(LTL) presented significant statistical differences (Table3). Principal Components Analysis (PCA) was carried outwith data from 25 isolates of Argentinean cattle and the 8fertile isolates from Spain. Significant correlations werefound, indicating that an increase in the number of hookscorrelates with a longer blade in both the large and smallhooks and with a shorter total length of the small hooks.The criterion considered for the number of factors to beextracted was the \u201cgreatest of the 75% variance rule\u201d andthe Scree test described by Cattell (12). Two factors werefinally extracted, which represented nearly 78% of the\nvariance. When isolates were plotted using both factors,two different groups became evident: one correspondingto the Argentinean isolates and the other to the Spanishones (Figure 1).\nGenotype identification\nAll Argentinean isolates (a total of 25) belonged to the\nG1 genotype, but different variants of the G1 haplotypeoriginally described (GenBank accession no. M84661 andGenBank accession no. AJ237632) were identified for theCO1 and NADH1 mitochondrial genes in the presentTable 2. Ratios (total and per organ) of viable and fertile cysts in cattle from Argentina and Spain\nRegion Statistical\nArgentina Spain significance\nViable to Total cyst ratio\nTotal 0.46 (189/408) 0.02 (13/527) 0.00Per Lung 0.44 (170/383) 0.01 (6/428) 0.00Organ Liver 0.74 (17/23) 0.07 (7/99) 0.00\nOther locations 1 (2/2) 0 \u2013\nFertile-to-total cyst ratioTotal 0.11 (44/408) 0.01 (8/527) 0.00Per Lung 0.08 (30/383) 0.01 (2/428) 0.00Organ Liver 0.56 (13/23) 0.06 (6/99) 0.00\nOther locations 0.50 (1/2) 0 \u2013\nFertile-to-viable cyst ratioTotal 0.23 (44/189) 0.62 (8/13) 0.00Per Lung 0.17 (30/170) 0.33 (2/6) 0.33Organ Liver 0.76 (13/17) 0.86 (6/7) 0.61\nOther locations 0.50 (1/2) 0 \u2013\nThe data in parenthesis indicate the number of cysts used in the calculus.\nTable 3. Rostellar-hook measurements of the protoscoleces of E. granulosus  from hydatid cysts of cattle origin from Argenti-\nna and Spain. S.D: standard deviation\nMorphometric Variables\nN\u00ba of LBL LTL SBL STL NUM\nsamples Average \u00b1 Average \u00b1 Average \u00b1 Average \u00b1 Average \u00b1\nS.D. S.D. S.D. S.D. S.D.\n(Maximum- (Maximum- (Maximum- (Maximum- (Maximum-\n-minimal) -minimal) -minimal) -minimal) -minimal)\nArgentina 24 13.52 \u00b1 0.37 24.72 \u00b1 0.53 9.27 \u00b1 0.3 20.10 \u00b1 0.30 37.61 \u00b1 0.79\n(12.9 -14.4) (24.0 - 26.2) (8.6 - 9.9) (19.4 - 20.8) (33 - 48)\nSpain 8 12.85 \u00b1 0.19 24.51 \u00b1 0.15 9 \u00b1 0.23 21.06 \u00b1 0.19 34.25 \u00b1 1.16\n(12.6 -13.1) (24.2 - 24.7) (8.8 - 9.4) (20.8 - 21.4) (32 - 36)\nStudent\u2019s t test t=4.876 t=1.164 t=2.349 t=8.444 t=9.220statistical significance\np=0.00 p=0.25 p=0.03 p=0.00 p=0.00\nLBL, blade length of large hooks; LTL, total length of large hooks; SBL, blade length of small hooks; LTL, total length of smal l hooks; NUM, number of\nhooks per rostellum. Lengths in micrometers.222 Revista Argentina de Microbiolog\u00eda (2009) 41: 218-225\nstudy. While some sequences were identical to the origi-\nnal one described for the CO1 gene (GenBank acces-sion no. M84661), there were two other different variantsin the CO1 sequence with transition mutations: one vari-ant with a mutation at position 73 (CxT) (GenBank acces-sion no. AF458871) and the other one with a mutation atposition 111 (TxC) (GenBank accession no. AF458875).For the NADH1 gene only one sample was identical tothe original one (GenBank accession no. AJ237632) and3 other different variants were registered in the rest of thesequences: one of the variable sequences showed a tran-sition mutation at position 282 (TxC) (GenBank acces-sion no. AF297617), another one showed mutations at 2different positions: 282 = TxC and 342 = CxT (NADH1_a)and the last one at 3 different positions: 27 = TxC; 181 =TxC and 282 = TxC (NADH1_b).\nDISCUSSION\nThe present work is the first to compare and deter-\nmine if there are differences in phenotypic and molecularfeatures in \nE. granulosus  cattle isolates from endemic\nareas in Argentina and Spain, where the abundance ofthis intermediate host as well as the importance in dis-ease transmission are different.\nIn both regions, the only genotype infecting cattle was\nG1 (common sheep strain), which is the most importantgenotype responsible for human infection (7) and alsobecause of its widespread distribution and wide range ofintermediate hosts.\nAlthough the G1, G2 and G5 genotypes have been\nfound to infect cattle in Argentina (19, 21), all the isolatesobtained in this study belonged to the G1 genotype. This\nsuggests that G1 is probably the most prevalent and theprincipal genotype responsible for the hydatid disease incattle and also in other hosts in the Argentinean areaunder study (3).\nThere are several studies where genetic differences\nwithin the G1 genotype of \nE. granulosus  have been de-\nscribed (5, 6, 10, 19, 21, 32, 33). Obwaller et al. (2004)\nprovided clear evidence that \u2018true\u2019 genetic variability ex-ists within different genotypes indicating that this hetero-geneity is not artefactual.\nResults show the existence of different variants or\nmicrovariants of the G1 genotype in the Argentinean iso-lates but not in the Spanish ones. While the Spanish iso-lates presented the original sequences described for bothgenes (7, 9), in Argentina there are more than one vari-ant for each gene. The variant for the CO1 gene with atransition mutation at position 73 found in the Argentineansamples had been registered earlier in this country asG1A (GenBank accession no. AF458871) in humans,dogs, cattle and pigs from different Argentinean provinces(19, 21), but also in cattle and sheep from Morocco(GenBank accession no. EF367289/90). The other vari-ant for the CO1 with the transition mutation at position111 found in this work had been previously registered asG1E variant (GenBank accession no. AF458875) in hu-mans from Chile (21). This variant was also recorded insheep from Piedmont, Italy (10), in dogs from China(GenBank accession no. DQ356882), in camels fromMorocco (GenBank accession no. EF367286) and in cat-tle from Turkey (GenBank accession no. EU178103) andAustralia (GenBank accession no. AJ508033). In thepresent work both variants were found in Argentineancattle, being the first record of the G1E variant for thesouth-eastern region of Buenos Aires province. The  ND1gene variant (transition mutation at position 282) regis-tered in this work has been previously found in sheepand humans in Argentina (33) (GenBank accession no.AF297617) but not in Spain, and this is the first record incattle from the south-eastern region of  Buenos Aires prov-ince for this variant. The other two ND1 variants wereonly found in one sample and not elsewhere using theBLAST search. Due to the low number of samples (onefrom each variant), no relationship could be drawn be-tween these variants and biological factors. The variantwith the mutation at position 282, which is the most preva-lent in the Argentinean samples, was also described inAlgeria (4) where the epidemiological situation reportedis quite similar to that occurring in the endemic region ofArgentina considered in this study. The variation intra G1described here confirms that this is the most variable geno-type. This is in agreement with the lowest intermediatehost specificity and the wider geographic distribution de-tected for it. Also, our results confirm that the sequenceof the ND1 gene fragment is more variable than that ofthe CO1 gene (9, 21, 29).\nFigure 1. Plot of E. granulosus isolates from cattle of Argentina\nand Spain obtained by the Principal Component Analysis. ESP:Spain, ARG: Argentina.\nEchinococcus granulosus  from Argentina and Spain 223\nIn most parts of the world G1 is mainly restricted to a\nsheep-dog cycle and cattle are usually considered as poorsuitable hosts for this genotype (2, 39-41). This is thesituation that exists in Central Spain, where sheep is themost important intermediate host for the disease. Span-ish cattle were only infected with the G1 genotype andmost of the isolates were non-viable and/or non-fertile(13, 26, 30, 36). However, in some countries like Tunisiaand Algeria, the number of cattle with fertile cysts is higher.Therefore, this host has been considered a suitable hostfor the G1 genotype in those countries, suggesting thatthe parasite appears to be well adapted to the circum-stances and is maintained in a cattle-dog cycle represent-ing a source of infection to dogs and humans (4, 25). Thissituation is quite similar to the one that occurs in the south-eastern region of Buenos Aires province, Argentina, whereapproximately 64% of the affected animals have fertilecysts: a similar percentage to those registered in Algeria(4). Also, the prevalence of the disease, the mean inten-sity of infection, the percentage of cysts by location andthe variants or microvariants of the G1 genotype are al-most the same as in Algeria but quite different from thosein Spain indicating different epidemiological situations (4).\nThe differences registered between Argentina and\nSpain were remarkable, the mean intensity of infectionwas about three times higher in Argentina than in Spainand the mean intensity of viable cysts was more than 60times higher in Argentina. Also, the total number of cattleconsidered in Argentina  presented viable cysts whereasonly 10% of the Spanish did so and the number of cattlewith fertile cysts was 10 times higher in Argentina, indi-cating that cattle are suitable hosts and could play animportant role in the transmission of the parasite in Ar-gentina but not in Spain. However, while the mean inten-sity of liver infection was similar in Argentinean and Span-ish cattle, the mean lung intensity was about four timeshigher in the Argentinean hosts, meaning that Argentineancattle are infected with a higher number of lung cysts perhost. Total mean intensity of infection and per organ (lungand liver) of viable and fertile cysts, the viable-to-total-cysts and the fertile-to-total cyst ratios were clearly higherin the Argentinean samples; however the total fertile-to-viable-cysts ratio was higher in Spanish samples, althoughno differences were found in this ratio when lungs andliver cysts were analyzed separately. The low ratio of vi-able cysts in Spanish cattle indicates that the parasitedoes not develop in suitable conditions and most of thecysts die; however, the few viable ones can complete theirdevelopment and therefore become fertile in the sameproportion seen in viable cysts in the Argentinean cattle.This suggests that the main difference between both re-gions is the parasite\u2019s capability to infect and survive incattle. Lungs are the most affected organs in both regions.\nRegarding the predominance of cysts in lungs rather\nthan in the liver, no agreement has been reached amongdifferent authors dealing with this subject (4, 17, 32, 39).According to Garc\u00eda Llamazarez \net al. (14), the greater\nnumber of cysts in lungs could be related to the fact thatlungs show less organic reaction to external agents thanliver. Nevertheless, there are several studies where theprevalence of hydatid cysts is greater in the liver, there-fore, the location of cysts could depend on several fac-tors such as the relationship between the oncospheresizes and the lymphatic vessel sizes in the intermediatehost (4, 17, 32, 39).\nThe ratios of viable-to-total cysts, fertile-to-total cysts\nand fertile-to-viable cysts are clearly higher in the liver.Another result, where the proportion of cattle fertile cystswas similar or greater in liver than in lungs, has beenrecorded in Benghazi, Libya (39). Therefore, viability andfertility are the most important phenotypic characteristicsdifferentiating the Argentinean and Spanish G1 cattle iso-lates. The number of viable and fertile cysts registered inSpanish cattle were lower compared to those registeredin Argentina. A possible explanation for this could be theresult obtained from treating or not treating cattle withbenzimidazole drugs, since this type of drugs interactswith metacestode viability and consequently, these para-sites could present a higher level of survival which wouldreflect in a greater number of viable and fertile cysts (23).But the usage or not of these drugs in the Argentineanand Spanish cattle under study cannot be assured be-cause this information was not collected for the aim ofthe present study.\nAnother methodology for strain determination is the\nuse of morphological techniques, which is almost advan-tageous because it is a quick and cheap characterizationmethod, especially in the field of epidemiology, whoseresults are compatible with genetic analyses (1, 2, 39).As regards the rostella, their arrangement and externalaspect were similar in both regions and the values of themorphometric variables analyzed were within the rangegiven by other authors for the common sheep strain (1, 2,39, 40). However, there were significant differences inalmost all the variables between the Argentinean andSpanish isolates. The results from the PCA analysis show-ing that all the morphological variables could be reducedto two functional ones coincide with previous studieswhere a multivariate analysis was performed (1, 3, 31).Also the PCA showed the existence of two distinct clearlyseparated groups: one corresponding to the Argentineansamples and the other to the Spanish ones.\nIn conclusion, the comparison of the epidemiological\ncysts features, of the larval rostellar hooks morphometry,and of the mitochondrial genes CO1 and ND1 sequences,showed some differences between cattle isolates fromthe endemic regions of Argentina and Spain studied inthe present work. The most important phenotypic factordifferentiating the Argentinean and Spanish cattle isolatesis related to their viability and fertility features. In addi-tion, the factorial analysis for morphometric data showedthe existence of two distinct clearly separated groups (one224 Revista Argentina de Microbiolog\u00eda (2009) 41: 218-225\ncorresponding to the Argentinean samples and the other\nto the Spanish ones). In addition, the comparison of se-quence data showed differences within the G1 genotype.Since the G1 genotype microvariants for the mitochon-drial genes CO1 and ND1 registered in the present studyappear in cattle as well as in sheep from the same regionof Argentina, we suggest that this genetic variability isindependent from the host species or breed (3). Probablyall the differences, from an epidemiological point of view,are related to the effectiveness of the control programmesof the hydatid disease in both countries. While in the south-eastern region of Buenos Aires province the prevalenceof the hydatid disease in cattle has not decreased be-tween 1999 and 2004, in Spain the decrease in the preva-lence of the disease in cattle, sheep and pigs between2000 and 2005 was achieved through efficient controlprogrammes  (3, 11, 14, 15, 16).\nFurther studies involving other epidemiological,\nmorphometric and molecular data from cattle and otherintermediate hosts (like sheep, pigs, and horses) wouldcontribute to expand this investigation.\nAcknowledgements:  The authors wish to acknowledge Mr.\nOscar Chasma\u2019s help in the collection of the bovine material inArgentina. This work was partially supported by PICT-O \u00b402 N\u00ba08-11342, BID 1728/OC-AR and PIP N\u00ba 02172, CONICET (Ar-gentina).\nREFERENCES\n1. Ahmadi NA. Using morphometry of the larval rostellar hooks\nto distinguish Iranian strains of Echinococcus granulosus.\nAnn Trop Med Parasitol 2004; 98: 211-20.\n2. Ahmadi N, Dalimi A. Characterization of Echinococcus\ngranulosus  isolates from human, sheep and camel in Iran.\nInfect Genet Evol 2006; 6: 85-90.\n3. Andresiuk MV. Determinaci\u00f3n de cepas de Echinococcus\ngranulosus y su importancia en la epidemiolog\u00eda de la\nhidatidosis-echinococcosis en el sudeste de la provinciade Buenos Aires\n. Tesis Doctoral, Universidad Nacional\nde Mar del Plata, Mar del Plata, Buenos Aires, Argentina,2009.\n4. Bardonnet K, Benchikh-Elfegoun MC, Bart JM, Harraga S,\nHannache N, Haddad S \net al. Cystic echinococcosis in\nAlgeria: cattle act as reservoirs of a sheep strain and maycontribute to human contamination . Vet Parasitol 2003; 116:\n35-44.\n5. Bart JM, Abdukader M, Zhang YL, Lin RY, Wang YH, Nakao\nM, \net al. Genotyping of human cystic echinococcosis in\nXinjiang, PR China. Parasitology 2006; 133: 571-9.\n6. Bart JM, Morariu S, Knapp J, Ilie MS, Pitulescu M, Anghel\nA, et al. Genetic typing of Echinococcus granulosus  in\nRomania. Parasitol Res 2006; 98: 130\u20137.\n7. Bowles J, Blair D, McManus DP. Genetic variants within\nthe genus Echinococcus identified by mitochondrial DNA\nsequencing. Mol Biochem Parasitol 1992; 54: 165-74.\n8. Bowles J, Blair D, McManus DP. Molecular genetic\ncharacterization of the cervid strain (northern form) of\nEchinococcus granulosus . Parasitology 1994; 109: 215-21.\n9. Bowles J, McManus DP. NADH dehydrogenase 1 gene\nsequences compared for species and strains of the genus\nEchinococcus . Int J Parasitol 1993; 23: 969-72.\n10. Busi M, Snabel V, Varcasia A, Garippa G, Perrone V, DeLiberato C, et al. Genetic variation within and between G1\nand G3 genotypes of Echinococcus granulosus in Italy\nrevealed by multilocus DNA sequencing.  Vet Parasitol 2007;\n150: 75\u201383.\n11. Carmena D, S\u00e1nchez-Serrano LP, Barbero-Mart\u00fd\u00ednez, I.\nEchinococcus granulosus  Infection in Spain. Zoonoses\nPublic Health 2008; 55: 156\u201365.\n12. Cattell RB. The Scree Test for the number of factors.\nMultivariate Behav Res 1966; 1: 245-76.\n13. Cuesta-Bandera C, McManus DP, Rishi AK. Characterization\nof Echinococcus granulosus  of Spanish origin by DNA\nrestriction endonuclease analysis and Southern blothybridization. Int J Parasitol 1988; 18: 137-41.\n14. Denegri GM, Elissondo M C, Dopchiz MC. Situaci\u00f3n de la\nhidatidosis-echinococcosis en la Rep\u00fablica Argentina. Mardel Plata, Buenos Aires, Argentina, Editorial Mart\u00edn, 2002.\n15. Dopchiz MC. Aspectos epidemiol\u00f3gicos de la hidatidosis-\nechinococcosis en el sudeste de la provincia de Buenos Aires.Mar del Plata, Buenos Aires, Argentina, Editorial Martin, 2006.\n16. Dopchiz MC, Elissondo MC, Andresiuk MV, Maiorini E,\nGuti\u00e9rrez AM, Muzulin PM, \net al. Pediatric hydatidosis in\nthe south-east of the Buenos Aires province, Argentina. RevArgent Microbiol 2009; 41: 105-11.\n17. Garc\u00eda Llamazares JL, Alvarez de Felipe AI, Redondo\nCarde\u00f1a PA, Prieto Fern\u00e1ndez JG. Estudio de la fertilidady viabilidad de quistes hidat\u00eddicos ovinos. Rev Esp SaludP\u00fablica 1997; 5: 445-9.\n18. Gonz\u00e1lez LM, Daniel-Mwambete K, Montero E, Rosenzvit\nMC, McManus DP\n. Further molecular discrimination of\nSpanish strains of Echinococcus granulosus.  Exp Parasitol\n2002; 102: 46-56.\n19. Haag KL, Ayala FJ, Kamenetzky L, Guti\u00e9rrez A, Rosenzvit\nM. Livestock trade history, geography, and parasite strains:the mitochondrial genetic structure of \nEchinococcus\ngranulosus in Argentina. J Parasitol 2004; 90: 234\u20139.\n20. Instituto Nacional de Estad\u00edsticas y Censos. INDEC. Sec-\ntor Agropecuario. Ganader\u00eda. http://www.indec.mecon.ar.\n21. Kamenetzky L, Guti\u00e9rrez AM, Canova SG, Haag KL,\nGuarnera EA, Parra A, et al. Several strains of Echinococcus\ngranulosus  infect livestock and humans in Argentina.  Infect\nGenet Evol 2002; 2: 129-36.\n22. Kedra HA, Swiderski Z, Tkach VV, Dubinski P, Paw\u00b3owski Z,\nStefaniak J, et al. Genetic analysis of Echinococcus granulosus\nfrom humans and pigs in Poland, Slovakia and Ukraine. Amulticentre study.\n Acta Parasitol 1999; 44: 248-54.\n23. Lahmar S, Ch\u00e9hida FB, P\u00e9tavy AF, Hammou A, Lahmar J,\nGhannay A, et al.  Ultrasonographic screening for cystic\nechinococcosis in sheep in Tunisia. Vet Parasitol 2007; 143:42-9.\n24. Lavikainen A, Lehtinen MJ, Meri T, Hirvela-Koski V, Meri\nS. Molecular genetic characterization of the Fennoscandiancervid strain, a new genotypic group (G10) of \nEchinococcus\ngranulosus . Parasitology 2003; 127: 207-15.\n25. Mrad S, Filisetti D, Oudni M, Mekki M, Belguith M, Nouri A,\net al. Molecular evidence of ovine (G1) and camel (G6)\nstrains of Echinococcus granulosus  in Tunisia and putative\nrole of cattle in human contamination . Vet Parasitol 2005;\n129: 267-72.\n26. Mwambete DK, Ponce-Gordo F, Cuesta-Bandera C. Genetic\nidentification and host range of the Spanish strains of\nEchinococcus granulosus.  Acta Trop 2004; 91:87-93.\n27. Nakao M, McManus DP, Schantz PM, Craig PS, Ito A. A\nmolecular phylogeny of the genus Echinococcus inferred\nfrom complete mitochondrial genomes. Parasitology 2007;134: 713-22.\n28. National Center for Biotechnology Information. NCBI.  http:/\n/www.ncbi.nlm.nih.gov.\n29. Obwaller A, Schneider R, Walochnik J, Gollackner B, Deutz\nA, Janitschke K, \net al. Echinococcus granulosus strainEchinococcus granulosus  from Argentina and Spain 225\ndifferentiation based on sequence heterogeneity in\nmitochondrial genes of cytochrome c oxidase-1 and NADHdehydrogenase-1. Parasitology 2004; 128: 569-75.\n30. Ponce Gordo F. Caracterizaci\u00f3n biol\u00f3gica de los genotipos\nde \nEchinococcus granulosus  de origen espa\u00f1ol. Tesis Doc-\ntoral, Universidad Complutense de Madrid, Madrid, Espa-\u00f1a, 1995.\n31. Ponce Gordo F, Cuesta Bandera C. Differentiation of\nSpanish strains of \nEchinococcus granulosus  using larval\nrostellar hook morphometry. Int J Parasitol 1997; 27: 41-9.\n32. Rinaldi L, Maurelli MP, Capuano F, Perugini AG, Veneziano\nV, Cringoli S. Molecular update on cystic echinococcosis incattle and water buffaloes of southern Italy. Zoonoses PublicHealth 2008; 55: 119-23.\n33. Rosenzvit MC, Zhang LH, Kamenetzky L, Canova S,\nGuarnera EA, McManus DP. Genetic variation and epidemiologyof \nEchinococcus granulosus in Argentina. Parasitology 1999;\n118: 523-30.\n34. Saarma U, J\u00f5gisalu I, Moks E, Varcasia A, Lavikainen A,\nOksanen A, et al. A novel phylogeny for the genus\nEchinococcus  based on nuclear data challenges\nrelationships based on mitochondrial evidence. Parasitology2009; 21: 1-12.\n35. Scott JC, Stefaniak J, Pawlowski ZS, McManus DP. Molecular\ngenetic analysis of human cystic hydatid cases from Poland:\nRecibido: 11/08/09 \u2013 Aceptado: 29/10/09identification of a new genotypic group (G9) of Echinococcus\ngranulosus . Parasitology 1997; 114:  37-43.\n36. Siles-Lucas M, Benito MC, Cuesta-Bandera C. Echino-\ncoccus granulosus : genomic and isoenzymatic study of\nSpanish strains isolated from different intermediate hosts.Vet Parasitol 1996; 63: 273-82.\n37. Siles-Lucas M, Felleisen R, Cuesta-Bandera C, Gottstein\nB, Eckert J. Comparative genetic analysis of Swiss andSpanish isolates of \nEchinococcus granulosus by southern\nhybridization and Random Amplified Polymorphic DNAtechnique. Appl Parasitol 1994; 35: 107-17.\n38. Smyth JD, Davies Z. Occurrence of physiological strains of\nEchinococcus granulosus  demonstrated by in vitro culture\nof protoscoleces from sheep and horse hydatid cysts. Int JParasitol 1974; 4: 443-5.\n39. Tashani OA, Zhang LH, Boufana B, Jegi A, McManus DP.\nEpidemiology and strain characteristics of \nEchinococcus\ngranulosus  in the Benghazi area of eastern Libya. Ann Trop\nMed Parasitol 2002; 96: 369-81.\n40. Thompson RCA, Kumaratilake LM, Eckert J. Observations\non Echinococcus granulosus  of cattle origin in Switzerland .\nInt J Parasitol 1984; 14: 283-91.\n41. Thompson RCA, McManus DP. Towards a taxonomic\nrevision of the genus Echinococcus . Trends Parasitol 2002;\n18: 452-7.226 Revista Argentina de Microbiolog\u00eda (2009) 41: 226-231 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 226-231 ART\u00cdCULO ORIGINAL\nAntibacterial and antioxidant activities of the essential oil  of\nArtemisia echegarayi Hieron. (Asteraceae)\nA. LACIAR1*, M. L. VACA RUIZ1, R. CARRIZO FLORES2, J. R. SAAD2\n 1\u00c1rea Microbiolog\u00eda , 2\u00c1rea de Qu\u00edmica Org\u00e1nica-INTEQUI-CONICET. Universidad Nacional de San Luis. Chacabuco y\nPedernera. 5700 San Luis. Argentina\n*Correspondence. E-mail: alaciar@unsl.edu.ar\nABSTRACT\nArtemisia echegarayi  Hieron. (Asteraceae) is commonly known in Argentina as \u201cajenjo\u201d. Many studies report high\nefficacy of essential oils against food-borne pathogenic bacteria. The antimicrobial activity and minimal inhibitoryconcentration of\n A. echegarayi  essential oil were evaluated against seven bacterial species of significant importance\nin food hygiene, by using the disc diffusion assay and the micro-well dilution method, respectively. Volatile compo-nents of the extract were analyzed by gas chromatography-mass spectrometry and major components were deter-mined. Furthermore, the essential oil was tested for its antioxidant activity. The essential oil inhibited the growth ofgram-positive and gram-negative tested bacteria, with the exception of \nProteus mirabilis . A. echegarayi  essential oil\npresented the lowest minimal inhibitory concentration against Listeria monocytogenes  and Bacillus cereus . Two terpe-\nnes, thujone and camphor, were identified from this essential oil as the principal constituents responsible for antibac-terial activity. The oil showed a free radical scavenging activity equivalent to 50% of the reference compound. Thesepreliminary studies showed promising results since this essential oil may provide an alternative to promote its use asa natural food additive.\nKeywords : \nArtemisia echegarayi , essential oil, antibacterial activity, antioxidant activity\nRESUMEN\nActividad antibacteriana y antioxidante del aceite esencial extra\u00eddo de Artemisia echegarayi Hieron.\n(Asteraceae). Artemisia echegarayi  Hieron. (Asteraceae), conocida como \u201cajenjo\u201d, es una planta t\u00edpica de la regi\u00f3n\nde Cuyo (Argentina). En este trabajo se evalu\u00f3 la actividad antimicrobiana in vitro y la concentraci\u00f3n inhibitoria\nm\u00ednima del aceite esencial extra\u00eddo de sus partes a\u00e9reas frente a especies bacterianas que con frecuencia contaminanlos alimentos. Se utilizaron las t\u00e9cnicas de difusi\u00f3n con discos en agar y microdiluci\u00f3n en placa respectivamente.Adem\u00e1s, se determin\u00f3 la actividad antioxidante de este aceite esencial \nin vitro por espectrofotometr\u00eda. En general,\ntanto las bacterias gram-positivas como las gram-negativas fueron inhibidas por este aceite, con excepci\u00f3n de Pro-\nteus mirabilis . Listeria monocytogenes y Bacillus cereus  resultaron ser las bacterias m\u00e1s sensibles. El an\u00e1lisis por\ncroma-tograf\u00eda en fase gaseosa y espectrometr\u00eda de masa permiti\u00f3 la identificaci\u00f3n cualitativa y cuantitativa de loscomponentes mayoritarios del aceite esencial del ajenjo. Entre ellos, la tuyona y el alcanfor se destacaron como losprincipales responsables de la actividad antibacteriana observada. Los datos preliminares obtenidos en el presenteestudio sugieren que el aceite esencial de \nArtemisia echegarayi  representa una alternativa para promover su empleo\ncomo aditivo natural en alimentos.\nPalabras clave:  Artemisia echegarayi , aceite esencial, actividad antibacteriana, actividad antioxidante.\nINTRODUCTION\nThe beneficial health effects of extracts from many types\nof plants have been acknowledged for centuries (13).\nEssential oils (EOs) are aromatic and volatile oily liq-\nuids obtained from plant material such as leaves, bark orfruit (22). Although the antibacterial properties of EOs havelong been known, the recent interest in alternative natu-rally derived antimicrobials has led to a renewed scien-tific interest in these substances. Many studies\n in vitro\nhave reported high efficacy of EOs against food-bornepathogenic bacteria (11, 18, 29).Nowadays, the excessive use of synthetic antimicro-\nbial compounds in food manufacture as additive agentsis well known, many of which are suspected for their re-sidual toxicity. Several EOs offer potential applications infood preservation, and the use of EOs in the food indus-try can help reduce the addition of chemical preserva-tives as well as the intensity of heat treatments, resultingin foods which are more naturally preserved and richer inorganic properties (16).\nBecause of the extraction mode, mostly by distillation\nfrom aromatic plants, the EOs contain a variety of volatilemolecules such as terpenes and terpenoids, phenol-de-Ford-borne bacteria and essential oil 227\nrived aromatic components and aliphatic components. In\nparticular, the antioxidant capacity of these compoundshas been described to promote their use as natural foodadditives (1).\nArtemisia echegarayi  Hieron. (Asteraceae) is com-\nmonly known as \u201cajenjo\u201d in the Region of Cuyo, Argen-tina. This is a plant of about one meter high, with ash-grey green colour leaves and clustered in spherical chap-ters (capitula) of 34-64 flowers.\n A. echegarayi  grows on\nslopes of the Central Andes region especially in the prov-inces of Mendoza, San Juan and La Rioja, at a height of2000-3000 m above sea level. Nowadays, there is notmuch information of the bioactivity of \nA. echegarayi  es-\nsential oil (EO). However, there are many reports on thebioactivities of essential oils of other species from thegenus \nArtemisia. Several of them are used in folk medi-\ncine, for example: Artemisia douglassiana  is used as gas-\ntric cytoprotector (20, 31) and topical bactericidal agent\non skin burns (26). A. annua is known by its antimalarial,\nanti-inflammatory and anti-carcinogenic  properties (19).\nThe purpose of the study presented here was to gain\ninsight on the antioxidant and antimicrobial activities of\nA. echegarayi  EO against a range of food-borne bacte-\nria, including gram-negative and gram-positive bacteria.Moreover, volatile components of the extract were ana-lyzed by gas chromatography-mass spectrometry (GC-MS) and the major components were determined.\nMATERIAL AND METHODS\nPlant material\n Artemisia echegarayi Hieron. (Asteraceae) aerial parts were\ncollected in Potrerillos, province of Mendoza, Argentina, in Feb-ruary 2008. The plant was identified by Ing. Luis Del Vitto, and avoucher specimen is kept at San Luis University (UNSL) her-barium, Argentina (N\u00b0\n 492).\nExtraction of essential oil\nFresh aerial parts (5,000 g) were cut into small pieces and\nsubjected to steam-distillation at 96 \u00b0C for 3 h using a Clevenger-type apparatus. The oil obtained was dried over anhydrous so-dium sulphate (21).\nChemical characterization of the essential oil\nThe \nA. echegarayi EO composition was determined by GC-\nMS through comparison of the major signals with an MS library(20). Retention times and mass spectral data were checked withthose obtained from authentic samples and/or from the MS instru-ment library. Relative percentages of the major components werecalculated by integrating the registered peaks. GC-MS experimentswere performed on an ion trap GCQ-Plus (Finnigan, ThermoQuest,Austin, TX, USA) instrument with MS-MS program using a silicacapillary column Rtx\n\u00ae -5MS (30 m x 0.25 mm ID, 0.25 \u00b5m). The\ncarrier gas was helium (40 cm/s-1). The port temperature was 200\n\u00b0C in the splitless mode with 1.0 ml injection volume. The initialGC temperature was maintained at 40 \u00b0C for 2 min, then increasedto 210 \u00b0C at 2 \u00b0C/min, and maintained at this temperature up to120 min. For the analysis of low resolution MS, the ion trap massdetector was set in full scan mode from \nm/z 50 to m/z 450. For the\nproduct analysis (CID), the precursor was selected using tandemmass spectrometry (MS/MS) scan standard function, with 0.5 Da\npeak-widths for the parent ion and dynamically programmed scans,as described previously (10).\nMicroorganisms\nA total of 8 bacteria were selected for this study. Two strains\nof\n Listeria monocytogenes were obtained from the Pasteur Insti-\ntute, France, culture collection: CLIP 74903 and CLIP 74904,while \nBacillus cereus , Staphylococcus aureus,  Escherichia coli ,\nSalmonella enterica  serovar Enteritidis, Salmonella enterica\nserovar Typhimurium  and Proteus mirabilis  were isolated at the\nUNSL laboratory. These bacteria were chosen in order to repre-sent the diversity of species responsible for food-borne diseases.\nAntimicrobial activity\nDisk diffusion assay. The antimicrobial activity of \nA.\nechegarayi EO was determined by the standard disc diffusion\ntechnique (CLSI) (25, 31). A population of approximately 108\nCFU/ml of each strain was inoculated on duplicate plates con-taining M\u00fceller Hinton Agar (MH) (Britania, Argentina) using sterilecotton swabs. The plates were allowed to dry for 5 min at roomtemperature. Sterilised paper discs (Britania, Argentina) of 6 mmdiameter were used. Ten microlitres of \nA. echegarayi EO were\nadded to impregnate paper disks and allowed to dry for 15 min.Commercial gentamicin discs (10 \u00b5g, Britania, Argentina) wereused as positive control. The discs were then placed asepticallyover the surface of the bacterial cultures on MH plates and incu-bated at 37 \u00b0C for 24 h. After incubation, the inhibition zonesaround paper discs were measured accurately using a metricruler. The assays were carried out on duplicate MH plates foreach strain. The experiments were replicated at least twice.\nDetermination of Minimal Inhibitory Concentration (MIC) .\nThe MICs of \nA. echegarayi  EO and gentamicin (antibiotic\nreference) were determined by the microplate method (micro-well dilution) according to the CLSI method\n (Clinical and Labora-\ntory Standard Institute, 2005) (formerly NCCLS) (8), in MH broth(Britania, Argentina) pH 7.2 supplemented with 0.01% (w/v) of2,3,5-triphenyltetrazolium chloride (TTN) as visual indicator ofbacterial growth. The inoculum of each strain was prepared from18 h broth culture and adjusted to the tube 0.5 of Mc Farlandscale (10\n8 bacterial cells). Then, they were diluted 100 times.\nThe EO was dissolved in 20% Tween 80 and then diluted withphosphate buffer saline (PBS) to the highest concentration to betested (75 \u00b5g/ml), and then serial two-fold dilutions were made inconcentration ranges from 75 to 2.4 \u00b5g/ml. In addition, gentami-cin dilutions were prepared in a concentration range from 128 to0.25 \u00b5g/ml. The 96-well plates were prepared by dispensing intoeach well 95 \u00b5l of nutrient broth and 5 \u00b5l of the inoculum (finalconcentration of 10\n4 CFU/ml). One hundred microlitre aliquot from\nthe stock solutions of the EOs and their serial dilutions initiallyprepared was transferred into six consecutive wells. The final vol-ume in each well was 200 \u00b5l. The plates were covered with sterileplate sealer and then incubated at 37 \u00b0C for 24 h. MIC was de-fined as the lowest concentration of the EO in the medium in whichthere was no visible growth after incubation (no red colour signify-ing live growth). It is established that TTN, a water-insoluble, col-orless compound, can be reduced to water-insoluble red formazanby a variety of organisms. TTN reduction is used as a quantitativemethod in the evaluation of tissue viability (33). The experimentswere replicated at least twice.\nThin-Layer chromatography (TLC)\nMerck F\n254 plates, 10 x 10 cm, 1mm thick were used.  A.\nechegarayi  EO was applied and the chromatogram developed\nusing n-hexane-ethyl acetate (95:5) as solvent. TLC plates wererun in duplicate. Spots and bands were visualized by H\n2SO4 spray\nreagent. Thujone (Sigma-Aldrich) and camphor (Sigma-Aldrich)were used as standards. TLC plates were dried overnight in asterile room for complete removal of solvent.228 Revista Argentina de Microbiolog\u00eda (2009) 41: 226-231\nBioautography\nPlates TLC were covered with 1-2 mm layer of soft medium\n(BHI with 0.6% agar) containing 0.1% (w/v) TTN (tetrazoliumred) and an aliquot of an overnight culture of \nL. monocytogenes\n(CLIP 74903) (108 CFU/ml) and P. mirabilis (108 CFU/ml). The\nplates were placed in a sterile tray, sealed to prevent the thinagar layer from drying, and incubated at 37 \u00b0C for 24 h. Wheremicrobial growth has been inhibited, an uncoloured area can beseen on the deep pink-red background. The plates were run induplicate.\nAntioxidant activity\n2, 2\u2019-diphenylpicrylhydrazyl (DPPH) assay\nThe hydrogen atom or electron donation ability of the corre-\nsponding oils and some pure compounds were measured fromthe bleaching of purpled coloured methanol solution of DPPH.This spectrophotometer assay uses stable DPPH as  reagent\n (5,\n20). Five hundred microlitres of this solution were added to 500\u00b5l of EO methanol solution in 1 cm path length disposablemicrocuvette. After a 30 min-incubation period at room tempera-ture, the absorbance at 517 nm was read against a blank. Inhibi-tion free radical DPPH in percent (I %) was calculated in thefollowing way:\n    I%= (\nABlank- ASample)/ ABlank \u00d7 100\n Where ABlank is the absorbance of the control reaction (con-\ntaining all reagents except the test compound), and ASample is the\nabsorbance of the test compound. Rutine, a quercetin glucosidewas used as reference compound. The assay was repeated twice.RESULTS\nThe EO extracted from leaves of A. echegarayi  plant\nby hydrodistillation presented light blue colour, fragrantsmell and density of 0.915 g/ml and a yield of 0.56 g/kg  ofplant material. The \nA. echegarayi  EO on the GC-MS\nanalysis resulted in the identification of 15 constituentsrepresenting 92.48% (Table 1). The major componentswere 3-thujanone (49.25%) and thujone (10.72%).These components have the following chemical groupsin their structure: hydrocarbons, alcohols, ketones andesthers.\nA. echegarayi  EO showed antibacterial activity against\nall tested bacteria, except for P. mirabilis.  Generally,  gram-\npositive bacteria were more sensitive to A. echegarayi\nEO than gram-negative bacteria, and L. monocytogenes\nCLIP 74903 and B. cereus  were among the most sensi-\ntive with MIC of = 2.4 \u00b5g/ml (Table 2).\nTo obtain some information on the active components,\nA. echegarayi  EO was analyzed by TLC on silica gel plates\nand assayed by bioautography. Figure 1 shows the ap-pearance of the chromatogram after treatment with \nL.\nmonocytogenes , indicating the localization of the bacte-\nrial inhibition zone.\nTable 1. Chemical composition of A. echegarayi  EO (by GC(1) and GC-MS(2) analysis)\nCompound Retention time (min) Percentage\nthujene 19.906 2.69\no-isopropyltoluene 23.466 1.19eucalyptol 23.936 3.404-thujanol 25.925 1.123-thujanone 30.158 49.25thujone 30.694 10.72\ncamphor 32.405 5.07\nborneol 34.203 5.26\n4-terpineol 34.902 3.35a-terpinol 35.842 1.15\nbornyl acetate 42.638 3.972-methyl-3-phenyl-propanoic acid 47.611 0.703-isopropylidene-tricycle[4.3.1.1.[2.5]undecan-10-one 55.766 1.03elixene 56.852 3.04\n3,4,4-trimethyl-3-[3-methyl-1,3-butadienyl]-bicycle[4.1.0]heptan-2-one, 67.496 0.54Total identified 92.48\n(1)GC: gas chromatography, (2)GC-MS: gas chromatography-mass spectrometry.Ford-borne bacteria and essential oil 229\nThe A. echegarayi  EO presented moderate antioxidant\nactivity (50% of free radical DPPH inhibition). Its antioxi-dant activity was lower than that of quercetin, a powerfulnatural antioxidant (100%).\nDISCUSSION\nThe use of EOs in food industry can be an alternative\nto satisfying the increasing consumers\u2019 demand for fresh-tasting, ready-to-eat, minimally-processed foods and alsoto developing \u201cnovel\u201d food products (e.g. less acidic, orwith lower salt content) (17).\nDetermination of the inhibition zones by means of the\ndisc diffusion method showed that the EO of an Argen-tine native plant,\n A. echegarayi, exhibited an antibacte-\nrial effect against gram-positive and gram-negativefoodborne pathogen tested bacteria. The minor suscepti-bility of gram-negative bacteria may be attributed to anouter membrane surrounding the cell wall which restrictsdiffusion of hydrophobic compounds through the li-popolysaccharide. Moreover, the periplasmic space con-\ntains enzymes, which are able to break down foreignmolecules introduced from outside (12). This can be con-firmed analyzing the chemical composition of the \nA.\nechegarayi  EO; therefore we could conclude that the an-\ntibacterial activity following TLC separation of EO  A.\nechegarayi  was found to be attributed mainly to the pres-\nence of two major constituents, thujone and camphor.They cause leaking of cell contents due to alterations onthe membrane permeation system (6).\nIn the present study, an interesting finding has been\nthat all strains tested, except \nP. mirabilis,  showed MICs\nranging from \u2264 2.4 to 18.7 \u00b5g/ml. These values confirm\nthe existence of a significant activity of A. echegarayi  EO\nagainst  gram-positive and gram-negative bacteria con-sidering Barbi\u00e9ri\u2019s reports which suggested that if the EOdisplayed a MIC lower than 100 \u00b5g/ml, the antimicrobialactivity is good (3).\n L. monocytogenes  CLIP 74903 was more susceptible\nthan L. monocytogenes  CLIP 74904. These results are in\nagreement with those reported by Barbi\u00e9re Holetz, whoreported that within bacterial species, EO efficacy wasdependent on the strain and in some cases on the strainorigin (27).\nMoreover, the results can be explained considering\nthe efficacy of the main components of EO isolated fromaerial parts of\n A. echegarayi . The chemical composition\nwas investigated by GC-MS and the results showed highcontents of terpenes: 3-thujanone, thujone, borneol andcamphor were the main components, whose contentswere 49.25%, 10.72%, 5.26% and 5.07% respectively.Among these, thujone and camphor are responsible forthe antimicrobial properties reported here. In this respect,they have also shown to be responsible for antibacterialactivity of EOs from different \nArtemisia species. For ex-\nample, thujone and camphor have been identified as themajor compounds with antibacterial activity in \nArtemisiaFigure 1.  Thin layer chromatography plate of A. echegarayi\nessential oil. (A) visual appearance. (B) Listeria monocytogenes\n(CLIP 74903) bioautography overlay. Arrows indicate regions of\ninhibition growth visualized with tetrazolium red. (1) A. echegarayi\nessential oil. (2) Thujone (standard). (3) Camphor (standard).Table 2: Antibacterial activity of A. echegarayi  EO\nBacteria Inhibition diameter (mm)(2)MIC\n(3)A. echegarayi  EO(4)Gentamicin(5)A. echegarayi  EO(6)Gentamicin\nS.  aureus 10.0 \u00b1 1.4 20.5 \u00b1 2.0 9.4 \u2264 0.25\nB.  cereus 9.70 \u00b1 0.6 22.5 \u00b1 2.0 \u2264 2.4 2.00\nL.  monocytogenes  (1)CLIP 74904 10.0 \u00b1 2.0 30.2 \u00b1 2.7 9.4 1.00\nL.  monocytogenes   (1)CLIP 74903 12.5 \u00b1 1.1 31.8 \u00b1 2.4 \u2264 2.4 1.00\nS. Typhimurium 6.30 \u00b1 0.6 21.0 \u00b1 1.4 18.7 0.50\nS. Enteritidis 7.70 \u00b1 0.6 22.0 \u00b1 2.8 18.7 1.00\nP. mirabilis 0.00 \u00b1 0.0 17.5 \u00b1 0.7 75 .0 4.00\nE. coli 9.00 \u00b1 0.0 23.5 \u00b1 2.0 18.7 1.00\n(1)CLIP: Listeria Collection of the Pasteur Institute; (2)MIC: Minimal inhibitory concentration; (3)A. echegarayi  essential oil, 10\u00b5l/disc;\n(4)10\u00b5g/disc;  (5)\u00b5g/mL; (6)\u00b5g/ml;  \u00b1: standard deviation.\n230 Revista Argentina de Microbiolog\u00eda (2009) 41: 226-231\nabsinthium , Artemisia scoparia  and Artemisia sieberiri\nEOs  (14, 24).\nTerpenes are naturally occurring substances produced\nby a wide variety of plants and animals. A broad range ofthe biological properties of terpenoids has been described,including cancer chemopreventive effects, antioxidant,antimicrobial, antifungal, antiviral, antihyperglycemic, anti-inflammatory, and antiparasitic activities (23).\nIdentification of terpenoid constituents as principal\nagents in this plant is consistent with the results of a num-ber of early studies on other plants. The antibacterial activ-ity of terpenoids is generally believed to involve actions onphospholipid membranes, where partitioning results indestabilisation and disorder culminating in ion leakage inbacteria and disruption of membrane-dependent energy-generating processes in eukaryotic microorganisms (28).\nThe EOs extracted by distillation of aromatic plants,\ncontain a variety of volatile molecules such as terpenesand terpenoids, phenol- derived aromatic components andaliphatic components. \nIn vitro physicochemical assays\ncharacterize most of them as antioxidants (4, 30). Thus,in this work, terpenes, particularly those with activatedmethylene groups in their molecules, could probably bethe reason of the antioxidant activity shown by \nA.\nechegarayi  EO. From this, it was inferred that it could be\nbeneficial for human health in line with recent findingsand common belief that many diseases are due to anoverload of oxidative stress reactions following excessiveconsumption of fat, sugar, meat, etc. Antioxidants arebelieved to be directly antimutagenic (7) and anticar-cinogenic due to their radical scavenging properties (9,15). However, recent work shows that in eukaryotic cells,essential oils can act as prooxidants by intermediate ofterpenes affecting the cellular redox status. This may playa significant \u201cprotective\u201d role by removing damaged cellsby apoptosis (2, 32).\nBecause \nA. echegarayi EO was inhibitory in small\nquantities to selected pathogenic microorganisms, thesepreliminary results suggest it may provide alternatives toconventional additives in food products. Furthermore, thisEO may add prooxidant effects and thus, could be em-ployed in traditional and modern medical domains.\nAcnowledgements: We thank the UNSL (Projects 7301 and\n8802), CONICET (PIP 6228) for the financial support of this study.\nREFERENCES\n1. Bakkali F, Averbeck S, Averbeck D, Idaomar M . Biological\neffects of essential oils- A review. Food Chem. Toxicology2007; 46: 446-75.\n2. Bakkali F, Averbeck S, Averbeck D, Zhiri A, Baudoux D,\nIdaomar M. Antigenotoxic effects of three essential oils indiploid yeast (\nSaccharomyces cerevisiae ) after treatments\nwith UVC radiation, 8-MOP plus UVA and MMS . Mutat. Res .\n2006; 606: 27-38.\n3. Barbi\u00e9ri Holetz  F, Pessini G, Sanches N, Garcia Cortez A,Nakamura C, Dias Filho B. Screening of some plants used\nin the Brazilian folk medicine for the treatment of infectiousdiseases. Mem. Inst. Oswaldo Cruz, Rio de Janeiro 2002;97: 1027-31.\n4. Basile A, Senatore F , Gargano R, Sorbo S, Del Pezzo M,\nLavitola A, et al. Antibacterial and antioxidant activities in\nSidris italica  (Miller) Greuter et Burdet essential oils. J\nEthnopharmacol 2006; 107: 240-8.\n5. Burits M, Bucar F. Antioxidant activity of Nigella sativa\nessential oil. Phytother Res 2000; 14: 323-8.\n6. Burt S. Essential oils: their antibacterial properties and\npotential applications in foods-a review. Int J Food Microbiol2004; 94: 223-53.\n7. Clark S. The biochemistry of antioxidants revisited. Nutr\nClin Pract 2002; 17: 5-17.\n8. Clinical and Laboratory Standard Institute (formerly NCCLS)\n2005; 15\nth Informational Supplement. Disc Diffusion. 5:1.\n9. Collins A. Antioxidant intervention as a route to cancer\nprevention. Eur J Cancer 2005; 41: 1923-30.\n10. Constantin M, Sartorelli P, Limburger R, Henriques A,\nSteppe M, Ferreira M, et al.  Essential oils from Piper\ncernuum and Piper regnellii : antimicrobial activities and\nanalysis by GC/MS and 13C-NMR. Planta Med . 2001; 67:\n771-3.\n11. Dorman H, Deans S. Antimicrobial agents from plants:\nantibacterial activity of plant volatile oils. J Appl Microbiol2000; 88: 308-16.\n12. Duffy C, Power R. Antioxidant and antimicrobial properties\nof some Chinese plants extracts. Int J Antimicrob Agents2001; 17: 527-9.\n13. Elgayyar M , Draughon F, Golden D, Mount J. Antimicrobial\nactivity of essential oils from plants against selectedpathogenic and saprophytic microorganisms. J Food Prot2001; 64: 1019-24.\n14. Farzaneh M, Ahmadzadeh M, Hadian J, Tehrani A.\nChemical composition and antifungal activity of the essentialoils of three species of \nArtemisia on some soil-borne\nphytopathogens. Commun Agric Appl Biol Sci . 2006; 71:\n1327-33.\n15. Ferguson L, Philpott M, Karunasinghe N. Dietary cancer and\nprevention using antimutagens. Toxicol . 2004; 198: 147-59.\n16. Gutierrez J, Barry-Ryan C, Bourke P. The antimicrobial\nefficacy of plant essential oil combinations and interactionswith food ingredients. Int J Food Microbiol 2008; 124: 91-7.\n17. Gutierrez J, Rodriguez G, Barry-Ryan C, Bourke P. Efficacy\nof plant essential oils against food-borne pathogens andspoilage bacteria associated with ready-to-eat vegetables:antimicrobial and sensory screening. J Food Prot 2008; 71:1846-54.\n18. Hammer K, Carson C, Riley T. Antimicrobial activity of\nessential oils and other plant extracts. J Appl Microbiol 1999;86: 985-90.\n19. Juteau F, Masotti V, Bessiere J, Dherbomez M, Viano J.\nAntibacterial and antioxidant activities of \nArtemisia annua\nessential oil. Phytother 2000; 73: 532-5.\n20. Lopes-Lutz D, Alviano D, Alviano C, Kolodziejczyk P.\nScreening of chemical composition, antimicrobial andantioxidant activities of \nArtemisia  essential oils.\nPhytochemistry 2008; 69: 1732-8.\n21. Norajit  K, Laohakunjit N, Kerdchoechun O. Antibacterial\neffect of Zingiberaceae  essential oils. Molecules 2007; 12:\n2047-60.\n22. Oussalah M, Caillet S, Lacroix M. Mechanism of action of\nSpanish oregano, Chinese cinnamon, and savory essentialoils against cell membranes and walls of \nEscherichia coli\nO157:H7 and Listeria monocytogenes . J Food Prot 2006;\n69: 1046-55.\n23. Paduch R, Kandefer-Szerszen M, Trytek M, Fiedurek J.\nTerpenes: substances useful in human healthcare. ArchImmnol Ther Exp (Warsz) 2007; 55: 315-27.Ford-borne bacteria and essential oil 231\n24. Rezaeinodehi A, Khangholi S.  Chemical composition of the\nessential oil of Artemisia absinthium  growing wild in Iran.\nPak J Biol Sci 2008; 11: 946-9.\n25. Rojas J , Ochoa V, Ocampo S, Mu\u00f1oz J. Screening for\nantimicrobial activity of ten medicinal plants used inColombian folkloric medicine: a possible alternative in thetreatment of non-nosocomial infections. Complement AlternMed 2006; 6: 2.\n26. Setzer W, Vogler B, Schmidt J, Leahy J, Rives R.\nAntimicrobial activity of four \nArtemisia  species of Iran.\nPhytother 2004; 75: 192-200.\n27. Singh A, Singh R, Bhunia A, Singh N. Efficacy of plant essential\noils as antimicrobial agents against Listeria monocytogenes\nin hotdogs. LWT Food Sci Techn 2003; 36: 787-94.\n28. Smith J, Tucker D, Watson K, Jones G. Identification of\nantibacterial constituents from the indigenous Australiamedicinal plant \nEremophila duttonii  F. Muell. ( Myopora-\nceae). J Ethnopharmacology 2007; 112: 386-93.29. Smith-Palmer J, Stewart J, Fyfe L. Antimicrobial properties\nof plant essential oils and essences against five importantfood-borne pathogens. Lett Appl Microbiol 1998; 26:118-22.\n30. Tuberoso C, Kowalczyk A, Coroneo V, Russo M, Dessi S,\nCabras P. Chemical composition and antioxidant,antimicrobial, and antifungal activities of the essential oilof \nAchillea ligustica all. J Agric Food Chem 2005; 53:\n10148-53.\n31. Vaca Ruiz M, Laciar A, Donadel O, Saad J, Carrizo Flo-\nres R. Anti-listerial activity of plant essential oils fromwestern region of Argentina. Annals Microbiol 2006; 56:369-71.\n32. Vukovic-Gacic S, Nikcevic S, Beric-Bjedov T, Knezevic-\nVukcevic J, Simic D. Antimutagenic effect of essential oil ofsage (\nSalvia officinalis  L.) and its monoterpenes against\nUV-induced mutations in Escherichia coli  and Saccharomy-\nces cerevisiae . Food Chem Toxicol 2006; 44: 1730-8.\nRecibido: 24/02/09 \u2013 Aceptado: 24/09/09232 Revista Argentina de Microbiolog\u00eda (2009) 41: 232-236 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 232-236 ART\u00cdCULO ORIGINAL\nLinden flower ( Tilia spp.) as potential vehicle of Clostridium\nbotulinum  spores in the transmission of infant botulism\nM. I. BIANCO, C. L\u00daQUEZ**, L. I. T. DE JONG, R. A. FERN\u00c1NDEZ*\n\u00c1rea Microbiolog\u00eda, Departamento de Patolog\u00eda, Facultad de Ciencias M\u00e9dicas, Universidad Nacional de Cuyo,\nCentro Universitario, Parque General San Mart\u00edn S/N, (5500) Mendoza, Argentina.\n*Correspondence. E-mail: rfernand@fcm.uncu.edu.ar\nABSTRACT\nInfant botulism is an intestinal toxemia caused principally by Clostridium botulinum . Since the infection occurs in the\nintestinal tract, numerous food products have been investigated for the presence of C. botulinum  and its neurotoxins.\nIn many countries, people use linden flower ( Tilia spp) tea as a household remedy and give it to infants as a sedative.\nTherefore, to help provide a clear picture of this disease transmission, we investigated the presence of botulinumspores in linden flowers. In this study, we analyzed 100 samples of unwrapped linden flowers and 100 samples oflinden flowers in tea bags to determine the prevalence and spore-load of \nC. botulinum.  Results were analyzed by the\nFisher test. We detected a prevalence of 3% of botulinum spores in the unwrapped linden flowers analyzed and aspore load of 30 spores per 100 grams. None of the industrialized linden flowers analyzed were contaminated withbotulinum spores. \nC. botulinum  type A was identified in two samples and type B in one sample. Linden flowers must\nbe considered a potential vehicle of C. botulinum,  and the ingestion of linden flower tea can represent a risk factor for\ninfant botulism.\nKey words:  botulinum spores, linden flower tea, infant botulism\nRESUMEN\nEl t\u00e9 de tilo como veh\u00edculo potencial de esporas de Clostridium botulinum en la transmisi\u00f3n del botulismo\ninfantil. El botulismo del lactante es una toxiinfecci\u00f3n causada, principalmente, por Clostridium botulinum . Debido a\nque esta infecci\u00f3n ocurre en el tracto intestinal, la presencia de esta bacteria y sus neurotoxinas ha sido investigadaen numerosos alimentos. En muchos pa\u00edses se utiliza el t\u00e9 de tilo (\nTilia spp.) como sedante natural, el que se\nadministra incluso a los lactantes. A fin de contribuir al esclarecimiento de la transmisi\u00f3n de esta enfermedad, seinvestig\u00f3 la prevalencia y la carga de esporas botul\u00ednicas en esta hierba. Se analizaron 100 muestras de tilo comer-cializado a granel y 100 muestras de tilo industralizado en \u201csaquitos\u201d. Los resultados de prevalencia fueron analizadospor el test de Fisher y la carga de esporas por la t\u00e9cnica del n\u00famero m\u00e1s probable. Se hall\u00f3 una prevalencia deesporas de \nC. botulinum del 3% en el tilo comercializado a granel, con una carga de 30 esporas/100 g de hierba. En\ntanto, ninguna de las muestras en saquitos acus\u00f3 la presencia del pat\u00f3geno. Se identificaron tres cepas de C.\nbotulinum , dos tipo A y una tipo B. En virtud de estos resultados, el tilo podr\u00eda considerarse un potencial veh\u00edculo de\nesporas de C. botulinum  y la administraci\u00f3n de sus infusiones a menores y lactantes, un riesgo para la transmisi\u00f3n de\nla enfermedad.\nPalabras clave:  esporas botul\u00ednicas, t\u00e9 de tilo, botulismo del lactante\n**Present address:  Botulism Public Health Research and Preparedness\nUnit, Centers for Disease Control and Prevention, Atlanta, Georgia, USAINTRODUCTION\nInfant botulism is an intestinal toxemia caused by\nbotulinum neurotoxins (BoNT) mainly produced by\nClostridium botulinum.  Some unusual strains of C.\nbutyricum  and C. baratii that produce BoNT type E and\nF, respectively, were isolated from a few patients withinfant botulism (2, 5, 7, 17, 23, 32)\n. Most cases result\nfrom C. botulinum  types A and B (2, 4); however, somerare bivalent strains, Ba and Bf, were identified in a few\ncases (6, 16, 18).\nSwallowed botulinum spores germinate, multiply, and\nvegetative cells produce BoNT  in situ (2, 32 ). Since these\nspores are ubiquitous and widely distributed in soil,environmental exposure has been identified as animportant risk factor for infant botulism (13, 22, 27). Soilis the principal source of these spore-forming bacteria,and botulinum spores may be present in dust; therefore,they can contaminate agricultural products. Due to thefact that the infection occurs in the intestinal tract,numerous food products have been investigated for thepresence of \nC. botulinum  spores and BoNTs. BotulinumBotulinum spores in linden flower ( Tilia spp) tea 233\nspores have been found in household dust (27), honey,\ncorn syrup (25), and in some medicinal plants (8, 30).However, for most cases of infant botulism, the source ofbotulinum spores\n has not been identified (4, 13, 25, 32).\nIn many countries, teas prepared with medicinal plants\nare frequently given to infants as household remedy;therefore, ingestion of teas prepared with medicinal plantscontaminated with botulinum spores could represent arisk for infant botulism. In Argentina, \nTilia spp. (linden\nflower) tea is commonly given to infants and somephysicians recommend this tea as a natural sedative. TheUS Food and Drug Administration (FDA) places lindenflower on the generally-recognized-as-safe (GRAS) listbased on the chemical composition of this herb. However,linden flowers could be contaminated with botulinumspores. These spores can resist high temperatures;therefore, boiling water to prepare linden flower tea doesnot destroy the spores, but, rather, activates them. Forthese reasons, our aim was to determine the prevalenceand spore-load of botulinum spores in linden flowers. Thisinformation is important to help elucidate the transmissionof infant botulism and prevent this illness.\nMATERIALS AND METHODS\nWe examined 200 samples of linden flowers that were\nobtained from markets and herbal stores from Mendoza, Argen-tina. Two groups of 100 samples were analyzed: 1) unwrappedlinden flowers, which are delivered in large amounts to the herbalstore and sold by weight to the customer in individual paper orplastic bags from open containers; and 2) linden flowers in teabags (industrialized linden flowers), which are industriallyprocessed, packaged in tea bags, and sold in closed boxes.\nThe samples were transferred to sterile recipients and stored\nat room temperature until examination. Then, 4 g of each sampleof linden flower was suspended in 40 ml of saline solution (0.15M NaCl) in a sterile recipient with hermetic closing. Suspensionswere vigorously shaken and filtered through sterile gauze; thefiltrates were centrifuged at 12,000 x g for 10 min to concentratethe spores. The pellets were suspended in 4 ml of saline solution,and these suspensions were subjected to 10 min of heat shockat 80 \u00b0C. The suspensions were inoculated in a chopped-meatmedium (CMM) (14) and incubated at 31 \u00b0C for 5 days. Afterincubation, broths were centrifuged at 12,000 x g for 20 min at 4\u00b0C. Cultures without signs of proteolysis were treated by mixingequal volumes of the supernatant culture and 1% trypsin (1:250,Difco) and incubated at 31 \u00b0C for 1 h. We inoculated 0.5 ml ofeach supernatant (each sample), in duplicate, intraperitoneallyin mice and observed the mice for 96 h for characteristic botulinalsigns and/or death (28).\nWe cultivated each of the toxic cultures in each of the following\nthree solid media by streaking the surface: 1) 1.5% agar, 2) 4%agar (9), and 3) egg yolk agar (11). The cultures were incubatedat 31 \u00baC in BBL jars with an atmosphere of 80% N\n2, 10% CO2,\nand 10% H2. After incubation for 24 h in the 1.5% agar media, 48\nh in the 4% agar media, and 72 h in the egg yolk media, suspectedcolonies were transferred to CMM and incubated at 31 \u00baC for 4days. The presence of BoNT in each of these cultures (fromisolated colonies) was investigated by inoculating broths in miceas previously described. To assure a pure culture, toxic brothswere cultivated in solid media, and these cultures were incubatedin aerobic and anaerobic conditions. We identified the genera\nClostridium  based on the following characteristics: gram positive,\nstrict anaerobe, and spore-forming rods. The cell morphology ofeach pure culture was observed by using an optical microscope.\nIsolated strains were characterized by biochemical tests: acidproduction from sugars, reaction in milk, meat, and gelatine,nitrate reduction, indole, lecithinase, and lipase production;esculin hydrolysis, and volatile acids production in peptone-yeastextract-glucose medium by gas-liquid chromatography (10).\nSerologic typing of the pure cultures was carried out by\nquantitative neutralization tests on toxic cultures with monovalentand polyvalent botulinum antitoxin (15). When the levels of BoNTswere not sufficient for a neutralization test, we cultivated strainsby dialysis in a cellophane sack immersed in toxin-productionmedium (33). After incubation at 32 \u00b0C for 6 days, the contentsof the cellophane sacks were centrifuged at 12,000 \u00d7 g for 10min at 4 \u00b0C and serially diluted twofold in buffered solution. Eachdilution was inoculated intraperitoneally into six mice (0.5 ml permouse). Deaths were recorded for 96 h, and the 50% lethal doses(LD\n50) were calculated by the Reed and Muench method (29).\nThe Fisher test was used to compare the prevalence of C.\nbotulinum spores in the two groups of linden flowers (unwrapped\nlinden flowers and linden flowers in tea bags).\nFor the three positive samples, the spore-load was estimated\nby the most probable number method (1). We use three dilutions(1:1, 1:5, and 1:25) and three tubes for each dilution. After 10min of heat shock at 80 \u00b0C, 1 ml of each dilution was inoculatedin each tube with CMM, and these cultures were incubated for 5days at 31 \u00b0C. The presence of \nC. botulinum was detected by\nbioassay as described previously.\nRESULTS\nPrevalence of botulinum spores in linden flower.\nWe detected C. botulinum spores in 3% (3/100) of\nunwrapped linden flower samples analyzed, but none ofthe industrialized linden flower samples appeared to becontaminated with these spores (0/100). The differencein the occurrence of botulinum spores between both typesof samples was analyzed by the Fisher test, and resultswere not significant (\np = 0.2462).\nSpore-load of  C. botulinum in linden flower.  We\ndetected 30 spores per 100 grams of linden flower in eachof the three positive samples (95% confidence limits:9-103 spores per 100 grams).\nPhenotypic characteristics of strains of \nC.\nbotulinum  isolated from linden flower. We isolated\nthree toxigenic strains of C. botulinum  from positive\nsamples of linden flower. The results of serological andbiochemical test were the following:\n1) \nSerological test.  Botulinum neurotoxin type A was\nidentified in two of the three positive samples and type Bin only one sample.\n2) \nBiochemical tests.  All isolated strains were gram-\npositive rods with oval and subterminal spores. The threestrains isolated from linden flower produced acid fromglucose. Mannitol, maltose, lactose, mannose, fructose,and sucrose were not fermented and nitrate was notreduced. Gelatine was liquefied. Indole and lecithinasewere not produced. Esculin was hydrolyzed and lipasewas produced. Milk and meat were digested. Acetic,propionic, butyric, isobutyric, valeric, isovaleric, andisocaproic acids were detected in peptone-yeast extract-glucose medium cultures by gas-liquid chromatography.234 Revista Argentina de Microbiolog\u00eda (2009) 41: 232-236\nAccording to biochemical test results, the three strains\ncorresponded to metabolic group I.\nDISCUSSION\nPrevalence of botulinum spores in linden flower.\nThe prevalence of botulinum spores found in unwrappedlinden flower (3%) was lower than that detected in thefollowing medicinal plants:\n Matricaria spp. (chamomile)\n(9), Lippia turbinata  (penny royal),  Alternanthera pungens\n(khakiweed),  Pimpinella anisum  (anise), and Senna\nacutifolia (senna) (30) (Table 1). These medicinal plants\ncan be contaminated with botulinum spores present inthe environment (i.e. soil, dust). The soil is the principalsource of botulinum spores and the height of the medici-nal plants can be an important factor in the contaminationwith these spores. The linden tree is several feet high;therefore, linden flower is less easily contaminated withbotulinum spores than other plants of minor height. Onthe contrary, chamomile, khakiweed, anise, penny royal,and senna are small shrubs growing close to the ground(Table 1); therefore, these plants are easily contaminatedwith botulinum spores. On the other hand, the highprevalence of\n C. botulinum  found by Satorres et al. (1999)\nin penny royal, khakiweed, anise, and senna could notbe real because of the few samples analyzed for eachone of these species (Table 1).\nThe prevalence of botulinum spores in linden flower\nwas also lower than the 6-10% detected in honey (3, 13,19, 20, 24, 31), but higher than that found in corn syrup(0.5%) (4). These spores have been detected in honeyfrom various countries (3, 12, 19, 20, 24, 26, 34) and somestudies have also considered honey consumption a risk\nfactor for this illness. For these reasons, and becausehoney is not nutritionally essential, the United States publichealth agencies, all major pediatricians, and the honeyindustry have recommended not to feed  infants youngerthan one year old with honey (4). Moreover, \nC. botulinum\ntype B spores were found in approximately 0.5% (5 of961) of light and dark corn syrup samples (20). However,in 1991 a FDA market survey of 738 corn syrup samplesconcluded that none contained \nC. botulinum  spores (21).\nTherefore, although the possible role of corn syrup in infantbotulism has been proposed, it is not a recognized sourceof botulinum spores or a risk factor for infant botulism (4).\nProbably, the absence of these spores in industrialized\nlinden flowers is due to the fact that the industrializationprocess reduces the contamination. Linden flowers in teabags are usually dried in closed furnaces (25-30 \u00b0C), whileunwrapped linden flowers are often dried in the open airor in sheds. Therefore, industrialized linden flowers areless exposed to contamination with spores present inenvironmental dust. In a previous study, we found similarresults when comparing the prevalence of botulinumspores in unwrapped chamomile and chamomile in teabags. Unwrapped chamomile showed a prevalence of13% whereas chamomile in tea bags of only 2% (9).Because botulinum spores can be present in environ-mental dust, an important way to prevent contaminationwith \nC. botulinum  of \u201cunwrapped\u201d herbs is to optimize the\nhygiene conditions in herbal stores and to keep theseherbs in closed bags.\nSpore-load of\n C. botulinum in linden flower. The\nminimum infective dose of C. botulinum  spores for human\nTable 1.  Prevalence of C. botulinum  in medicinal plants\nMedicinal Approximate Number of Number of Prevalence of Reference\nplant height (f)  samples  positive  botulinum\nstudied (f) samples spores (%)\nLinden flower\n(Tilia spp.)\n- Unwrapped 15-20 100 3 3 This study- In tea bags 15-20 100 0 0 This study\nChamomile(\nMatricaria  spp.)\n- Unwrapped 0.50 100 13 13 9- In tea bags 0.50 100 2 2 9\nPenny royal(\nLippia turbinata ) 1.50 9 1 11.1 30\nAnise(\nPimpinella anisum ) 1.00 9 1 11.1 30\nKhakiweed(\nAlternathera pungens ) 0.15 7 1 14.9 30\nSenna(\nSenna acutifolia ) 0.10 3 1 33.3 30Botulinum spores in linden flower ( Tilia spp) tea 235\ninfants is unknown; however, from estimates from\nexposure to spore-containing honey, this dose may beas low as 10 to 100 (3, 4). This value is higher than thespore-load detected in the three positive samples of lin-den flowers (30 spores per 100 grams); however, a cupof linden flower tea is prepared with several grams of thisherb, and linden flower tea may be ingested by an infantseveral times a day, for many days. Therefore, repetitivedoses of this tea could accumulate the minimun infectivedose of \nC. botulinum  necessary for infant botulism. This\nspore-load is similar to that detected in chamomile (30-40 spores/100g) (9) and smaller than that detected inhoney (5-80 spores/g) (3). However, infants may be morefrequently given herbal teas than honey. In Mendoza, inwestern Argentina, epidemiological data of patients withinfant botulism showed that 9.6% (10/104) had ingestedherbal teas, while 4.8% (5/104) of patients were honey-fed (8). Moreover, a study about the use of alternativemedicine in Mendoza showed that children are commonlygiven herbal teas (Femen\u00eda, Guida, Azcurra \net al., perso-\nnal communication ). An 18.92% of infants had ingestedsome kind of herbal teas, and linden flower tea was oneof the most common teas given to infants. This 18.9% ofinfants (younger than one year old) had ingested teasprepared with the following medicinal plants: \nMatricaria\nspp. (64.3%), Tilia spp. (14.3%), Chenopodium  ambro-\nsioides (14.3%), Peumus boldus  (7.1%), Eucalyptus  spp.\n(7.1%), Pimpinella anisum  (7.1%), Artemisia douglasiana\n(7.1%), and a mixture of Chamomilla recutita, A. pungens,\nMentha viridis, L. turbinata,  and Faeniculum vulgare  (\u201ct\u00e9\ndel ni\u00f1o\u201d) (7.1%) (Femen\u00eda, Guida, Azcurra et al., perso-\nnal communication).\nPhenotypic characteristics of strains of C.\nbotulinum  isolated from linden flower. Serotypes A and\nB are the most frequently identified in cases of infantbotulism around the world. In Argentina, between theyears 1982 and 2006, \nC. botulinum  type A has been\nidentified in 99.75% (409/410) of patients with infantbotulism whereas \nC. botulinum  type B was detected in\none case (9). Moreover, we observed that strains of C.\nbotulinum  isolated from linden flower and from infant\nbotulism cases showed similar biochemical charac-teristics. These results suggest that \nC. botulinum  strains\npresent in linden flower could collaborate to produce infantbotulism.\nAn important way to prevent the occurrence of infant\nbotulism results from not giving infants food products inwhich the presence of botulinum spores has beenreported. Results presented in this study suggest thatunwrapped linden flowers are a potential vehicle of \nC.\nbotulinum  spores. Therefore, to minimize the risk of\nacquisition of infant botulism, we recommend that lindenflower tea prepared with unwrapped linden flowers shouldnot be given to infants under one year of age.Acknowledgements.  We thank Mar\u00eda Isabel Farace (Chief\nof Sanitary Bacteriology Service) and Edgardo Castelli(Laboratory Staff) from the Administraci\u00f3n Nacional de Labora-torios e Institutos de Salud (A.N.L.I.S.) \u201cDr. Carlos G. Malbr\u00e1n\u201d(Buenos Aires, Argentina), and Daniel Abdala Pacheco fromHospital Materno Infantil \u201cDr. Humberto J. Notti\u201d (Mendoza, Ar-gentina). This work was supported by grants from Facultad deCiencias M\u00e9dicas and Secretar\u00eda de Ciencia y T\u00e9cnica, Univer-sidad Nacional de Cuyo, Mendoza, Argentina. M.I. Bianco andC. L\u00faquez had fellowship assistance from CONICET, Argentina.\nReferences\n1. American Public Health Association. APHA Technical\nCommittee on Microbiological Methods for Foods. In:Vanderzant C, Splittstoesser DF, editors. Compendium ofMethods for the Microbiological Examination of Foods, 3\nrd\ned., Washington D.C., 1992, p. 105-19.\n2. Arnon SS. Creation and development of the public service\norphan drug human botulism immune globulin. Pediatrics2007; 119: 785-9.\n3. Arnon SS, Midura TF, Damus K, Thompson B, Wood RM,\nChin J. Honey and other environmental risk factors for infantbotulism. J Pediatr 1979; 94: 331-6.\n4. Arnon SS. Infant botulism. In: Feigen RD, Cherry JD,\nSaunders WB, editors. Textbook of Pediatric InfectiousDisease, 4\nth ed., Philadelphia, 1998, p. 1758-66.\n5. Aureli P, Fenicia L, Pasolini B, Gianfranceschi M, McCroskey\nLM, Hatheway CL. Two cases of type E infant botulismcaused by neurotoxigenic \nClostridium butyricum  in Italy. J\nInfect Dis 1986; 154: 207-11.\n6. Barash JR, Arnon SS. Dual toxin-producing strain of\nClostridium botulinum  type Bf isolated from a California patient\nwith infant botulism. J Clin Microbiol 2004; 42: 1713-5.\n7. Barash JR, Tang TWH, Arnon SS. First case of infant\nbotulism caused by Clostridium baratii  type F in California.\nJ Clin Microbiol 2005; 43: 4280-2.\n8. Bianco MI. Botulismo del lactante: Transmisi\u00f3n por plantas\nmedicinales y su inhibici\u00f3n por probi\u00f3ticos. Tesis de Doc-torado. Facultad de Ciencias Exactas, F\u00edsico-Qu\u00edmicas yNaturales, Universidad Nacional de R\u00edo Cuarto. C\u00f3rdoba,Argentina 2008.\n9. Bianco MI, L\u00faquez C, de Jong, LIT, Fern\u00e1ndez RA.\nPresence of \nClostridium botulinum  spores in Matricaria\nchamomilla  (chamomile) and its relationship with infant\nbotulism. Int J Food Microbiol 2007; 121: 357-60.\n10. Centers for Disease Control. Laboratory Methods in\nAnaerobic Bacteriology. In: Dowell VR, Hawkins TM, editors.CDC Laboratory Manual, Atlanta, 1981.\n11. Dezfulian M, McCroskey LM, Hatheway CL, Dowell VR.\nSelective medium for isolation of \nClostridium botulinum  from\nhuman feces. J Clin Microbiol 1981; 13: 526-31.\n12. Fenicia L, Ferrini AM, Aureli P, Pocecco M. A case of infant\nbotulism associated with honey feeding in Italy. Eur JEpidemiol 1993; 9: 671-3.\n13. Fox CK, Keet CA, Strober JB. Recent advances in infant\nbotulism. Pediatr Neurol 2005; 32: 149-54.\n14. Gim\u00e9nez DF, Ciccarelli AS. Studies on strain 84 of\nClostridium botulinum . Zentralbl Bakteriol [Orig] 1970; 215:\n212-20.\n15. Gim\u00e9nez DF, Gim\u00e9nez JA. Serological subtypes of botulinal\nneurotoxin. In: DasGupta BR, editor. Botulinum and TetanusNeurotoxins, New York, 1993, p. 421-31.\n16. Gim\u00e9nez DF. \nClostridium botulinum  subtype Ba. Zentralbl\nBakteriol 1984; 257: 68-72.\n17. Hall JD, McCroskey LM, Pincomb BJ, Hatheway CL.\nIsolation of an organism resembling Clostridium baratii  which236 Revista Argentina de Microbiolog\u00eda (2009) 41: 232-236\nproduces type F botulinal toxin from an infant with botulism.\nJ Clin Microbiol 1985; 21: 654-5.\n18. Hatheway CL, McCroskey LM. Examination of feces and\nserum for diagnosis of infant botulism in 336 patients. JClin Microbiol 1987; 25: 2334-8.\n19. Hauschild AHW, Hilsheimer R, Weiss KF, Burke RB.\nClostridium botulinum in honey, syrups, and dry infant\ncereals. J Food Prot 1988; 51: 892-4.\n20. Kautter DA, Lilly T, Solomon HM, Lynt RK. Clostridium\nbotulinum spores in infant foods: a survey. J Food Prot 1982;\n45: 1028-9.\n21. Lilly T Jr, Rhodehamel EJ, Kautter DA, et al. Incidence of\nClostridium botulinum spores in corn syrup and other syrups.\nJ Food Prot 1991; 54: 585-7.\n22. L\u00faquez C, Bianco MI, Sagua MD, Barzola CP, de Jong LIT,\nDegarbo SM, et al. Relationship between the incidence of\ninfant botulism and the presence of botulinum toxin-producing Clostridia in the soil of Argentina, 1982-2005. JPediatr Neurol 2007; 5: 279-86.\n23. McCroskey LM, Hatheway CL, Fenicia L, Pasolini B, Aureli\nP. Characterization of an organism that produces type Ebotulinal toxin but which resembles \nClostridium butyricum\nfrom the feces of an infant with type E botulism. J ClinMicrobiol 1986; 23: 201-2.\n24. Midura TF, Snowden S, Wood RM, Arnon SS. Isolation of\nClostridium botulinum  from honey. J Clin Microbiol 1979; 9:\n282-3.25. Midura TF. Update: infant botulism. Clin Microbiol Rev 1996;\n9: 119-25.\n26. Nakano H, Okabe T, Hashimoto H, Sakaguchi G. Incidence\nof Clostridium botulinum  in honey of various origins. Jpn J\nMed Sci Biol 1990; 43: 183-95.\n27. Nevas M, Lindstr\u00f6m M, Virtanen A, Hielm S, Kuusi M, Arnon\nSS, et al. Infant botulism acquired from household dust\npresenting as sudden infant death syndrome. J ClinMicrobiol 2005; 43: 511-3.\n28. Notermans SH, Nagel J. Assays for botulinum and tetanus\ntoxins. In: Simpson LL, editor. Botulinum and TetanusNeurotoxins, Academic Press, San Diego. 1989, p. 319\u201331.\n29. Reed LJ, Muench H. A simple method for estimating fifty\nper cent end points. Am J Hyg 1938; 27: 493-7.\n30. Satorres SE, Alcaraz LE, Fern\u00e1ndez RA, Centorbi ON.\nIsolation of \nClostridium botulinum  in medicinal plants.\nAnaerobe 1999; 5: 173-5.\n31. Schocken-Iturrino RP, Carneiro MC, Kato E, Sorbara JOB,\nRossi OD, Grebasi LER. Study of the presence of sporesof \nClostridium botulinum  in honey in Brazil. FEMS Immunol\nMed Microbiol 1999; 24: 379-82.\n32. Sobel J. Botulism. Clin Infect Dis 2005; 41: 1167-73.33. Sterne M, Wentzel LM. A new method for the large-scale\nproduction of high-titre botulinum formol-toxoid types C andD. J Immunol 1950; 65: 175-83.\n34. Sugiyama H, Mills DC, Kuo LJ. Number of \nClostridium\nbotulinum spores in honey. J Food Prot 1978; 41: 848-50.\nRecibido: 14/04/09 \u2013 Aceptado: 25/08/09Modelo de contaminaci\u00f3n cruzada por VTEC 237 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 237-244 ART\u00cdCULO ORIGINAL\nModelo de contaminaci\u00f3n cruzada por Escherichia coli\nverocitotoxig\u00e9nica durante la elaboraci\u00f3n de\nhamburguesas caseras y evaluaci\u00f3n cuantitativa de riesgos\nM. L. SIGNORINI1*, L. S. FRIZZO2\n1Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas, Estaci\u00f3n Experimental Agropecuaria Rafaela, Instituto Nacional\nde Tecnolog\u00eda Agropecuaria, Ruta 34 km 227, (2300) Rafaela, 2Departamento de Salud P\u00fablica Veterinaria, Facultad\nde Ciencias Veterinarias, Universidad Nacional del Litoral. Kreder 2805, (3080) Esperanza, Pcia. de Santa Fe, Argentina.\n*Correspondencia: E-mail: marcelo.signorini@gmail.com\nRESUMEN\nEl objetivo del presente trabajo fue generar un modelo probabil\u00edstico para evaluar cuantitativamente el riesgo de\ncontaminaci\u00f3n cruzada de E. coli verocitotoxig\u00e9nica (VTEC) durante el proceso de elaboraci\u00f3n de hamburguesas\ncaseras y su impacto en la salud p\u00fablica. El modelo tuvo en cuenta un grupo de pr\u00e1cticas culinarias corrientes y acada una de ellas se le asign\u00f3 la probabilidad asociada de transferencia de VTEC entre los alimentos y los utensiliosde cocina. Las distribuciones de probabilidad que mejor describieron cada paso del proceso fueron incorporadas enel programa @Risk\n\u00ae y se realizaron las simulaciones empleando el an\u00e1lisis Monte Carlo. La manipulaci\u00f3n de alimen-\ntos crudos (en este caso, la carne picada) antes de la preparaci\u00f3n de alimentos que no demandan cocci\u00f3n (como lasguarniciones de vegetales frescos que suelen acompa\u00f1arlas) (\nOdds ratio , OR = 6,57), as\u00ed como el h\u00e1bito del lavado\nde manos (OR = 12,02) y de las tablas que se utilizan durante la elaboraci\u00f3n de estos platos (OR = 5,02), fueron losprincipales factores de riesgo de contaminaci\u00f3n cruzada del pat\u00f3geno entre la carne y las verduras. La informaci\u00f3naportada por este modelo deber\u00eda considerarse durante el dise\u00f1o de estrategias de comunicaci\u00f3n del riesgo dels\u00edndrome ur\u00e9mico hemol\u00edtico para acentuar la importancia que estos factores pueden tener en la transmisi\u00f3n de laenfermedad.\nPalabras clave: Contaminaci\u00f3n cruzada, evaluaci\u00f3n cuantitativa de riesgos, hamburguesas, \nE. coli, s\u00edndrome ur\u00e9mico\nhemol\u00edtico.\nABSTRACT\nQuantitative risk model for verocytotoxigenic Escherichia coli  cross-contamination during hamburger\npreparation.  The objective of this study was to develop a quantitative risk model for verocytotoxigenic Escherichia coli\n(VTEC) cross-contamination during hamburger preparation at home. Published scientific information about the disease\nwas considered for the elaboration of the model, which included a number of routines performed during food preparationin kitchens. The associated probabilities of bacterial transference between food items and kitchen utensils which bestdescribed each stage of the process were incorporated into the model by using @Risk\n\u00ae software. Handling raw meat\nbefore preparing ready-to-eat foods (Odds ratio, OR, 6.57), as well as hand (OR = 12.02) and cutting board (OR =5.02) washing habits were the major risk factors of VTEC cross-contamination from meat to vegetables. The informationprovided by this model should be considered when designing public information campaigns on hemolytic uremicsyndrome risk directed to food handlers, in order to stress the importance of the above mentioned factors in diseasetransmission.\nKey words: Cross-contamination, quantitative risk assessment, hamburger, \nE. coli, hemolytic uremic syndrome\nINTRODUCCI\u00d3N\nEscherichia coli  verocitotoxig\u00e9nica (VTEC) y en parti-\ncular el serogrupo O157:H7 es una importante causa dediarrea en seres humanos, que puede derivar en gravessecuelas como el s\u00edndrome ur\u00e9mico hemol\u00edtico (SUH).En Argentina, la tasa de incidencia del SUH en menoresde 5 a\u00f1os (13,9 por 100.000 individuos) es 10 veces su-perior a la notificada en los pa\u00edses industrializados, conuna letalidad del 2 al 5% (7). Adicionalmente, es la pri-\nmera causa de insuficiencia renal aguda y la segunda deinsuficiencia renal cr\u00f3nica en ni\u00f1os. El 30% de los ni\u00f1osy adolescentes que reciben trasplante renal han padeci-do SUH (7).\nVTEC est\u00e1 presente en las heces y los intestinos de\nanimales sanos y puede contaminar la carne durante elproceso de sacrificio y faenado de bovinos\n (6, 11, 12).\nDentro de los alimentos implicados en la transmisi\u00f3n de238 Revista Argentina de Microbiolog\u00eda (2009) 41: 237-244\nesta enfermedad se destaca la carne bovina insuficien-\ntemente cocida; en particular, la hamburguesa es un pro-ducto asociado a los brotes de SUH (6). Recientemente,los vegetales crudos han sido responsables de la apari-ci\u00f3n de este tipo de brotes, lo cual puede deberse a lacontaminaci\u00f3n de \u00e9stos con aguas de riego contamina-das o a la diseminaci\u00f3n del pat\u00f3geno durante la prepara-ci\u00f3n de los alimentos en los hogares, por contaminaci\u00f3ncruzada hacia otros productos listos para su consumo(14). En los Estados Unidos de Norteam\u00e9rica, el porcen-taje de brotes de SUH que estuvieron ligados al consu-mo de alimentos no c\u00e1rnicos fue del 12,5% en el a\u00f1o1994 y del 21% en 1996. Los vegetales contaminadoscomo resultado de la contaminaci\u00f3n cruzada fueron al-gunos de los veh\u00edculos m\u00e1s frecuentemente asociados ala transmisi\u00f3n del agente\n (21).\nA partir de una encuesta realizada en hogares del\ncentro de la provincia de Santa Fe (4, 13) se comprob\u00f3que alrededor de la mitad de las hamburguesas consu-midas son elaboradas en ellos inmediatamente antes desu consumo. Esto incrementar\u00eda la probabilidad de con-taminaci\u00f3n cruzada entre la carne, los utensilios de coci-na y otros alimentos que no requieren cocci\u00f3n y que sue-len acompa\u00f1ar a las hamburguesas a modo de guarni-ci\u00f3n.\nDada la alta incidencia de SUH, la carencia de un tra-\ntamiento espec\u00edfico y la alta morbilidad, la prevenci\u00f3nprimaria de las infecciones por VTEC es fundamental paradisminuir su impacto sanitario (14). Las estrategias decontrol de los riesgos de infecci\u00f3n por VTEC se puedenaplicar en diferentes etapas de la cadena alimentaria ysu efectividad depender\u00e1 del conocimiento que se tengasobre el impacto que cada etapa posee sobre la probabi-lidad de aparici\u00f3n de la infecci\u00f3n.\nEl objetivo del presente trabajo fue generar un mode-\nlo probabil\u00edstico que describa la din\u00e1mica de contamina-ci\u00f3n cruzada de VTEC entre la carne empleada en laelaboraci\u00f3n casera de hamburguesas, los vegetales quelas acompa\u00f1an habitualmente como guarnici\u00f3n y los uten-silios que intervienen durante la preparaci\u00f3n, a fin deevaluar cuantitativamente el riesgo de transmisi\u00f3n de laenfermedad y su impacto en la salud p\u00fablica.\nMATERIALES Y M\u00c9TODOS\nComponentes del modelo\nEl proceso de elaboraci\u00f3n de hamburguesas en los hogares\nfue modelado estoc\u00e1sticamente bajo la premisa de que las ham-burguesas a menudo se sirven acompa\u00f1adas por vegetales fres-cos (lechuga y tomate). Durante la preparaci\u00f3n de los alimentosse emplean una serie de objetos que pueden contaminarse conVTEC; adem\u00e1s, ciertas pr\u00e1cticas culinarias contribuyen a la con-taminaci\u00f3n cruzada. Por simplicidad, s\u00f3lo se consider\u00f3 un n\u00fa-mero peque\u00f1o de objetos y rutinas que en conjunto reflejan larealidad de la preparaci\u00f3n del alimento (Figura 1). Los objetosconsiderados fueron la carne molida para la preparaci\u00f3n de lashamburguesas, las manos de quien prepara la comida (de aqu\u00eden m\u00e1s, el \u201coperador\u201d), los vegetales como acompa\u00f1amiento delas hamburguesas, la tabla para cortar los alimentos y el grifo\ndel agua. Las acciones consideradas fueron: preparaci\u00f3n de lahamburguesa (PH), corte de los vegetales (CV), lavado de ma-nos (LM) y lavado de la tabla (LT).\nPara la construcci\u00f3n del modelo se recurri\u00f3 a informaci\u00f3n\ncient\u00edfica publicada sobre las tasas de transferencia demicroorganismos entre los diferentes elementos. La informaci\u00f3nsobre prevalencia y concentraci\u00f3n de VTEC en la carne picadafue obtenida a partir de una evaluaci\u00f3n cuantitativa de riesgosde VTEC por consumo de hamburguesas realizada en Argenti-na (18), mientras que los h\u00e1bitos de consumo hogare\u00f1os fueronobtenidos a partir de una encuesta realizada durante los mesesde junio y julio de 2008 en hogares del centro de la provincia deSanta Fe, Argentina (13). Las distribuciones de probabilidad quemejor describieron cada etapa del proceso (Tabla 1) fueron in-corporadas en el programa @Risk\n\u00ae versi\u00f3n 4.5 (Palisade, New\nYork), y se realizaron las iteraciones correspondientes empleandola t\u00e9cnica de simulaci\u00f3n Monte Carlo para generar las variablesde resultado (ej. probabilidad de adquirir SUH). La t\u00e9cnica deMonte Carlo selecciona repetidamente valores al azar a partirde las distribuciones de probabilidad que caracterizan a las va-riables de entrada del modelo y genera m\u00faltiples escenarios delproblema. Con los resultados obtenidos se estim\u00f3 la probabili-dad de infecci\u00f3n por VTEC asociada al consumo de vegetalescontaminados, producto de la contaminaci\u00f3n cruzada durantela elaboraci\u00f3n casera de hamburguesas y se identificaron lasvariables m\u00e1s importantes que impactan en dicho evento.\nSupuestos t\u00e9cnicos del modelo\nLos modelos de simulaci\u00f3n con frecuencia necesitan intro-\nducir supuestos subjetivos, que pueden tener un impacto sobrelos resultados de la evaluaci\u00f3n de riesgos. Consecuentemente,estos supuestos deben ser tenidos en cuenta en el momento deanalizar los resultados. El presente modelo introdujo los siguien-tes supuestos t\u00e9cnicos:\na) Aunque el grupo de VTEC es muy amplio y est\u00e1 compues-\nto por cepas pat\u00f3genas y no pat\u00f3genas con caracter\u00edsticasbioqu\u00edmicas diferentes, se consider\u00f3 que el grupo en su totali-dad presenta similares propiedades de adhesi\u00f3n a las superfi-cies.\nb) Los diferentes estados del ciclo de crecimiento bacteriano\nno fueron incluidos en el modelo y, considerando que el tiempoentre la preparaci\u00f3n del alimento hasta su consumo es muy cor-to, tampoco se modelaron los procesos de crecimiento oinactivaci\u00f3n de VTEC.\nFigura 1. Modelo conceptual. Objetos y acciones que intervie-\nnen durante la preparaci\u00f3n de las hamburguesas caseras y elacondicionamiento de los vegetales que ser\u00e1n utilizados comoguarnici\u00f3n. Preparaci\u00f3n de la hamburguesa (PH), corte de losvegetales (CV), lavado de manos (LM) y lavado de la tabla (LT).Modelo de contaminaci\u00f3n cruzada por VTEC 239\nc) Este modelo consider\u00f3 que la \u00fanica fuente de VTEC era\nla carne molida, de modo que el riesgo de infecci\u00f3n se asumi\u00f3dependiente \u00fanicamente de la transferencia de bacterias des-de la carne a trav\u00e9s de las manos del operador, de la tablaempleada para la preparaci\u00f3n del alimento y del grifo de aguahacia los vegetales. No se consider\u00f3 la posible contaminaci\u00f3nprevia de los vegetales por el uso de aguas de riego contami-nadas.\nd) No se tom\u00f3 en consideraci\u00f3n la contaminaci\u00f3n que pudie-\nra ocurrir por transmisi\u00f3n interhumana por transferencia del pa-t\u00f3geno entre distintos operadores por deficiente lavado de lasmanos.\ne) Los cuchillos no fueron considerados como fuentes de\ncontaminaci\u00f3n, ya que el modelo se centr\u00f3 en la contaminaci\u00f3na partir de la preparaci\u00f3n de hamburguesas, en cuya prepara-ci\u00f3n no interviene el cuchillo. Este utensilio s\u00f3lo se emplea paracortar las verduras, y se descart\u00f3 la posibilidad de su contactoprevio con la hamburguesa o con su materia prima.Desarrollo del modelo\nLas variables empleadas en la construcci\u00f3n del modelo, las\ndistribuciones de probabilidad empleadas para su simulaci\u00f3n ylas fuentes de la informaci\u00f3n utilizada se presentan en la Tabla1. La prevalencia de carne molida contaminada con VTEC (P\nh) y\nla concentraci\u00f3n inicial del pat\u00f3geno (Ch) surgieron de una eva-\nluaci\u00f3n cuantitativa de riesgos de VTEC en hamburguesas enArgentina (18).\nEl peso de las hamburguesas (Peso\nh) y el n\u00famero de ham-\nburguesas consumidas por persona (Nh) fueron obtenidos a partir\nde una encuesta sobre h\u00e1bitos de consumo realizada en hoga-res del centro de la provincia de Santa Fe (13).\nLas probabilidades de que las hamburguesas se preparen\nantes que las verduras (PH\nae) y de que los operadores se laven\nlas manos (Plm) y laven la tabla donde prepararon las hambur-\nguesas (Plt) fueron modeladas siguiendo una distribuci\u00f3n binomial\ncon una incertidumbre arbitraria, dada la falta de informaci\u00f3n alrespecto publicada en revistas cient\u00edficas.Tabla 1. Distribuciones de probabilidad contempladas en el modelo de riesgos de contaminaci\u00f3n cruzada por VTEC.\nVariable Descripci\u00f3n  Unidad Distribuci\u00f3n/Modelo\nP\nhPrevalencia de VTEC en carne molida Beta General (0,29931, 0,12735, 0,000043062, 1)(18)\nChConcentraci\u00f3n de VTEC en carne molida log10 UFC/g 10 Triangular (-3,26,-2,75,2,67) (18)\nPesohPeso de las hamburguesas g Pert (60,83,105) (12)\nNhN\u00famero de hamburguesas consumidas Discreta ({0,5;1;2;3;4}, {2;7;27;7;1}) (13)\npor persona\nNtotalN\u00famero de VTEC en carne molida Poisson (Ch x Pesoh x Nh)\nPHaeProbabilidad de preparar las hamburguesas Binomial (1,Uniforme (0,1))antes que las verduras\nP\nlmProbabilidad de que los cocineros se laven Binomial (1,Triangular (0, 0,5, 1))las manos\nP\nltProbabilidad de que laven la tabla Binomial (1,Triangular (0, 0,5, 1))\nRlmReducci\u00f3n de la contaminaci\u00f3n por lavado % Exponencial (3,2396, Shift (-0,10699) (1, 3, 8)\nde manos\nTh-mTransferencia de VTEC de carne molida a % Log normal (7,7933, 7,864, Shift (0,091172) (1, 3, 8)\nmanos del cocinero\nTm-gTransferencia de VTEC de las manos del % Log normal (0,67538, 3,3581, Shift(0,0014066) (1, 3, 8)\ncocinero al grifo\nTg-mTransferencia de VTEC del grifo a las % Exponencial (5,1095, Shift (0,04793) (1, 3, 8)\nmanos del cocinero\nTm-vTransferencia de VTEC de las manos del % Log normal(5,2679, 5,823, Shift (-0,37878) (1, 3, 8)\ncocinero a las verduras\nTh-tTransferencia de VTEC de la carne molida % Log normal (12,7, 7,0087, Shift (0,54332) (1, 3, 8)\na la tabla\nTt-vTransferencia de VTEC de la tabla a las % Log logistic (-0,42502, 11,002, 3,8223) (1, 3, 8)\nverduras\nD Dosis ingerida de VTEC con las verduras UFC\nPenfModelo Beta-Poisson 1-[1+D/ \u03b2]-\u03b1 (20)\n\u00e1 Par\u00e1metro alfa-Poisson 0,0571 (20)\n\u00e2 Par\u00e1metro Beta-Poisson 2,2183 (20)\nPSUH|enfProbabilidad de adquirir SUH dado que Uniforme (0,03,0,09) (10)\nenferm\u00f3\nPmort|SUHProbabilidad de morir posterior a SUH Uniforme (0,022,0,048) (15)\nPSUHProbabilidad de adquirir SUH PSUH|enf x Penf\nPmortMortalidad Pmort|SUH x PSUH240 Revista Argentina de Microbiolog\u00eda (2009) 41: 237-244\nPara el c\u00e1lculo de las tasas de transferencia del pat\u00f3geno se\nemplearon los estudios publicados por Luber et al. (3), Montville\ny Schaffner (8) y Chen et al. (1). Si bien el primer estudio est\u00e1\nbasado en la transferencia de Campylobacter  y los dos restan-\ntes utilizaron como modelo microbiano a Enterobacter aerogenes ,\nse consider\u00f3 que VTEC presenta el mismo comportamiento encuanto a su adherencia a las diferentes matrices y, por ende, lasmismas tasas de transferencia.\nLa dosis ingerida (D) de VTEC a partir de los vegetales que\nacompa\u00f1an una comida de hamburguesas fue obtenida a partirdel n\u00famero de pat\u00f3genos presentes en la carne molida y consi-derando las diferentes tasas de transferencia entre los objetosinvolucrados (manos del operador, tabla para preparar alimen-tos y grifo) en el modelo de riesgos.\nPara incorporar la probabilidad de enfermar (P\nenf) en funci\u00f3n\nde la dosis ingerida del pat\u00f3geno se emple\u00f3 una distribuci\u00f3nBeta-Poisson publicada por Strachan \net al. (20), quienes utiliza-\nron datos sobre un brote de E. coli O157 e informaci\u00f3n cient\u00edfica\npublicada, asumiendo ausencia de un nivel umbral para enfer-mar. Asimismo, se asumi\u00f3 que toda la poblaci\u00f3n ten\u00eda la mismavulnerabilidad para enfermar luego de la ingesti\u00f3n de VTEC. Noobstante, es sabido que los ni\u00f1os de menos de 5 a\u00f1os y losadultos mayores poseen una probabilidad de sufrir secuelas gra-ves como SUH y mortalidad mayor que el resto de la poblaci\u00f3n.\nLa probabilidad de sufrir secuelas como SUH o mortalidad\nfue asumida como una fracci\u00f3n de la probabilidad de enfermar.Noris y Remuzzi (10) estimaron que la probabilidad de sufrirSUH (P\nSUH|enf) es de 3% a 9% (10), y Rivas inform\u00f3 una mortali-\ndad por SUH (Pmort|SUH) de 2,2% a 4,8% para el per\u00edodo 1995 a\n2004, a partir de informaci\u00f3n proveniente del Sistema de Vigi-lancia Epidemiol\u00f3gico Argentino (15), en ambos casos para lapoblaci\u00f3n de menores de 5 a\u00f1os.\nAn\u00e1lisis de sensibilidad\nPara determinar el impacto que tienen las variables de en-\ntrada del modelo sobre las variables de resultado (ej. probabili-dad de adquirir SUH), se realiz\u00f3 un an\u00e1lisis de sensibilidad pormedio del cual se determin\u00f3 el grado de asociaci\u00f3n entre dichasvariables empleando la correlaci\u00f3n de Pearson. La probabilidadde adquirir una infecci\u00f3n por VTEC se consider\u00f3 \u201csensible\u201d auna determinada variable del modelo de riesgos cuando el co-eficiente de correlaci\u00f3n entre estos par\u00e1metros fue elevado.\nA las variables que presentaron mayor coeficiente de corre-\nlaci\u00f3n con el riesgo de adquirir una infecci\u00f3n con el pat\u00f3geno seles realiz\u00f3 un an\u00e1lisis de sensibilidad avanzado. Este consisti\u00f3en realizar 5000 iteraciones del modelo manteniendo fijo el va-lor correspondiente a los percentiles 1%, 5%, 25%, 50%, 75%,95% y 99% (7 simulaciones con 5000 iteraciones cada una, entotal 35 000 iteraciones) de cada variable de inter\u00e9s, dejandovariar libremente el resto de las variables que componen elmodelo. Los valores extremos de probabilidad de adquirir la in-fecci\u00f3n por el pat\u00f3geno (riesgo de infecci\u00f3n habiendo fijado elvalor de la variable de entrada en los percentiles 1% y 99%)fueron utilizados para calcular el \nOdds ratio  (OR) para las dife-\nrentes variables estudiadas (ej. probabilidad de adquirir SUH sining\u00fan operador se lava las manos / probabilidad de adquirirSUH si todos los operadores se lavan las manos).\nTanto el an\u00e1lisis de sensibilidad b\u00e1sico como el an\u00e1lisis de\nsensibilidad avanzado fueron realizados con el programa @Risk\n\u00ae\nversi\u00f3n 4.5 (Palisade, New York).\nRESULTADOS\nLa Figura 2 muestra las distribuciones de probabili-\ndad del n\u00famero de VTEC (UFC) en la carne molida (A),en las manos del operador (B) y en las verduras luego dela preparaci\u00f3n de las hamburguesas (C). La probabili-dad de que dichos objetos presenten al menos una c\u00e9lu-\nla de VTEC fue de 68,52%, 12,22% y 13,02%, respecti-vamente. Como se puede observar, el n\u00famero promediode pat\u00f3genos te\u00f3ricamente presentes en las manos delos operadores (2,7 UFC) y en la verdura (4,5 UFC) esmenor que el presente en la carne molida (920 UFC), lacual fue considerada como la fuente desde donde se di-semina al resto de los objetos.\nLa Figura 3 muestra la distribuci\u00f3n acumulada de la\nprobabilidad de sufrir una infecci\u00f3n por VTEC, de adqui-rir SUH y de morir por SUH luego de una comida de ham-burguesas caseras. Esta distribuci\u00f3n resulta de graficarla probabilidad de cada uno de los eventos, por comida,como resultado de cada una de las 5000 iteraciones quese realizaron al modelo. La probabilidad de adquirir lainfecci\u00f3n por consumo de vegetales en una comida dehamburguesas fue de 1,25 x 10\n-4 (IC95% 1,2 x 10-8 \u2013 0,11);\nla probabilidad condicional de padecer SUH luego dehaber sido infectado por VTEC fue de 7,07 x 10\n-6 (IC95%\n6,6 x 10-10 \u2013 6,76 x 10-3) y la probabilidad de morir a con-\nsecuencia de SUH fue de 2,45 x 10-7 (IC95% 2,45 x 10-11\n\u2013 5,49 x 10-4). Es decir que por cada 10 millones de por-\nciones de hamburguesas caseras con vegetales que seconsuman se generar\u00edan 1250 infecciones por VTEC, delas cuales 70 evolucionar\u00edan a SUH y esto ser\u00eda la causade muerte de 2 a 3 personas.\nSe encontr\u00f3 una correlaci\u00f3n significativa entre 3 de\nlas variables de entrada del modelo y el riesgo de adqui-rir SUH tras la infecci\u00f3n por VTEC. El lavado de manosdel operador luego de manipular la carne molida (r =0,314), la elaboraci\u00f3n de hamburguesas antes que lapreparaci\u00f3n de los vegetales (r = 0,207) y el lavado de latabla luego de elaborar las hamburguesas (r = 0,181)fueron aquellas variables que arrojaron mayores valoresabsolutos en el an\u00e1lisis de correlaci\u00f3n. Por otra parte, seencontr\u00f3 una baja correlaci\u00f3n entre la probabilidad depresentaci\u00f3n del SUH y la posible transferencia del pat\u00f3-geno entre el grifo de agua y las manos del operador (r =0,019) (Figura 4).\nLos valores de probabilidad de adquirir SUH de los\nextremos de las curvas de la Figura 5 (correspondientesa los percentiles 1% y 99%) fueron utilizados para calcu-lar el OR para las variables que presentaron mayor co-rrelaci\u00f3n. As\u00ed, el OR de adquirir SUH fue 12,02 vecesmayor en caso que los operadores no se laven las ma-nos; 6,57 veces mayor cuando se preparan las hambur-guesas (a partir de carne molida cruda) antes que losvegetales que las acompa\u00f1an y 5,02 veces mayor si nose lava la tabla donde se procesa la carne molida, mien-tras que fue 6,57 veces menor por el hecho de prepararlas hamburguesas (a partir de carne molida cruda) luegoque los vegetales que las acompa\u00f1an. De esta manera,el riesgo de adquirir SUH se ve sustancialmente modifi-cado cuando estas 3 variables se incorporan en el mo-delo (Figura 5) y pueden considerarse los principales fac-Modelo de contaminaci\u00f3n cruzada por VTEC 241\ntores de riesgo de contaminaci\u00f3n cruzada de VTEC en-\ntre la carne y los vegetales. En contraposici\u00f3n, ese ries-go fue solamente de 1,039 cuando se consider\u00f3 la trans-ferencia del pat\u00f3geno entre el grifo de agua y las manosdel operador (Figura 5). Asimismo, es interesante desta-car la importancia que tiene la contaminaci\u00f3n cruzadacausada a trav\u00e9s de las manos del operador contra lainsignificancia del aporte de la interacci\u00f3n entre el grifo yesas mismas manos.DISCUSI\u00d3N\nMediante la evaluaci\u00f3n cuantitativa de riesgos descri-\nta se pretendi\u00f3 generar un modelo que permita explorarcon mayor profundidad procesos cr\u00edticos durante las eta-pas finales de la cadena agroalimentaria, como parte deevaluaciones de riesgos hol\u00edsticas del tipo \u201cde la granjaa la mesa\u201d. Una de las principales ventajas que tienenlos modelos que se desarrollan siguiendo esta metodo-Figura 2. Distribuci\u00f3n de probabilidad acumulada del n\u00famero de VTEC en: A)\ncarne molida, B) manos del cocinero y C) vegetales.\n242 Revista Argentina de Microbiolog\u00eda (2009) 41: 237-244\nlog\u00eda es que pueden ser utilizados a posteriori, indepen-\ndientemente del pat\u00f3geno que uno quiera estudiar, mo-dificando solamente algunas pocas variables que le sonpropias al agente etiol\u00f3gico.\nLos resultados muestran que las bajas cargas\nmicrobianas en las manos del operador y en los vegeta-les son producto de la baja probabilidad de transferenciaentre los diferentes objetos durante la preparaci\u00f3n delalimento, aunque en ciertas ocasiones puede encontrar-se un n\u00famero elevado de microorganismos producto dela contaminaci\u00f3n cruzada. El solo hecho de que el n\u00fa-mero estimado de pat\u00f3genos presentes en las manosdel operador sea relativamente bajo no descarta la im-portancia que \u00e9stas tienen en la trasmisi\u00f3n del pat\u00f3genoa los vegetales y en la posterior infecci\u00f3n y adquisici\u00f3nde SUH.\nEl presente trabajo concuerda con las conclusiones\npublicadas por Mylius \net al. (9) con referencia a la impor-\ntancia que presentan las actividades que se desarrollanen una cocina como medio de contaminaci\u00f3n cruzadaentre los alimentos. Con base en los datos publicados enla literatura cient\u00edfica (1, 3, 8), es altamente probable quelas manos de quienes cocinan transfieran pat\u00f3genosdesde diferentes alimentos, aunque no es posible des-cartar como una ruta de contaminaci\u00f3n cruzada la faltade limpieza de las tablas donde se preparan los alimen-tos. A partir de un estudio de casos y controles, Rivas \net\nal. (14) informaron que la pr\u00e1ctica de lavarse las manos\nsiempre con agua y jab\u00f3n despu\u00e9s de manipular carnecruda tiene un OR de 0,23 (IC 95% 0,1 \u2013 0,6), es decir,casi 5 veces menos riesgo de adquirir SUH que si no selleva a cabo dicha pr\u00e1ctica, lo que representa un OR in-ferior al estimado por este modelo te\u00f3rico.\nEl h\u00e1bito de preparar alimentos crudos antes que los\nalimentos listos para su consumo, incentivado muchasveces por el hecho de que es durante el transcurso de lacocci\u00f3n de los primeros cuando se preparan los segun-dos, favorece la contaminaci\u00f3n cruzada y aumenta el ries-go de transmisi\u00f3n de pat\u00f3genos entre alimentos. El lava-do de la tabla empleada durante la preparaci\u00f3n de losalimentos presenta un elevado OR, lo que pone de mani-fiesto su importancia para reducir la contaminaci\u00f3n cru-zada. Otra medida que puede sugerirse es el empleo dedos tablas diferentes, una para la preparaci\u00f3n de las ham-burguesas y otra para manipular los alimentos listos parasu consumo, como los vegetales frescos.\nAunque el riesgo estimado de adquirir la infecci\u00f3n fue\nmuy bajo en el presente trabajo, no puede considerarseinsignificante, ya que debe contemplarse el n\u00famero deporciones de hamburguesas que se sirven anualmente(magnitud de la exposici\u00f3n). Seg\u00fan datos del SENASA(17), se comercializan durante un a\u00f1o alrededor de 526millones de hamburguesas en Argentina. Considerandolos datos aportados por la encuesta realizada a hogaresen el centro de la provincia de Santa Fe (13), anualmen-te se preparan en forma casera una cantidad similar deFigura 3. Probabilidad de adquirir una infecci\u00f3n por VTEC, SUH\ny mortalidad.\nFigura 4. Coeficientes de regresi\u00f3n entre la probabilidad de ad-\nquirir SUH y los principales factores predictivos del modelo cuan-titativo de riesgos.\nFigura 5. Variaci\u00f3n en la probabilidad de adquirir SUH en fun-\nci\u00f3n del cambio en las principales variables que inciden en elmodelo.\nProbabilidad acumulada\nLog Probabilidad\nPercentilLog Probabilidad (SUH)Modelo de contaminaci\u00f3n cruzada por VTEC 243\nhamburguesas. Un estudio publicado por Mc Cormick et\nal. (5) indica que aproximadamente un 8% de los consu-\nmidores de la provincia de Buenos Aires (Argentina)acompa\u00f1a las hamburguesas con vegetales. Teniendoen cuenta los datos anteriores, se estim\u00f3 que el n\u00fameropromedio de personas que potencialmente podr\u00edan ad-quirir SUH a consecuencia de la contaminaci\u00f3n cruzadaes 88, considerando la variabilidad y la incertidumbrepresente en los factores incorporados al modelo. Estorepresenta cerca del 20% del total de casos de SUH quese producen en Argentina anualmente, dado que se re-gistran entre 400 y 450 nuevos casos cada a\u00f1o (14). Latransmisi\u00f3n de la enfermedad ha evolucionado y en laactualidad m\u00e1s del 20% de los casos se vinculan confuentes diferentes de la carne bovina (21). El n\u00fameropromedio de casos anuales de esta enfermedad calcula-do mediante el presente modelo de simulaci\u00f3n (88 ca-sos) avala el concepto de que el modelo escogido esrepresentativo de las operaciones que se realizan du-rante la elaboraci\u00f3n de estos alimentos y, por lo tanto,que es extrapolable.\nAunque el modelo estim\u00f3 un n\u00famero de pat\u00f3genos\nrelativamente bajo en las manos del operador, el lavadode \u00e9stas tiene una influencia determinante en la trasmi-si\u00f3n del pat\u00f3geno a los vegetales, y el riesgo puede serdisminuido sustancialmente si esa pr\u00e1ctica se incorporadurante el proceso de elaboraci\u00f3n. Por otra parte, es lla-mativo c\u00f3mo esas mismas manos al interactuar con elgrifo no incorporan al modelo un nivel de riesgo impor-tante y parecer\u00eda que toda especulaci\u00f3n que pueda ha-cerse en cuanto a la incorporaci\u00f3n o no de grifos accio-nados con pedalera en una cocina hogare\u00f1a no estar\u00edajustificada por este modelo. Sin embargo, es destacadala funci\u00f3n que cumple este tipo de equipos en las plantasprocesadoras de alimentos, en donde los grifos manipu-lados por un alto n\u00famero de operarios pueden llegar aconvertirse en importantes fuentes de contaminaci\u00f3n cru-zada. Sin duda, el n\u00famero reducido de operadores pre-sentes en la cocina hogare\u00f1a tiene influencia sobre latransferencia de pat\u00f3genos y as\u00ed, sobre el bajo riesgo detransmisi\u00f3n estimado.\nDe todas maneras, las medidas de prevenci\u00f3n para\ndesarrollar en los hogares deber\u00edan apuntar a controlarlos factores que poseen un mayor riesgo relativo y endonde se destacan 3 de las variables estudiadas, 2 delas cuales est\u00e1n relacionadas con procedimientos de hi-giene (lavado de manos y lavado de la tabla) y la restan-te puede verse afectada por modificaciones propias delas rutinas, m\u00e1s precisamente por el orden en que sellevan a cabo las tareas. Estas medidas de prevenci\u00f3nprimaria de la salud ya hab\u00edan sido destacadas por Rivero\net al. (16) y forman parte de las recomendaciones emiti-\ndas por la asociaci\u00f3n \u201cLucha contra el S\u00edndrome Ur\u00e9micoHemol\u00edtico\u201d (2) y por la Sociedad Argentina de Pediatr\u00eda(19), por lo que este modelo contribuye con la comunica-ci\u00f3n del riesgo cuantificando el impacto que tanto las\nmedidas de limpieza y desinfecci\u00f3n como la modifica-ci\u00f3n de las rutinas culinarias pueden tener sobre la trans-misi\u00f3n de la enfermedad.\nEl presente modelo permiti\u00f3 descubrir \u00e1reas de inves-\ntigaci\u00f3n que deber\u00edan profundizarse para reducir la in-certidumbre existente sobre ciertos par\u00e1metros cr\u00edticosde los h\u00e1bitos culinarios de la poblaci\u00f3n, especialmenteen las variables relacionadas con la frecuencia con laque se manipulan alimentos crudos antes que alimentoslistos para su consumo y la frecuencia de lavado de ma-nos y de tablas, las cuales fueron asignadas arbitraria-mente. Por lo anterior, el modelo deber\u00e1 ser revisado enel futuro cuando se disponga de informaci\u00f3n que permitareducir dichas fuentes reconocidas de incertidumbre. Detodas maneras, aunque el modelo presenta incertidum-bre, aporta una base cient\u00edfica que permite corroborar laimportancia que tienen las pr\u00e1cticas culinarias en la trans-misi\u00f3n de enfermedades. La informaci\u00f3n generada porestos modelos cuantitativos de riesgos deber\u00eda ser con-siderada en la elaboraci\u00f3n de estrategias de interven-ci\u00f3n y comunicaci\u00f3n del riesgo hacia las personas quemanipulan alimentos, para acentuar la importancia quelos 3 principales factores predictivos pueden tener en latransmisi\u00f3n de la enfermedad y el impacto que se gene-rar\u00eda en caso de adoptar medidas higi\u00e9nicas y pr\u00e1cticasculinarias adecuadas.\nCONCLUSIONES\nEl orden seguido durante la preparaci\u00f3n de los pla-\ntos cuando se sirven alimentos que se consumen cru-dos combinados con alimentos con cocci\u00f3n previa, as\u00edcomo los h\u00e1bitos de lavado de manos y de las tablasdonde se elaboran los alimentos, son los principalesfactores de riesgo de contaminaci\u00f3n cruzada de VTECentre la carne cruda y las verduras. Aunque se identifi-caron importantes fuentes de incertidumbre que debe-r\u00edan ser reducidas en futuros trabajos de investigaci\u00f3n,el presente modelo puede ser empleado en evaluacio-nes cuantitativas de riesgos del tipo \u201cde la granja a lamesa\u201d para reflejar todas las fuentes de transmisi\u00f3n depat\u00f3genos al humano. La informaci\u00f3n aportada por estemodelo deber\u00eda ser tomada en consideraci\u00f3n duranteel dise\u00f1o de estrategias de comunicaci\u00f3n del riesgo delSUH dirigida a quienes participan en la elaboraci\u00f3n decomidas.\nAgradecimientos: Los autores desean agradecer los apor-\ntes realizados por Sara Bertero (SENASA.- Rafaela), MirnaS\u00e1nchez (SENASA.- Santa Fe), Carlos Ameri (SENASA), MartaRivas (Instituto Nacional de Enfermedades Infecciosas ANLISDr. Carlos G. Malbr\u00e1n), Nicol\u00e1s Winter, Guillermo Negri y NataliaBonvin (Secretar\u00eda de Agricultura, Ganader\u00eda, Pesca y Alimen-tos). L.S. Frizzo es becario del Consejo Nacional de Investiga-ciones Cient\u00edficas y T\u00e9cnicas (CONICET).244 Revista Argentina de Microbiolog\u00eda (2009) 41: 237-244\nBIBLIOGRAF\u00cdA\n1. Chen Y, Jackson KM, Chea FP, Schaffner DW. Quanti-\nfication and variability analysis of bacterial cross-contamination rates in common food services tasks. J FoodProtect 2001; 64: 72-80.\n2. Lucha contra el S\u00edndrome Ur\u00e9mico Hemol\u00edtico. \u00bfC\u00f3mo pre-\nvenir el S\u00edndrome Ur\u00e9mico Hemol\u00edtico? Disponible en:www.lusuh.org.ar. \u00daltimo acceso: 29 de enero de 2009.\n3. Luber P, Brynestad S, Topsch D, Scherer K, Bartelt E.\nQuantification of \nCampylobacter  species cross-conta-\nmination during handling of contaminated fresh chickenparts in kitchens. Appl Environ Microbiol 2006; 72: 66-70.\n4. Mar\u00edn V, Quinteros C, Tarabla H, Signorini M. H\u00e1bitos de\nconsumo de hamburguesas y el riesgo de exposici\u00f3n a\nEscherichia coli VTEC. XVII Reuni\u00f3n Cient\u00edfica T\u00e9cnica de\nla Asociaci\u00f3n Argentina de Veterinarios de Laboratorios deDiagn\u00f3stico, 2008, Resumen E8, Santa Fe, Argentina.\n5. Mc Cormick M, Lacaze ML, Pereyra AM, Battistini M. Se-\nlecciones alimentarias en hogares de Buenos Aires y susalrededores. En: Traversa O, editores. Cuadernos del Cen-tro de Estudios del Sistema Agroalimentario. Facultad deCiencias Agrarias, Universidad Nacional de Lomas deZamora, Llavallol, Provincia de Buenos Aires (Argentina),1999, p. 51-80.\n6. Meichtri L, Miliwebsky E, Gioffr\u00e9 A, Chinen I, Baschkier A,\nChillemi G, \net al. Shiga toxin-producing Escherichia coli  in\nhealthy young beef steers from Argentina: prevalence andvirulence properties. Int J Food Microbiol 2004; 96: 189-98.\n7. Ministerio de Salud y Ambiente de la Naci\u00f3n. Diarrea aguda\nen Argentina. Precauciones especiales durante el per\u00edodode verano. Epi-Noticias, 2005, A\u00f1o IV, N\u00famero 527, pp 3.\n8. Montville R, Schaffner DW. Inoculum size influences\nbacterial cross contamination between surfaces. ApplEnviron Microbiol 2003; 69: 7188-93.\n9. Mylius SD, Nauta MJ, Havelaar AH. Cross-contamination\nduring food preparation: A mechanistic model applied tochicken-borne \nCampylobacter . Risk Anal 2007; 27: 803-12.\n10. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am\nSoc Nephrol 2005; 16: 1035-50.11. Omisakin F, MacRae M, Ogden ID, Strachan NJC.\nConcentration and prevalence of Escherichia coli  O157 in cattle\nfeces at slaughter. Appl Environ Microbiol 2003; 69: 2444-7.\n12. Padola NL, Sanz ME, Lucchesi PM, Blanco JE, Blanco J,\nBlanco M, et al. First isolation of the enterohaemorrhagic\nEscherichia coli  O145:H- from cattle in feedlot in Argenti-\nna. BMC Microbiol 2002; 2: 6-10.\n13. Quinteros C, Mar\u00edn V, Tarabla H, Signorini M. H\u00e1bitos de\nconsumo de hamburguesas en el centro de la provincia deSanta Fe. XVII Reuni\u00f3n Cient\u00edfica T\u00e9cnica de la Asocia-ci\u00f3n Argentina de Veterinarios de Laboratorios de Diag-n\u00f3stico, 2008; Resumen E9, Santa Fe, Argentina.\n14. Rivas M, Sosa-Estani S, Rangel J, Caletti MG, Vall\u00e9s P,\nRold\u00e1n CD, \net al. Risk factors for sporadic Shiga Toxin\u2013\nproducing Escherichia coli  infections in children, Argenti-\nna. Emerg Infect Dis  2008; 14: 763-71.\n15. Rivas M. S\u00edndrome Ur\u00e9mico Hemol\u00edtico. En: Foro de In-\nvestigaci\u00f3n en Salud en Argentina. 1\u00ba Taller de Validaci\u00f3ny adaptaci\u00f3n de metodolog\u00edas de fijaci\u00f3n de prioridades enla selecci\u00f3n de investigaciones en salud en Argentina, 2006;Olavarr\u00eda, Argentina.\n16. Rivero MA, Padola NL, Etcheverr\u00eda AI, Parma AE.\nEscherichia coli  enterohemorr\u00e1gica y s\u00edndrome ur\u00e9mico\nhemol\u00edtico en Argentina. Medicina (Buenos Aires) 2004;64: 352-6.\n17. SENASA. Ameri C. 2008. Comunicaci\u00f3n personal.18. Signorini M, Tarabla H. Quantitative risk assessment for\nverocytotoxigenic \nEscherichia coli  in ground beef\nhamburgers in Argentina. Int J Food Microbiol 2009; 132:153-6.\n19. Sociedad Argentina de Pediatr\u00eda. S\u00edndrome Ur\u00e9mico\nHemol\u00edtico. Recomendaciones para su prevenci\u00f3n. Dispo-nible en: www.sap.org.ar/index. \u00daltimo acceso: 29 de ene-ro de 2009.\n20. Strachan NJC, Doyle MP, Kasuga F, Rotariu O, Ogden ID.\nDose response modelling of \nEscherichia coli  O157\nincorporating data from foodborne and environmentaloutbreaks. Int J Food Microbiol 2005; 103: 35-47.\n21. USDA-APHIS. An Update: \nEscherichia coli O157:H7 in\nhumans and cattle. Centers for Epidemiology and AnimalHealth, 1997, Fort Collins, Colorado (EE.UU.), p. 30.\nRecibido: 03/03/09 \u2013 Aceptado: 18/08/09Ochratoxin A content in red wine 245 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 245-250 ART\u00ccCULO ORIGINAL\nFate of ochratoxin A content in Argentinean red wine during a\npilot scale vinification\nM. L. PONSONE1, M. L. CHIOTTA1, M. COMBINA2, 3, A. M. DALCERO1, 3, S. N. CHULZE1, 3*\n1Departamento de Microbiolog\u00eda e Inmunolog\u00eda, Facultad de Ciencias Exactas, F\u00edsico, Qu\u00edmicas y Naturales, Universidad\nNacional de R\u00edo Cuarto, Ruta Nacional N\u00ba 36 Km 601, (5800) R\u00edo Cuarto, C\u00f3rdoba; 2Instituto Nacional de Tecnolog\u00eda\nAgropecuaria (INTA), Luj\u00e1n de Cuyo, Mendoza; 3 Members of the Research Career of CONICET, Argentina\n*Correspondence. E-mail: schulze@exa.unrc.edu.ar\nABSTRACT\nThe aim of this work was to evaluate the fate of ochratoxin A (OTA) content from must to wine during the red wine\nmaking process in a pilot scale vinification. The study was done using musts obtained from two red grape varieties(Bonarda and Tempranillo) artificially contaminated with two OTA levels. A duplicate set of tanks of 100 l each wasestablished for each must (Bonarda and Tempranillo). The fermentations were initiated by inoculation of two \nSaccha-\nromyces spp. strains having different fermentation performance. The must from the Tempranillo variety was spiked\nwith 6 \u00b5g/l of OTA while that from the Bonarda variety with 0.3 \u00b5g/l of the toxin. Samples were collected at differentstages of the process. Performance of the alcoholic and malolactic fermentations was monitored. Titratable andvolatile acidity, pH, ethanol, sugar and SO\n2 concentrations were determined following standard methods proposed by\nthe Office International de la Vigne et du Vin (OIV). OTA analysis was done by HPLC. Detection and quantificationlimits were 0.01 and 0.1 ng/ml, respectively. The OTA levels during the vinification trials dropped to an average ofabout 86.5%. The type of \nSaccharomyces strains used showed no effect on toxin reduction.\nKey words: ochratoxin A, wine, grapes, vinification process\nRESUMEN\nEvoluci\u00f3n del contenido de ocratoxina A en vinos tintos argentinos durante el proceso de vinificaci\u00f3n a\nescala piloto. El objetivo del presente trabajo fue evaluar la evoluci\u00f3n del contenido de ocratoxina A (OTA) en\nmostos durante un proceso de vinificaci\u00f3n a escala piloto. Se utilizaron mostos de dos variedades de uvas tintas(Bonarda y Tempranillo) contaminados artificialmente con dos niveles distintos de OTA. El ensayo fue llevado a cabopor duplicado en tanques de fermentaci\u00f3n de 100 l cada uno. La fermentaci\u00f3n se inici\u00f3 mediante la inoculaci\u00f3n dedos cepas de \nSaccharomyces  spp. con diferentes caracter\u00edsticas fermentativas. El mosto de la variedad Tempranillo\nfue contaminado con 6 \u00b5g/l de OTA y el mosto de la variedad Bonarda con 0,3 \u00b5g/l de la toxina. Se colectaronmuestras durante los diferentes estadios del proceso de vinificaci\u00f3n. Se estableci\u00f3 el avance de dicho proceso sobrela base de  la evoluci\u00f3n de las fermentaciones alcoh\u00f3lica y malol\u00e1ctica.  Se determin\u00f3 la acidez total y vol\u00e1til, el pH yel contenido de etanol, de az\u00facar y de SO\n2 siguiendo los protocolos est\u00e1ndares propuestos por la Oficina Internacio-\nnal de la Vid y el Vino (OIV). El contenido de OTA se evalu\u00f3 por HPLC. Los l\u00edmites de detecci\u00f3n y cuantificaci\u00f3nfueron 0,01 y 0,1 ng/ml,\n respectivamente. Los niveles de OTA disminuyeron alrededor del 86,5% al final del proceso\nde vinificaci\u00f3n. El tipo de cepa de Saccharomyces spp. utilizada no tuvo efecto sobre la reducci\u00f3n de OTA.\nPalabras clave : ocratoxina A, vino, uvas, proceso de vinificaci\u00f3n\nINTRODUCTION\nArgentina is a major producer and exporter of wine\nin the world. The wine industry plays an important rolein the Argentinean economy. Also, Argentina is con-cerned with producing wine with both good qualitystandards and absence of  fungal natural contaminantssuch as ochratoxin A (OTA). OTA is a mycotoxin pro-duced by several species of \nPenicillium  and Aspergillus\nin different food commodities, including grapes (12).The toxin shows nephrotoxic, immunotoxic and neuro-toxic effects on animals (13, 14). The International\nAgency for Research of Cancer (IARC) has classifiedOTA as a group 2 B carcinogen based on toxicity onrats (13).\nThe presence of OTA in wine was reported for the first\ntime in 1996 (25). Later surveys in Europe, Australia, andSouth America have shown OTA occurrence in wine andgrape products (3, 6, 7, 12, 18). Studies carried out indifferent countries, including Argentina have demonstrated\nthat \nAspergillus niger  aggregate and Aspergillus carbonarius\nare the main prevalent species on grapes (2, 6, 19).246 Revista Argentina de Microbiolog\u00eda (2009) 41: 245-250\nWine has been shown to be a significant contributor\nfor human OTA exposure together with cereals, coffee,beer and raisins (14). During the wine making process,OTA needs to be considered as a possible contaminant,since OTA levels in wine have been shown to be relatedto pre-harvest grape contamination.\nThe European Community has fixed a maximum allowed\nlimit of 2.0 \u00b5g/l of OTA for wines, grape must and grapejuice intended for direct human consumption (8).\nDuring the winemaking process, the Argentinean com-\npanies use different \nSaccharomyces  spp. strains as start-\ners. The strain selection depends on the winemaker\u2019s ob-jectives.\nInformation about OTA persistence and transforma-\ntion during processing will be useful to establish qualitycontrol systems based on hazard analysis and criticalcontrol points (HACCP) and the implementation of cor-rective actions during the vinification process.\nStudies on the fate of OTA during the vinification proc-\ness have been conducted in different countries usingmicrovinification trials (9, 15, 16, 20). The aim of thisstudy was to evaluate the fate of OTA during vinificationat a pilot scale for the first time in Argentina, in order toassess the scaling effect on OTA reduction, using twored grape varieties commonly used in Argentina for redwine production, and two types of \nSaccharomyces  spp.\nstrains.\nMATERIALS AND METHODS\nWinemaking trials. Winemaking trials were performed dur-\ning the 2006 vintage using \u201cTempranillo\u201d and \u201dBonarda\u201d red grapevarieties. The pilot - scale vinification was carried out employingtechnology currently used in the wine industry in Argentina.Chemical composition of the musts to initiate the fermentationprocess is shown in table 1. Due to the fact that OTA naturalgrape contamination  was not observed, musts for vinificationwere spiked with two OTA  levels (Sigma, St Luis, USA) in orderto evaluate the effects of  high and low contamination levelsduring  the fermentation process. Tempranillo and Bonarda mustswere artificially contaminated with 6 \u00b5g/l and 0.3 \u00b5g/l of OTArespectively. These levels were chosen arbitrarily, consideringhigher and lower levels than the maximum limit established byEU (2 \u00b5g/l).In order to evaluate the effect of the yeast strain used as\nstarter in the fermentation process on the ochratoxin A dynamic,two strains of \nSaccharomyces , S. bayanus  EC1118 and S.\ncerevisiae  ICV-D80, were assayed: The former shows good per-\nformance for barrel fermentation, it ferments well at low tem-peratures and flocculates well with very compact lees. Besides,it produces a lot of SO\n2 (up to 30 ppm) so it can inhibit malolactic\nfermentation. S. cerevisiae  ICV-D80 can ferment high sugar and\npolyphenol musts. Under proper nutrition conditions, aerationand fermentation temperatures below 28 \u00b0C, the strain fermentsup to 16% alcohol. \nS. cerevisiae  ICV-D80 also brings high fore-\nmouth volume, big mid-palate mouthfeel and intense fine graintannin to red wines.\nThe fermentation trials were carried out in four 100 l tanks as\nfollows:\ni. Must from Tempranillo grapes inoculated with a commer-\ncial \nS. bayanus  EC1118.\nii. Must from Tempranillo grapes inoculated with a commer-\ncial S. cerevisiae ICV-D80.\niii. Must from Bonarda grapes inoculated with a commercial\nS. bayanus  EC1118.\niv. Must from Bonarda grapes inoculated with a commercial\nS. cerevisiae  ICV-D80.\nVinification trials were started by crushing-destemming grapes,\nproducing must pomaces (skins and seeds). 50 mg/l of SO2 was\nadded to each must, and inoculated with 2 x 106 CFU/ml of the\ncommercial Saccahromyces spp. strains. The temperature in\neach tank was kept in the range of 24-28 \u00b0C during macerationand alcoholic fermentation (AF) for 7-10 days. After completionof alcoholic fermentation, a first settling and racking was carriedout to remove the pomaces from the wine. Then, malolacticfermentation (MLF) took place spontaneously, due to lactic acidbacteria present in the wine. After a second racking to removethe yeast sediment, the wine was stabilized for bottling andstorage.\nSampling of must and wine during winemaking. The sam-\nples were taken from each tank, in triplicate, after the pumping-over to obtain homogeneous samples during fermentation, atthe stages indicated in Figure 1.\nOTA analysis. The OTA content was determined following\nthe methodology proposed by Visconti \net al (1999). In brief, must\nand wine were diluted with water solution containing PEG (1%)and NaHCO\n3 (5%), mixed, and filtered to remove particulate\nmatter. Ten ml portion was taken and added to an immunoaffinitycolumn (OchraTest\nTM; Vicam, Digen Ltd, Oxford, UK). The col-\numn was washed with 10 ml PBS containing 1% Tween 20 andthen with 10 ml double distilled water. OTA was eluted from thecolumn with 1.5 ml of methanol (HPLC grade), at a flow rate of1-2 drops per second.\nThe HPLC apparatus system was a Hewlett-Packard\n(Waldbronn, Germany) chromatograph with a loop of 50 ml,\nTable 1. Chemical composition of musts used for vinification\nMusts Total Acidity Free Total Brix B\u00e9 pH EAN*\n(g/l SO\n2SO2T (mg/l)\nTartaric (mg/l) (mg/l)\n Acid)\nTempranillo 3.59 16.00 54.40 24.70 13.90 3.50 169.4\nBonarda 4.13 8.96 44.80 21.50 12.45 3.50 126.0\n*EAN: Easily assimilable NitrogenOchratoxin A content in red wine 247\nequipped with a spectrofluorescence detector (excitation, 333\nnm; emission, 460 nm) and a C18 column (150 x 4.6 mm, 5 \u00b5mparticle size; Supelcosil LC-ABZ, Supelco, Bellefonte, PA, USA),connected to a precolumn (20 x 4.6 mm, 5 \u00b5m particle size;Supelguard LC-ABZ, Supelco). The mobile phase was pumped\nat 1.0 ml/min, and consisted of an isocratic system as follows:\n99:99:2 acetonitrile, water and acetic acid respectively. OTA wasquantified on the basis of HPLC fluorometric response comparedwith OTA standard (purity > 99%; Sigma Aldrich Co., St Louis,MO, USA). The lowest limit of detection was 0.01 ng/ml and thequantification limit was 0.1 ng/ml.\nRecovery experiments. Recovery experiments were per-\nformed in triplicate by spiking OTA free samples of must withOTA levels of 2, 5 and 10 ng/ml. (Table 2).\nPhysico-chemical analysis. Progress of the alcoholic fer-\nmentation (AF) was monitored daily by decline in total solublesolids using a gravimetric method as density (B\u00e9). pH, total sugar,ethanol (%), SO\n2, volatile acidity and total acidity were deter-\nmined according to the standard methods of OIV (1990) (17).MLF was followed by malic acid detection with a commercialELISA kit (Roche\n\u00ae) following the manufacturer\u2019s protocol.\nStatistical analysis. To determine the significance of OTA\nreduction at the end of the process, an statistical analysis of theOTA reduction percentage in bottled wines was carried out bythe analysis of variance (ANOVA; \np<0.001), followed by a Tukey\ntest.\nRESULTS AND DISCUSSION\nDuring the vinification process the performance of\nmalolactic fermentation was monitored (Fig. 2). Thecharacteristics of the wines were evaluated; the resultsare shown in table 3. The mean ethanol content was14.1% (v/v) with a minimum of 13.2% (v/v) and a maxi-mum of 15% (v/v). The levels of OTA in the wines afterTable 2. Recoveries from blank musts fortified with ochratoxin\nA at different levels ( n = 3)\nSpicking level Mean Recovery (%) \u00b1 SD*1R.S.Dr (%)*2\nng/ml\n2 107.6 \u00b1 4.0 3.7\n5 100.6 \u00b1 3.0 2.9\n10 100.5 \u00b1 4.7 4.6\nMean of means 104.7 \u00b1 3.9 3.73\n*1SD = Standard Deviation\n*2RSDr (%) = Relative standard deviation intra-laboratory.\nFigure 1. Red winemaking flow-chart, showing the sampling\nstages chosen for OTA analysis during the vinification process.\nFigure 2. Evolution of L-Malic Acid content through a pilot scale vinification process (n=3), at each time analyzed (T: Tempranillo; B:\nBonarda; EC11 18:  S.  bayanus  EC1118;  D80: S. cerevisiae ICV-D80).\n248 Revista Argentina de Microbiolog\u00eda (2009) 41: 245-250\nthe vinification trial are reported in Figure 3. The mean\nOTA content, reached 70 ng/l in the musts contaminatedwith 0.3 \u00b5g/l, while in those contaminated with 6 mg/l themean final value was 903 ng/l .\nThis study showed the fate of OTA concentration\nthroughout the vinification process at a pilot scale (frommust to wine). The step that showed the first OTA levelreduction, 62% and 46% for must with high (Tempranillo)and low (Bonarda) levels of OTA contamination, respec-tively, occurred soon after conditioning the contaminatedmusts with additional reductions upon racking from juiceand gross lees. From this point to the end of the alcoholicfermentation process, the mean reduction of OTA reached84 and 89% for wines obtained from Tempranillo andBonarda, respectively (Fig. 3 a, b). During fermentation(either alcoholic or malolactic), the OTA content decreasedin the liquid fraction. This reduction was then further rein-forced after the final stages of the process (Table 4).  There\nTable 3. Chemical composition of final wines\nWine Total Acidity Volatil Acidity Sugar Content Free SO2Total SO2Ethanol\ng/l g/l (g/l) (mg/l) (mg/l) (% v/v)\nTartaric Acid Acetic Acid\nTempranillo\nS. bayanus 5.625 0.305 1.88 40.96 64.00 14.8\nICV- EC1118Tempranillo\nS. cerevisiae  D80 5.620 0.275 5.90 35.85 57.60 15.0\nBonarda\nS. bayanus 6.000 0.330 1.80 34.60 57.60 13.2\nICV-EC1118Bonarda\nS. cerevisiae  D80 5.770 0.310 2.18 38.40 55. 04 13.4\nFigure 3. Evolution of ochratoxin A content through the pilot scale vinification process in must from Tempranillo and Bonarda grapes.\nThe method for evaluation of OTA contamination through the process showed a mean recovery of 101.3% evaluated in the spikingrange (n=3), at each time analyzed (T: Tempranillo; B: Bonarda; EC11 18:  \nS.  bayanus  EC1118;  D80: S. cerevisiae ICV-D80).were highly significant differences (p < 0.001) between the\nOTA content of the grape must and wines for all thetrials evaluated. Both yeast strains were able to noticeablyand significantly reduce the initial OTA content, but in theTempranillo grape variety no significant differences in thebehaviour between the strains used were observed. Inthis particular case, the lack of differences among OTAreduction according to the yeast strain used agrees withdata obtained by Scott \net al. (21) and Caridi et al. (5),\nwhich showed no differences in OTA reduction by sev-eral \nSaccharomyces spp. strains evaluated. The differ-\nence in the behaviour between the yeast strains observedin Bonarda musts could be explained by the low level ofOTA used at the beginning of the process.\nThe significant reduction of OTA during the vinification\nprocess could be explained by the partition of the toxinbetween the liquid and the solid phase, due to an exten-sive adsorption of OTA onto the solid parts of the grapes\nOchratoxin A content in red wine 249\nand yeast lees as it has been demonstrated by other re-\nsearchers (10, 16). An adsorption mechanism ontobiomass surface could be explained by the overall nega-tive charge in the cell walls and the acidic nature of OTA(4). Also, Fernandes \net al. (10), Gambuti et al. (11) and\nLeong et al. (16) working on vinification trials reported a\ndecrease in wine OTA content mainly due to the removalof OTA by adsorption onto suspended solids in mustsand wines. Solfrizzo \net al. (22) and Visconti et al. (24)\nreported that, on average, between 70-95% of OTA isretained in pressed grape pomace during microvinification trials.\nIn general, all the vinification trials showed an average\n86.5% of OTA reduction. Similar results were obtainedby Leong \net al. (16) during micro-vinification trials of\ngrapes with an initial OTA concentration, ranging from 2to 114 \u00b5g/kg. Under our experimental conditions, the OTAreduction was dependent on the initial OTA level in themusts.\nAlso, it was observed that during fermentation (either\nalcoholic or malolactic) the OTA content decreased inthe liquid fraction. These data agree with Fernandes \net\nal. (9), who reported a decrease in the OTA content from\nmust to wine.\nSince the risk of OTA contamination increases during\nthe grape ripening, a good sanitary stage of grapes atharvest time will be essential to prevent OTA wine con-tamination. Therefore, this stage will be one of the criti-cal control points in the wine production chain as it waspostulated in a previous study (1).\nThe results showed that under the conditions simulat-\ning the vinification process in Argentina, OTA levels canbe reduced by around 86.5% during the process.\nAcknowledgements: This work was supported by a grant\nfrom ANPCyT (PICT 25522) and SECyT Secretar\u00eda de CienciaTable 4. Removal of OTA in wines obtained from two grape varieties using two\ndifferent commercial strains of Saccharomyces after 30 days of fermentation\n(p<0.001).\nWine Range of removed Media\nOTA (%) percentage of removed OTA\n(n=3) \u00b1 SD*\nTempranillo\nS. bayanus ICV- EC1118 82-84 83 \u00b1 0.82(b)\nTempranillo\nS. cerevisiae  D80 85-88 86 \u00b1 1.25 (b)\nBonarda\nS. bayanus 99-100 100 \u00b1 0.47(a)\nICV-EC1118Bonarda\nS. cerevisiae  D80 75-79 77 \u00b1  1.63 (c)\n*SD: Standard deviation\ny T\u00e9cnica, Universidad Nacional de R\u00edo Cuarto). We also thank\nCONICET (L. Ponsone is a CONICET fellow).\nREFERENCES\n1. Battilani P, Giorni P, Languasco L, Pietri A, Bertuzzi AT.\nDynamic of fungi responsible fror ochratoxin A in grape.Results from a survey on their presence in Italy in 2000.Bioactive Fungal Metabolites-Impact and Exploitation,  2001;p 47, Swansea UK.\n2. Battilani P, Giorni P, Pietri A. Epidemiology of toxin\nproducing fungi and ochratoxin A occurrence in grape. EuropJ Plant Pathol 2003; 109: 715-22.\n3. Burdaspal PA, Legarda TM. Ocratoxina A en vinos, mostos\ny zumos de uva elaborados en Espa\u00f1a y en otros pa\u00edseseuropeos. Alim 1999; 299: 107-13.\n4. Castellari M, Versari A, Fabi\u00e1n A, Parpinello GP, Galassi\nS. Removal of ocrhatoxin A in red wines by means ofadsorption treatments with commercial finning agents. JAgric Food Chem 2001; 46: 3917-21.\n5. Caridi A, Galvano F, Tafuri A, Ritieni A. Ochratoxin A\nremoval during winemaking. Enz and Microbial Tech 2006;40: 122-6.\n6. Da Rocha Rosa CA, Palacios V, Combina M, Fraga ME,\nDe Oliveira Rekson A, Magnoli CE, Dalcero AM. Potentialochratoxin A producers from wine grapes in Argentina andBrazil. Food Add Contam 2002; 19: 408-14.\n7. European Commission. Commision Regulation (EC) N\u00b0\n1881/2006 of 19 December 2006 setting maximum levelsfor certain contaminants in foodstuffs. Offic J Eur Union2006; 364: 5-24.\n8. European Commission. Commission Regulation (EC) N\u00ba\n123/2005 of 26 January 2005 amending Regulation (EC)No 466/ 2001 as regards ochratoxin A. Off J Eur Union2005; L25: 3-5.\n9. Fernandes A, Venancio A, Moura F, Garrido J, Cerdeira A.\nFate of ochratoxin A during a vinification trial. Asp AppMicrobiol 2003; 68: 73-80.\n10. Fernandes A, Ratola N, Cerdeira A, Alves A, Ven\u00e2ncio A.\nChanges in ochratoxin A concentration during winemaking.Am J Enol Vitic 2007; 58: 92-96\n11. Gambutti A, Strollo D, Genovese A, Ugliano M, Ritieni A.\nInfluence of enological practices on ochratoxin A concen-tration in wine.  Am J Enol Vitic 2005; 56: 155-62.250 Revista Argentina de Microbiolog\u00eda (2009) 41: 245-250\n12. Hocking AD, Varelis P, Pitt JI, Cameron S, Leong S.\nOccurrence of ochratoxin A in Australian wine. Aust J GrapeWine Res 2003; 9: 72-8.\n13. International Agency for Research on Cancer (IARC).\nOchratoxin A. In: IARC editors. Monographs on theevaluation of carcinogenic risks to human: some naturallyoccurring substances; food items and constituents,heterocyclic aromatic amines and mycotoxins. Lyon, France,1993; 56: 489-521.\n14. JECFA, Joint FAO/WHO Experts Committee on Food\nAdditives. 2001; Vol 47. \n15. Leong S, Hocking AD, Scott ES. Ochratoxin A: from grapes\nto wine. In: Blair RJ, Pretorius IS, editors., Proceedings ofthe Twelfth Australian wine industry Technical Conference.Australian Wine Industry Technical Conference Inc. 2004;p. 299. Adelaide, Australia.\n16. Leong SL, Hocking AD, Varelis P, Gannikopoulos G, Scott,\nES. Fate of Ochratoxin A during vinification of semillon andShiraz grapes. J. Agric.Food Chem. 2006; 54: 6460-4.\n17. Office International de la Vigne et du Vin (O.I.V.). Recueil\ndes m\u00e9thodes internacionales d\u00b4analyse des vins et desmo\u00fbts. Edits O.I.V.: 1990; p 368. Paris, France.\n18. Ospital M, Cazabeil JM, Betberder AM, Tricard C, Creppy\nE, Medina B. L\u2019Ochratoxine A dans les vins. Rev Fran\u00e7aised\u2019Oenol 1998; 169: 16-8.\n19. Ponsone ML, Combina M, Dalcero A, Chulze S. OchratoxinA and ochratoxigenic \nAspergillus  species in Argentinean\nwine grapes cultivated under organic and non-organicsystems. Int J Food Microbiol 2007; 114: 131-5.\n20. Ratola N, Abade E, Simoes T, Ven\u00e2ncio A,  Alves A. Evolution\nof ochratoxin A  content from must to wine in Port Winemicrovinification. Anal Bioanal Chem 2005; 382: 405-11.\n21. Scott PM, Kanhere SR, Lawrence GA, Daley EF, Farber\nJM. Fermentation of wort containing added Ochratoxin Aand fumonisins B1 and B2. Food Addit Contam 1995; 12:31-40.\n22. Solfrizzo, M., Panzarini, G., Visconti, A. Fate of ochratoxin\nA during vinification of naturally contaminated primitivo andneogramaro grapes. XII International IUPAC Symposiumon Mycotoxins and Phycotoxins, 2007, Abstract 1425Istambul, Turkey.\n23. Visconti A, Pascale M, Centonze G. Determination of\nochratoxin A in wine by means of immunoaffinity columnclean-up and high-performance liquid chromatography \nJ\nChromatogr A 1999; 864: 89-101.\n24. Visconti A, Perrone G, Cozzi G, Solfrizzo M. Managing\nOchratoxin A risk in the wine food chain. XII InternationalIUPAC Symposium on Mycotoxins and Phycotoxins, 2007,Abstract 1421 Istambul, Turkey.\n25. Zimmerly B and Dick R. Ochratoxin A in table wine and\ngrapes juice: occurrence and risk assessment. Food AdditContam 1996; 13: 655-68.\nRecibido: 10/03/09 \u2013 Aceptado: 22/09/09Toxinas de Clostridium perfringens 251 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 251-260 ART\u00cdCULO ESPECIAL\nToxinas de Clostridium perfringens\nW. E. MORRIS*, M. E. FERN\u00c1NDEZ-MIYAKAWA\nInstituto de Patobiolog\u00eda, Centro Nacional de Investigaciones Agropecuarias, Instituto Nacional de Tecnolog\u00eda Agropecuaria,\nLos Reseros y Las Caba\u00f1as, (1712) Castelar, Pcia. Buenos Aires, Argentina\n*Correspondencia. E-mail: wmorris@cnia.inta.gov.ar\nRESUMEN\nClostridium perfringens  es un bacilo grampositivo anaerobio con capacidad de formar esporas. Es uno de los pat\u00f3genos\nbacterianos con mayor distribuci\u00f3n en el medio ambiente, ya que  puede ser aislado de muestras de suelo y de agua\ny adem\u00e1s forma parte de la microbiota intestinal de animales y humanos. Sin embargo, en ciertas ocasiones puedeactuar como pat\u00f3geno oportunista y causar enfermedades como la gangrena gaseosa, la enterotoxemia del ovino ydel caprino y la disenter\u00eda del cordero, entre otras. En humanos, est\u00e1 asociado a enfermedades como la intoxicaci\u00f3npor alimentos, la enterocolitis necrotizante en ni\u00f1os y la enteritis necr\u00f3tica o \npigbel de las tribus de Pap\u00faa-Nueva\nGuinea. El renovado inter\u00e9s que existe actualmente en el estudio de C. perfringens  como pat\u00f3geno veterinario y\nhumano, junto con el avance de la biolog\u00eda molecular, han hecho posible que la ciencia tenga hoy un conocimientom\u00e1s profundo sobre la biolog\u00eda y la patogenia de esta bacteria. En esta revisi\u00f3n bibliogr\u00e1fica se discuten y actualizanlos principales aspectos de la patogenia intestinal de \nC. perfringens  teniendo en cuenta las toxinas con mayor impor-\ntancia m\u00e9dica descritas hasta el presente.\nPalabras claves : Clostridium perfringens , toxinas, enterotoxemia\nABSTRACT\nToxins of Clostridium perfringens . Clostridium perfringens  is an anaerobic gram-positive spore-forming bacillus. It\nis one of the pathogens with larger distribution in the environment; it can be isolated from soil and water samples,which also belongs to the intestinal flora of animals and humans. However, on some occasions it can act as anopportunistic pathogen, causing diseases such as gas gangrene, enterotoxemia in sheep and goats and lamb dysentery,among others. In human beings, it is associated to diseases such as food poisoning, necrotic enterocolitis of the infantand necrotic enteritis or pigbel in Papua-New Guinea tribes. The renewed interest existing nowadays in the study of \nC.\nperfringens  as a veterinarian and human pathogen, together with the advance of molecular biology, had enabled\nscience to have deeper knowledge of the biology and pathology of these bacteria. In this review, we discuss andupdate the principal aspects of \nC. perfringens  intestinal pathology, in terms of the toxins with major medical relevance\nat present.\nKey words: Clostridium perfringens , toxins, enterotoxemia\nINTRODUCCI\u00d3N\nClostridium  perfringens  es un bacilo grampositivo\nanaerobio con capacidad de formar esporas (124). Per-tenece al g\u00e9nero \nClostridium , el cual est\u00e1 compuesto por\naproximadamente 150 especies, filogen\u00e9ticamenteheterog\u00e9neas, que no representan un tax\u00f3n coherente(114). Algunos clostridios son pat\u00f3genos y causan enfer-medades, principalmente por efecto de potentes toxinasextracelulares. Entre las especies pat\u00f3genas m\u00e1s cono-cidas se encuentran \nClostridium botulinum , C. tetani y C.\ndifficile (110).\nEn la \u00faltima d\u00e9cada, el uso generalizado de la PCR y\nel secuenciamiento gen\u00f3mico han producido importan-tes avances en el aislamiento, la identificaci\u00f3n y la ca-racterizaci\u00f3n de distintas bacterias, incluyendo a losclostridios (131). Adem\u00e1s, la posible utilizaci\u00f3n de estosmicroorganismos como armas biol\u00f3gicas en acciones de\nbioterrorismo ha incrementado el inter\u00e9s de muchos go-biernos en su estudio (93, 107). Tal es el caso de algu-nas especies de \nClostridium  como C. botulinum , consi-\nderado clase A por el Centers for Disease Control  de EE.\nUU. (CDC), y de la toxina \u00e9psilon de C. perfringens  tipos\nB y D, que es considerada clase B por el citado organis-mo (61, 93, 108).\nC. perfringens , previamente denominado Clostridium\nwelchii (74), es uno de los miembros del g\u00e9nero\nClostridium  que ha sido objeto de renovado inter\u00e9s en el\ncampo cient\u00edfico por sus caracter\u00edsticas biol\u00f3gicas y suimportancia biom\u00e9dica. \nC. perfringens  es uno de los\npat\u00f3genos bacterianos m\u00e1s ampliamente distribuidos enel medio ambiente (128).\n Puede ser aislado de muestras\nde suelo y de agua y forma parte de la flora intestinal deanimales y humanos (81). Sin embargo, \nC. perfringens252 Revista Argentina de Microbiolog\u00eda (2009) 41: 251-260\npuede en ciertas ocasiones comportarse como un pat\u00f3-\ngeno oportunista. En la producci\u00f3n ganadera este hechoreviste gran importancia por ser el agente causal de en-fermedades como la gangrena gaseosa, la enterotoxemiadel ovino y del caprino, y la disenter\u00eda del cordero, entreotras (11, 66, 109, 121). En humanos, por su parte, est\u00e1asociado a enfermedades como la intoxicaci\u00f3n por ali-mentos, la enterocolitis necrotizante en ni\u00f1os y la enteri-tis necr\u00f3tica o \npigbel de las tribus de Pap\u00faa-Nueva Gui-\nnea (63, 109).\nLa bacteria\nC. perfringens  no presenta motilidad y forma esporas\nin vitro s\u00f3lo en medios de cultivo especiales (91). Crece\nr\u00e1pidamente en medios ricos en carbohidratos en los queproduce, mediante la fermentaci\u00f3n de \u00e9stos, grandescantidades de hidr\u00f3geno y di\u00f3xido de carbono, que ayu-dan a mantener el ambiente anaer\u00f3bico. Sin embargo,\nC. perfringens  es relativamente aerotolerante (66). Ha\nsido, adem\u00e1s, la primera bacteria grampositiva de la cualfue posible obtener el mapa gen\u00f3mico completo (15). Estehecho fue facilitado por su relativa tolerancia al ox\u00edgeno,r\u00e1pido crecimiento y, sobre todo, por su capacidad paraser manipulado gen\u00e9ticamente (91).\nLas cepas de \nC. perfringens  pueden poseer una c\u00e1p-\nsula cuya composici\u00f3n en carbohidratos var\u00eda entre ais-lamientos; esto permite su serotipificaci\u00f3n capsular (117).Este m\u00e9todo de clasificaci\u00f3n fue empleado con \u00e9xito en-tre los a\u00f1os 1950 y 1980 para investigar los brotes deintoxicaci\u00f3n por alimentos asociados a \nC. perfringens  en\nInglaterra (117). Sin embargo, la t\u00e9cnica no fue tan efec-tiva durante la investigaci\u00f3n de brotes ocurridos enEE.UU. y Jap\u00f3n. En la actualidad, la toxinotipificaci\u00f3n esel m\u00e9todo m\u00e1s difundido de clasificaci\u00f3n de \nC.\nperfringens . Este m\u00e9todo tipifica a la bacteria en cinco\ntipos (A, B, C, D y E) seg\u00fan la producci\u00f3n de las toxinasalfa, beta, \u00e9psilon y iota (Tabla 1). Sin embargo, la viru-lencia de \nC. perfringens  se debe no solo a estas cinco\ntoxinas, sino tambi\u00e9n a un repertorio compuesto, hastael momento, de 15 toxinas proteicas (91, 110). Dentrodel resto de las toxinas no utilizadas en la clasificaci\u00f3n,pero importantes desde el punto de vista patol\u00f3gico, seencuentra la enterotoxina de \nC. perfringens  o CPE, res-\nponsable de diarreas en humanos y animales; la recien-temente descubierta toxina NetB, relacionada con la en-\nteritis necr\u00f3tica en aves (53); y la toxina beta-2, aparen-temente asociada a ciertos cuadros de enteritis (110).\nClostridium perfringens  es un microorganismo con alto\ngrado de intercambio gen\u00e9tico; esto le permite la trans-ferencia de factores de virulencia y le otorga la capaci-dad de producir las diferentes toxinas como resultado dela p\u00e9rdida o la ganancia de los genes espec\u00edficos (15,44). Es decir que no existen grandes diferencias entrelos diferentes tipos de \nC. perfringens,  a no ser el acarreo\nde ciertos genes de virulencia. Por otro lado, cierta evi-dencia indica que algunos de estos factores de virulen-cia, codificados en pl\u00e1smidos, pueden ser transferidoshorizontalmente (7, 44, 83). El movimiento gen\u00e9tico hori-zontal tambi\u00e9n est\u00e1 facilitado por transposones (12). Endefinitiva, la universalidad de\n C. perfringens  sumada a la\nindependencia de los factores de virulencia denota elpotencial patog\u00e9nico de esta bacteria, especialmente sise tiene en cuenta que es parte de la microbiota del in-testino.\nLa enterotoxina\nLa enterotoxina de \nC. perfringens  \u2013conocida como\nCPE seg\u00fan su sigla en ingl\u00e9s\u2013 fue purificada y caracteri-zada en la d\u00e9cada de 1970 (41, 115). Desde entonces,se ha acumulado suficiente evidencia para proponer aesta toxina como causante principal de la intoxicaci\u00f3npor alimentos producida por \nC. perfringens  tipo A, una\nde las enfermedades m\u00e1s comunes relacionadas con laingesta de comida. En Estados Unidos, la intoxicaci\u00f3nalimentaria por \nC. perfringens  tipo A se encuentra entre\nla 2a y 3a causa de intoxicaci\u00f3n por alimentos en huma-\nnos (103, 126). Asimismo, esta toxina se asocia con el 5-15% de las enfermedades gastrointestinales humanasdistintas de las intoxicaciones alimentarias; como porejemplo la diarrea producida por antibi\u00f3ticos (9). Por otrolado, la enterotoxina tiene importancia en la medicinaveterinaria por ser la causa de diarreas en diversas es-pecies animales como los porcinos, los ovinos, los bovi-nos, los equinos, las aves y los c\u00e1nidos (21, 48, 56, 75,80, 110, 128, 129).\nLas cepas de \nC. perfringens  que llevan el gen cpe\nson en su mayor\u00eda del tipo A, aunque todos los toxinotipospueden codificarla (66). La presencia del gen \ncpe es poco\ncom\u00fan: alrededor del 5% de los aislamientos globalesde \nC. perfringens  tipo A son positivos para cpe (23). El\ngen cpe puede encontrarse tanto en el cromosoma como\nen un pl\u00e1smido de gran tama\u00f1o (20, 22), y se cree que laubicaci\u00f3n de este gen podr\u00eda definir el tipo de enferme-dad producida. Por ejemplo, las cepas de \nC. perfringens\ntipo A responsables de la intoxicaci\u00f3n por alimentos usual-mente presentan este gen en el cromosoma, mientrasque las cepas de \nC. perfringens  tipo A causantes de\ndiarreas asociadas a antibi\u00f3ticos y diarreas espor\u00e1dicassuelen presentarlo en un pl\u00e1smido (20, 22). Hasta elmomento, no se han producido aislamientos de cepasTabla 1. Clasificaci\u00f3n de C. perfringens basada en la produc-\nci\u00f3n de toxinas\nToxinotipo Toxinas\nAlfa Beta Epsilon Iota\nA+ - - -B+ + + -C+ + -D+ - + -E+ - - +Toxinas de Clostridium perfringens 253\nque codifiquen simult\u00e1neamente el gen de la enterotoxina\nen forma cromos\u00f3mica y plasm\u00eddica. La causa de estadiferencia en las enfermedades producidas podr\u00eda de-berse a que las cepas de \nC. perfringens  que codifican la\nenterotoxina en el cromosoma presentan una mayor re-sistencia a las altas temperaturas durante la cocci\u00f3n (126)que las cepas de \nC. perfringens  con el gen cpe presente\nen pl\u00e1smidos (102). En este \u00faltimo caso, la asociaci\u00f3ncon enfermedades no relacionadas con alimentos podr\u00edadeberse a la capacidad de transferencia del pl\u00e1smido quecontiene la secuencia codificante de la enterotoxina adiferentes cepas de \nC. perfringens  presentes en el tracto\nintestinal (102).\nLa enterotoxina tiene actividad letal, citot\u00f3xica y\nenterot\u00f3xica. En el intestino delgado de diferentes ma-m\u00edferos produce da\u00f1o morfol\u00f3gico y fisiol\u00f3gico, lo cualoriginar\u00eda la diarrea observada en humanos y otras es-pecies animales (25, 79). El mecanismo de acci\u00f3n deesta toxina se inicia con la uni\u00f3n a un receptor celularproteico \u2013o a varios\u2013 (65), que podr\u00eda incluir ciertas pro-te\u00ednas de la familia de las claudinas. Estas prote\u00ednas tie-nen un importante papel en la formaci\u00f3n de la uni\u00f3n es-trecha de las c\u00e9lulas epiteliales (33, 49, 50). Luego deesta uni\u00f3n, la enterotoxina se localiza en un complejo deprote\u00ednas (~90 kDa), el cual es necesario, pero no sufi-ciente, para ejercer toxicidad (127). Este peque\u00f1o com-plejo proteico es el precursor de un par de complejosmayores, uno de ~155 kDa y otro de ~200 kDa que inclu-ye a la ocludina, otra prote\u00edna de la uni\u00f3n estrecha, apa-rentemente removida desde esta ubicaci\u00f3n (108).\nHay evidencia que indica que la formaci\u00f3n del com-\nplejo de 155 kDa forma poros en la membrana celular, loque llevar\u00eda a un aumento de la permeabilidad celularcon la consecuente citotoxicidad (40, 54, 127). El meca-nismo de muerte celular es dependiente de la concentra-ci\u00f3n de toxina y de la concentraci\u00f3n de ciertos ionesextracelulares, como el calcio (17). La evidencia existen-te indica que la apoptosis ser\u00eda el mecanismo predomi-nante a bajas concentraciones y la necrosis a altas con-centraciones (17). En ambos casos la enterotoxina pro-duce da\u00f1o histopatol\u00f3gico en el intestino \nin vivo (68), lo\nque lleva a la p\u00e9rdida de electrolitos y fluidos que se ob-serva en modelos experimentales (79, 105, 109). Sinembargo, no est\u00e1 claro si los cambios en la uni\u00f3n estre-cha e incluso los procesos inflamatorios producidos porla toxina tambi\u00e9n podr\u00edan contribuir a estos cambios fi-siol\u00f3gicos.\nEstudios recientes han demostrado que el receptor\npara CPE se expresa en c\u00e9lulas neopl\u00e1sicas, raz\u00f3n porla cual se investiga su posible uso en el tratamiento delc\u00e1ncer (55, 69, 100, 101).\nLa toxina alfa\nLa toxina alfa es el principal factor de virulencia de la\ngangrena gaseosa en humanos y animales (66) y de laenteritis necr\u00f3tica de bovinos, equinos y pollos (3, 11,58, 80, 129, 130). Todos los tipos de \nC. perfringens po-\nseen los genes codificantes para esta toxina ( plc); sin\nembargo, no todas las cepas la producen y existen gran-des variaciones en las cantidades producidas (26). Estatoxina tiene actividad enzim\u00e1tica, tanto de fosfolipasa(fosfolipasa-C o FLC) como de esfingomielinasa (SMasa)y, adem\u00e1s, es hemol\u00edtica y dermonecr\u00f3tica (111).\nEl gen \nplc tiene ubicaci\u00f3n cromos\u00f3mica (116) y su\nexpresi\u00f3n es estimulada por la disminuci\u00f3n de la tempe-ratura (64). El significado biol\u00f3gico de esto ser\u00eda que encondiciones adversas, como las que imperan en el sueloo en el ambiente externo, la bacteria necesitar\u00eda producirm\u00e1s FLC, para degradar membranas y otros l\u00edpidos delambiente y generar as\u00ed fuentes de carbono y energ\u00eda.Esto no suceder\u00eda a la temperatura corporal.\nLa estructura cristalizada de la toxina alfa de \nC.\nperfringens  muestra que la prote\u00edna madura est\u00e1 organi-\nzada en dos dominios, el amino terminal, que contiene laactividad FLC, y el carboxi terminal de uni\u00f3n que es de-pendiente de calcio. Los productos de la hidr\u00f3lisis songrupos polares unidos a fosfatos solubles en agua y unacola unida a un esqueleto de glicerol insoluble en agua.La estructura del fosfol\u00edpido (el grupo de la cabeza polar)y el grado de insaturaci\u00f3n y largo de la cola tienen pro-funda influencia en la eficiencia con la cual \u00e9stos sonhidrolizados por ciertas FLC (77). Dependiendo de lacomposici\u00f3n de los l\u00edpidos de la membrana celular, latoxina alfa puede ser hemol\u00edtica en presencia de calcio,como sucede en los eritrocitos humanos, de ratones y deovejas. En cambio, esto no sucede en el caso de loseritrocitos de conejos o de caballos (77).\nLa hidr\u00f3lisis de fosfol\u00edpidos de membrana resulta en\nla acumulaci\u00f3n de diacilglicerol, compuesto que puedeactivar v\u00edas celulares que contribuyen al efecto citot\u00f3xicoobservado, como la v\u00eda del \u00e1cido araquid\u00f3nico (77). Estaacumulaci\u00f3n act\u00faa como activador de la prote\u00edna-kinasaC, enzima que a su vez puede activar las fosfolipasas Cy D de las c\u00e9lulas eucari\u00f3ticas (31, 32, 119). Asimismo,la activaci\u00f3n de esta v\u00eda llevar\u00eda a la producci\u00f3n detromboxano A2, un potente mediador de la respuestainflamatoria. Parecer\u00eda que la toxina alfa imita la acci\u00f3nde la FLC intracelular en la membrana de c\u00e9lulaseucariotas (99).\nC. perfringens  tipo A produce enteritis necr\u00f3tica en\npollos (3, 58, 80). Durante mucho tiempo la evidenciaacumulada hizo suponer firmemente que la toxina alfaproducida por este tipo de  \nC. perfringens  era la respon-\nsable de los principales signos de la enfermedad (2, 34).Sin embargo, la b\u00fasqueda de vacunas eficaces muestraque otras toxinas o factores no descubiertos a\u00fan, ade-m\u00e1s de la toxina alfa, ser\u00edan necesarios para proveerprotecci\u00f3n contra la enfermedad (118). Un trabajo recienteen el cual a cepas de casos cl\u00ednicos de  \nC. perfringens  se\nles suprimio el gen de la toxina alfa, pareceria aportarevidencia concluyente de que la toxina alfa no es esen-cial en el desarrollo de la enteritis necr\u00f3tica (52). Sin254 Revista Argentina de Microbiolog\u00eda (2009) 41: 251-260\nembargo, un trabajo posterior (4) puso en duda el mode-\nlo animal utilizado en los experimentos de Keyburn et al.\n(52), argumentando que los animales en estudio podr\u00edanhaber estado colonizados con cepas salvajes producto-ras de enteritis necr\u00f3tica previo al ensayo.\nLa acci\u00f3n de la toxina alfa en el intestino de especies\nanimales (con la excepci\u00f3n de los pollos) es poco cono-cida, como tambi\u00e9n lo es su acci\u00f3n como factor de viru-lencia en casos de enterotoxemia (11, 77). Existe aso-ciaci\u00f3n entre la toxina alfa de \nC. perfringens  tipo A y la\nabomasitis de los terneros (90). Tambi\u00e9n se considera a\nC. perfringens  tipo A el agente causal de la enteritis\nnecrotizante bovina; sin embargo, el papel que la toxinaalfa juega en esta enfermedad de los bovinos es contro-vertido (60). La toxina alfa inoculada en asas de intestinodelgado de ratas \nin vivo caus\u00f3 influjo de neutr\u00f3filos en la\nmucosa, con incrementos en la actividad de la N-acetil-beta-glucosaminidasa intraluminal y en la permeabilidad,lo que indica da\u00f1o de la mucosa (82) y contracci\u00f3n delintestino delgado (98). En explantes intestinales de co-nejo incubados \nin vitro con toxina alfa se observ\u00f3 da\u00f1o\nen el epitelio (47). En cerdos, ovinos y bovinos inyecta-dos por v\u00eda endovenosa se observ\u00f3 enteritis, escaso da\u00f1odel epitelio intestinal, diarrea transitoria, hem\u00f3lisisintravascular y da\u00f1o capilar (78, 79). En ovinos, la toxinaalfa caus\u00f3 da\u00f1os morfol\u00f3gicos con alteraci\u00f3n del trans-porte de agua en el intestino (25).\nEstudios recientes asocian a la toxina alfa y a cepas de\nC. perfringens  tipo A no enterotoxig\u00e9nico con enfermeda-\ndes humanas diferentes de la gangrena gaseosa (43, 45).Entre \u00e9stas se encuentran casos fatales de enteritisnecr\u00f3tica (45) y el s\u00edndrome de muerte s\u00fabita del lactante(47). El hecho de que sean escasos los reportes de enfer-medades humanas asociadas a esta toxina puede deber-se, al menos en parte, a la alta degradabilidad de la toxinaen el intestino, lo cual dificulta su detecci\u00f3n. A esto sesuma el hecho de que hasta hace poco, el m\u00e9todo m\u00e1susado para la detecci\u00f3n era la seroneutralizaci\u00f3n en rat\u00f3n(66). Con esta t\u00e9cnica, un resultado falso negativo puededarse por insuficiente material o material no fresco. Dadoque los antisueros espec\u00edficos para esta prueba no siem-pre est\u00e1n a disposici\u00f3n en el mercado y que esta toxinaposee baja letalidad en ratones, el diagn\u00f3stico resulta a\u00fanm\u00e1s dificultoso (66, 123). El empleo de los ELISA de cap-tura para la detecci\u00f3n de toxinas clostridiales no siempreresuelve el problema mencionado, ya que la alta sensibili-dad de estas t\u00e9cnicas puede resultar en la obtenci\u00f3n defalsos positivos (67, 123).\nLa toxina beta\nLa toxina beta fue originalmente purificada y parcial-\nmente caracterizada a fines de la d\u00e9cada de 1970 (92,93). Trabajos posteriores determinaron que la toxina for-maba poros (selectivos para cationes monovalentes) enbicapas lip\u00eddicas y en membranas de c\u00e9lulas sensibles(104), lo que aporta evidencia de que la toxina podr\u00edafuncionar como una neurotoxina y producir constricci\u00f3n\narterial (94, 95).\nUno de los principales factores de virulencia de \nC.\nperfringens  tipos B y C es la toxina beta, que es muy\nsensible a la degradaci\u00f3n por tripsina. Los animales re-ci\u00e9n nacidos o con deficiencias nutricionales son usual-mente los m\u00e1s susceptibles de ser infectados por estosmicroorganismos (11). Seg\u00fan estudios recientes, la toxi-na beta es el principal factor que contribuye a la letalidadde \nC. perfringens  tipo B y C (25, 30).\nC. perfringens  tipo B es responsable de algunas en-\nfermedades de origen intestinal en rumiantes, principal-mente ovejas, aunque tambi\u00e9n se han aislado cepas deeste tipo de animales cl\u00ednicamente sanos (122). Enovinos, la disenter\u00eda del cordero y la enteritis hemorr\u00e1gicaocurren en animales de menos de 3 semanas de vida, sibien tambi\u00e9n pueden observarse en animales de mayoredad. El resultado de la infecci\u00f3n es una enterotoxemiaacompa\u00f1ada de enteritis, hemorragia profusa y ulceraci\u00f3ndel intestino delgado (110). Tambi\u00e9n existe una asocia-ci\u00f3n del tipo B con casos de enteritis hemorr\u00e1gica encabras, vacas y potrillos (110).\nNo se dispone de mucha informaci\u00f3n acerca de la\npatog\u00e9nesis de las infecciones causadas por el tipo B, yno se conocen los efectos individuales o sin\u00e9rgicos delas toxinas alfa, beta, \u00e9psilon u otras toxinas menoressobre los signos cl\u00ednicos observados.\nC. perfringens  tipo C causa enteritis necr\u00f3tica en cor-\nderos, terneros, potrillos y cerdos neonatos, aunque hansido reportados casos en perros, pollos y llamas. Loscerdos reci\u00e9n nacidos son com\u00fanmente m\u00e1s afectadosque otros animales. En los animales infectados se ob-serva diarrea y disenter\u00eda, con materia fecal sangui-nolenta, y muerte. Esta bacteria tambi\u00e9n produceenterocolitis necr\u00f3tica en humanos, una enfermedad po-tencialmente letal (46, 57). Los primeros informes de estaenfermedad surgieron a fines de la Segunda GuerraMundial durante un brote que afect\u00f3 en Alemania a per-sonas mal nutridas. El origen de la contaminaci\u00f3n fueatribuido a carne de conejo enlatada. La enfermedad fuenombrada \ndarmbrand  (intestinos en llamas). En la litera-\ntura m\u00e1s reciente, los casos m\u00e1s reconocidos y estudia-dos de enteritis necr\u00f3tica provienen de Pap\u00faa-NuevaGuinea, donde la enfermedad es conocida como \npigbel.\nLa ingesta de carne de cerdo obtenida en condicionesde higiene deficientes y cocida insuficientemente, con-sumida junto con la batata, dio origen al alto n\u00famero decasos registrados. Esta costumbre tribal de ocasionesfestivas, aportaba suficiente cantidad de bacterias con lacarne y esto, sumado a los inhibidores de la tripsina apor-tados por la batata, evitaban la degradaci\u00f3n de la toxinabeta en el intestino del hu\u00e9sped. La introducci\u00f3n de unavacuna basada en toxoide beta redujo significativamentela incidencia de la enfermedad en esa zona geogr\u00e1fica.Adem\u00e1s de estos pocos reportes relacionados con bro-tes, se han descrito varios casos espor\u00e1dicos de enteri-Toxinas de Clostridium perfringens 255\ntis necr\u00f3tica que afectaron principalmente a personas con\nproblemas pancre\u00e1ticos o intestinales (89). Una dietapobre en prote\u00ednas y problemas en la motilidad intestinalpueden favorecer el desarrollo de la enfermedad. El prin-cipal s\u00edntoma es dolor abdominal (46), tambi\u00e9n puedenaparecer v\u00f3mitos y diarrea sanguinolenta. Los casos m\u00e1scomplicados pueden desarrollar obstrucci\u00f3n intestinal pornecrosis del intestino delgado. La muerte puede ocurrirtambi\u00e9n por toxemia, la que en algunos casos se produ-ce muy r\u00e1pidamente (46).\nLa toxina \u00e9psilon\nLa toxina \u00e9psilon es la toxina clostridial m\u00e1s potente\nluego de las neurotoxinas tet\u00e1nica y botul\u00ednica (85, 86).Es producida y secretada como una prototoxina con unpeso molecular de 32,7 kDa, que al sufrir un clivajeproteol\u00edtico espec\u00edfico adquiere su m\u00e1xima actividad bio-l\u00f3gica (96). Esta activaci\u00f3n puede ser catalizada porproteasas como la tripsina, la quimotripsina y una zinc-metaloproteasa producida por \nC. perfringens  (70) en el\ntracto gastrointestinal (85). El gen de esta toxina ( etx)\nest\u00e1 codificado en un elemento extracromos\u00f3mico, unpl\u00e1smido de gran tama\u00f1o (51).\nLa toxina \u00e9psilon es t\u00f3xica para c\u00e9lulas de la l\u00ednea\nMadin-Darby canine kidney  (MDCK) y, en menor medi-\nda, para la l\u00ednea G-402 de c\u00e9lulas de leiomioblastomahumano (84, 106). Diversos trabajos realizados con c\u00e9-lulas MDCK muestran que la toxina \u00e9psilon induce hin-chaz\u00f3n, formaci\u00f3n de burbujas, fragmentaci\u00f3n y lisis ce-lular. Adem\u00e1s, se demostr\u00f3 que en las c\u00e9lulas MDCK latoxina \u00e9psilon forma un complejo en la membranacitoplasm\u00e1tica, aunque su ingreso a la c\u00e9lula no es ne-cesario para ejercer toxicidad (87, 88). En estas c\u00e9lulas,la acci\u00f3n citot\u00f3xica se correlaciona con la formaci\u00f3n deun gran complejo de membrana que causa una r\u00e1pidap\u00e9rdida de potasio con entrada de sodio y cloruro, mien-tras que la concentraci\u00f3n de calcio se incrementa; estoda como resultado una p\u00e9rdida de la viabilidad celular(88). La toxina \u00e9psilon se une a microdominios de mem-brana resistentes a los detergentes (\nlipid raft) y se\noligomeriza y forma un poro en membranas celulares tan-to sinaptosomales como de c\u00e9lulas MDCK (73, 87). Elporo formado en la membrana celular permitir\u00eda el pasa-je de solutos hidrof\u00edlicos de hasta una masa molecularde 1 kDa. Este canal estar\u00eda constituido por unaheptamerizaci\u00f3n de la toxina que, sugestivamente, coin-cide con otras toxinas citol\u00edticas como la toxina alfa de\nStaphylococcus aureus  (38), la aerolisina de Aeromonas\nhydrophila  (14, 87) y la toxina citol\u00edtica ClyA de Escherichia\ncoli (59, 125). La estructura cristalizada de la toxina mues-\ntra que forma un poro barril \u00e2, el cual exhibe alguna simi-litud estructural con la aerolisina, otra toxina formadorade poro (19).\nUna baja concentraci\u00f3n de toxina \u00e9psilon puede de-\ntener la divisi\u00f3n celular sin matar inmediatamente a lasc\u00e9lulas, y causar un descenso en su n\u00famero y un signifi-cativo aumento de su volumen medio (10). La uni\u00f3n es-\npec\u00edfica a este tipo de c\u00e9lulas se debe probablemente ala presencia de un receptor, el que ser\u00eda necesario parala actividad biol\u00f3gica de la toxina (87). En forma recientese demostr\u00f3 que la l\u00ednea de c\u00e9lulas epiteliales de t\u00fabulocolector distal de ri\u00f1\u00f3n de rat\u00f3n mpkCCDcl4 es tambi\u00e9nsensible a la acci\u00f3n de la toxina \u00e9psilon (18). Estas c\u00e9lu-las conservan ciertas caracter\u00edsticas del transporte i\u00f3nicode las c\u00e9lulas epiteliales, por lo que han sido \u00fatiles paracaracterizar los efectos de la toxina \u00e9psilon en lahomeostasis celular. En estas c\u00e9lulas, la toxina \u00e9psilonse une principalmente a las membranas del lado apicalde las c\u00e9lulas y oligomeriza sobre esta superficie, sin di-fundir hacia el interior de la c\u00e9lula. Sobre la superficieapical existen proteasas que activar\u00edan a la prototoxina\u00e9psilon.\nAunque se desconoce el receptor de esta toxina, se\nsabe que es una prote\u00edna de superficie anclada porglucosilfosfatidilinositol. La toxina \u00e9psilon produjo unaca\u00edda de la resistencia transepitelial y del potencial el\u00e9c-trico en estas c\u00e9lulas crecidas en monocapa. Esto esti-mul\u00f3 temporariamente la absorci\u00f3n de sodio e indujo unacorriente i\u00f3nica entrante con el consecuente aumento dela concentraci\u00f3n de calcio intracelular (24). Asimismo, latoxina ocasion\u00f3 una r\u00e1pida p\u00e9rdida del ATP celular yactiv\u00f3 a la prote\u00edna quinasa activada por AMP (que sensael estado metab\u00f3lico). La toxina tambi\u00e9n produjopermeabilizaci\u00f3n mitocondrial y translocaci\u00f3n nuclear delfactor inductor de apoptosis, un efector de muerte celularindependiente de caspasas. Adem\u00e1s, en las c\u00e9lulasmpkCCDcl4 la toxina \u00e9psilon indujo una necrosis carac-terizada por la reducci\u00f3n en el tama\u00f1o del n\u00facleo, perosin fragmentaci\u00f3n del ADN. Llamativamente, aunque laeliminaci\u00f3n de los dominios ricos en colesterol de la mem-brana celular evit\u00f3 la oligomerizaci\u00f3n de la toxina y redu-jo el influjo de sodio y calcio, no impidi\u00f3 la p\u00e9rdida delATP celular ni la muerte celular. Estos hallazgos indicanque la toxina \u00e9psilon produce una r\u00e1pida necrosis en estasc\u00e9lulas, y que la p\u00e9rdida de ATP interviene en el procesode muerte celular sin estar correlacionada con lapermeabilizaci\u00f3n de la membrana celular y la difusi\u00f3ni\u00f3nica causada por la toxina (24).\nLa principal actividad biol\u00f3gica de la toxina \u00e9psilon es\nla generaci\u00f3n de edema (11). Esta toxina es letal ydermonecr\u00f3tica, aunque no es hemol\u00edtica (66). Se hadescrito que eleva la presi\u00f3n sangu\u00ednea, incrementa lapermeabilidad vascular e intestinal y causa da\u00f1o renal ycontracci\u00f3n del \u00edleon en ratas (13, 35, 74, 76, 97). Escapaz de pasar la barrera hematoencef\u00e1lica y acumular-se en el cerebro (85). Una propiedad b\u00e1sica de la toxina\u00e9psilon es que incrementa la permeabilidad vascular porla alteraci\u00f3n de las uniones estrechas entre las c\u00e9lulasendoteliales (1); esto produce da\u00f1o y edema en diversos\u00f3rganos, como pulm\u00f3n, coraz\u00f3n, ri\u00f1\u00f3n y cerebro (11).En el cerebro, el da\u00f1o neuronal y los des\u00f3rdenes neuro-l\u00f3gicos est\u00e1n asociados con los edemas perivasculares256 Revista Argentina de Microbiolog\u00eda (2009) 41: 251-260\n(por el aumento de la permeabilidad vascular) y con la\nposible interacci\u00f3n con las neuronas del hipocampo, quelleva a una excesiva liberaci\u00f3n de glutamato (71, 72).\nEn ovejas y ratones se observ\u00f3 un aumento en la ab-\nsorci\u00f3n de inmunoglobulinas anti-toxina dift\u00e9rica cuandofueron coadministradas con la toxina \u00e9psilon, lo que lle-v\u00f3 a suponer que esta toxina incrementar\u00eda la permeabi-lidad del intestino delgado y facilitar\u00eda su propia absor-ci\u00f3n y pasaje a la circulaci\u00f3n general (6, 13). Se ha infor-mado que la toxina \u00e9psilon altera la permeabilidadparacelular del epitelio del intestino delgado (6, 13). Estopodr\u00eda explicar la mayor absorci\u00f3n intestinal de toxina\u00e9psilon y la acumulaci\u00f3n de fluido en el intestino que seobserv\u00f3 en animales de experimentaci\u00f3n (24, 120, 121),as\u00ed como en casos cl\u00ednicos (28). Sin embargo, no existenestudios experimentales sobre la capacidad de absor-ci\u00f3n de la toxina en el intestino delgado y grueso de ovinosy caprinos, as\u00ed como tampoco existe informaci\u00f3n compa-rativa sobre las diferencias de permeabilidad paracelularen el tracto intestinal. Tampoco se cuenta con estudiosfuncionales precisos acerca de la actividad de la toxina\u00e9psilon sobre epitelios intestinales, y considerando queen condiciones patol\u00f3gicas \nC. perfringens  puede ser ais-\nlado de diferentes secciones del tracto intestinal (66), nose puede descartar que la toxina \u00e9psilon tenga actividadsobre este tejido.\nLa toxina iota\nLa toxina iota de \nC. perfringens  tipo E es un miembro\nde la familia de las toxinas binarias, como la toxina iotade \nC. spiroforme , la toxina CDT de C. difficile , la toxina\nC2 de C. botulinum  y la toxina \u00e1ntrax de B. anthracis\n(16). Estas toxinas binarias est\u00e1n formadas por un p\u00e9ptidode uni\u00f3n (Ib) de unos 81 kDa y un p\u00e9ptido enzim\u00e1tico(ADP-ribosiltransferasa) de 45 kDa (Ia). El primero esnecesario para la internalizaci\u00f3n del segundo (62). Latoxina iota requiere de la remoci\u00f3n proteol\u00edtica de un frag-mento propept\u00eddico, el cual permite que la unidad Ib seinserte en la membrana e interact\u00fae con la porci\u00f3n Ia(39). Al insertarse en la membrana celular, el segmentoIb forma un poro heptam\u00e9rico que permite la salida delos iones K\n+ y Na+, adem\u00e1s de la entrada de la porci\u00f3n Ia\na la c\u00e9lula. Una vez dentro de la c\u00e9lula, Ia ribosila la G-actina y termina por despolimerizar los filamentos deactina, con la consiguiente destrucci\u00f3n del citoesqueletocelular (39). La activaci\u00f3n de la toxina iota ocurre, gene-ralmente, por efecto de las proteasas presentes en eltracto intestinal (110).\nLa toxina iota es dermonecr\u00f3tica, citot\u00f3xica,\nenterot\u00f3xica e induce da\u00f1o histopatol\u00f3gico intestinal (16).Sin embargo, durante mucho tiempo se dud\u00f3 de su efec-to pat\u00f3geno (110, 128); \u00e9ste se confirm\u00f3 hace alrededorde treinta a\u00f1os (8, 16, 84). En 1978, Patton \net al. (84)informaron un brote de enterotoxemia en una colonia de\nconejos. Los animales afectados presentaban enteritisnecr\u00f3tica y hemorr\u00e1gica aguda. Se aisl\u00f3 la toxina iota delcontenido intestinal de los conejos afectados; esta toxi-na produjo lesiones agudas en el ciego de conejos sa-nos inoculados, salvo en aquellos a los que se los prote-gi\u00f3 con un antisuero espec\u00edfico contra la toxina (84). Aun-que existen informes de enterotoxemia asociada a estabacteria en otras especies (112), s\u00f3lo se la ha podidoreproducir en conejos.\nEstudios recientes han dado a las toxinas binarias, y\nen especial a la toxina iota, mayor importancia, dado quepodr\u00edan utilizarse como transportadoras e internalizadorasde drogas en c\u00e9lulas procariotas (5).\nDos nuevas toxinas\nA mediados de 1980, de una cepa de tipo C se purifi-\nc\u00f3 y caracteriz\u00f3 una prote\u00edna t\u00f3xica letal (enterot\u00f3xica ynecrotizante) de 28 kDa, identificada inicialmente comotoxina beta. En 1997, Gibert \net al. (36) aislaron una toxi-\nna de 28 kDa del contenido intestinal de un cerdo conenteritis necrotizante. Esta toxina era citot\u00f3xica para c\u00e9-lulas CHO y, adem\u00e1s, provocaba enteritis hemorr\u00e1gicaal ser inoculada en asas ligadas de cobayo (36). El gende esta prote\u00edna de 28 kDa fue secuenciado, y se pudoestablecer que su producto no era la toxina beta, sinouna prote\u00edna diferente, a la que se llam\u00f3 beta-2 (36).\nEl gen de la toxina beta-2 puede ser encontrado en\ntodos los tipos de \nC. perfringens  y se halla codificado en\nun pl\u00e1smido en la mayor\u00eda de las cepas que lo contienen.\nEsta toxina ha sido asociada con diversas enferme-\ndades intestinales en animales (36, 37, 42, 60), pero tam-bi\u00e9n se ha aislado de pacientes humanos con enferme-dades gastrointestinales (29, 30, 60). Aunque en los \u00falti-mos a\u00f1os ha aumentado considerablemente la cantidadde publicaciones sobre la toxina beta-2 y su asociaci\u00f3ncon enfermedades ent\u00e9ricas, la mayor\u00eda de los trabajoss\u00f3lo informan la presencia de bacterias con el gencodificante de la toxina, de modo que la asociaci\u00f3n entrela enfermedad y la toxina aparece como una cuesti\u00f3nnetamente especulativa (27, 113).\nEn febrero de 2008, Keyburn \net al. (53) comunicaron\nla existencia de una nueva toxina clostridial responsablede la enteritis necrotizante en pollos: la NetB. El gen dedicha toxina fue caracterizado a partir de cepas de \nC.\nperfringens  tipo A, aisladas del contenido intestinal de\naves con esta enfermedad. La NetB ser\u00eda una toxina detipo formadora de poro. Estos autores reprodujeron lainfecci\u00f3n en aves libres de pat\u00f3genos, a las que se lesinocul\u00f3 la toxina recombinante purificada o cepas queportaban el gen de la toxina o que carec\u00edan de \u00e9ste. S\u00f3lolas aves que recibieron la toxina purificada o la cepa conla toxina desarrollaron enteritis necrotizante (53).Toxinas de Clostridium perfringens 257\nCONCLUSIONES\nC. perfringens  es un microorganismo que reviste suma\nimportancia en medicina humana y veterinaria ya que,pese a ser parte de la microbiota intestinal, es potencial-mente pat\u00f3geno y letal, tanto para animales como parael hombre. Tanto es as\u00ed que el uso de algunas de sustoxinas como potenciales armas bioterroristas ha gene-rado cierta preocupaci\u00f3n en algunos pa\u00edses. Sin embar-go y a modo de contracara, otras de sus toxinas podr\u00edanser usadas en el tratamiento de enfermedades, comotransportadoras e internalizadoras de drogas en c\u00e9lulasprocariotas (toxina iota) o en ciertas terapias antitumorales(enterotoxina).\nEn el \u00e1mbito de la medicina veterinaria, \nC. perfringens\ngenera importantes p\u00e9rdidas en la producci\u00f3n ganadera.En el caso de la producci\u00f3n av\u00edcola, por ejemplo, el re-ciente descubrimiento de una toxina (NetB), presente encepas de \nC. perfringes tipo A aisladas de aves con enteri-\ntis necr\u00f3tica, abre una nueva l\u00ednea de investigaci\u00f3n, rele-vante tanto para el conocimiento de la patogenia de estosmicroorganismos como para el desarrollo de nuevas va-cunas. Esta toxina, o tal vez otras tambi\u00e9n, podr\u00edan estarinvolucradas en la enteritis necr\u00f3tica por \nC. perfringens\ntipo A observada en otras especies animales.\nDado el renovado inter\u00e9s que existe en el estudio de\nC. perfringens  y sus toxinas, es posible que en los pr\u00f3xi-\nmos a\u00f1os tengamos un perfil m\u00e1s completo de la biolo-g\u00eda de esta bacteria como comensal y como pat\u00f3geno.Esta informaci\u00f3n permitir\u00e1 dilucidar su papel en enfer-medades ent\u00e9ricas en las que su participaci\u00f3n a\u00fan esincierta.\nAgradecimientos:  Agradecemos la generosa ayuda de Yanil\nR. Parma. M.E. Fern\u00e1ndez-Miyakawa es investigador delCONICET.\nBIBLIOGRAF\u00cdA\n1. Adamson RH, Ly JC, Fern\u00e1ndez-Miyakawa M, Ochi S,\nSakurai J, Uzal F , et al. Clostridium perfringens  epsilon-\ntoxin increases permeability of single perfused microvesselsof rat mesentery. Infect Immun 2005; 73: 4879-87.\n2. Al-Sheikhly F, Truscott RB. The pathology of necrotic ente-\nritis of chickens following infusion of crude toxins of\nClostridium perfringens  into the duodenum. Avian Dis 1977;\n21: 241-55.\n3. Baba E, Fuller AL, Gilbert JM, Thayer SG, McDougald LR.\nEffects of Eimeria brunetti  infection and dietary zinc on ex-\nperimental induction of necrotic enteritis in broiled chickens.Avian Dis 1992; 36: 59-62.\n4. Barbara AJ, Trinh HT, Glock RD, Songer JG. Necrotic en-\nteritis-producing strains of \nClostridium perfringens  displace\nnon-necrotic enteritis strains from the gut of chicks. VetMicrobiol 2008; 126: 377-82.\n5. Barth H, Stiles BG. Binary actin-ADP-ribosylating toxins and\ntheir use as molecular Trojan horses for drug delivery intoeukaryotic cells. Curr Med Chem 2008; 15: 459-69.\n6. Batty I, Bullen JJ. The effect of \nClostridium welchii  type D\nculture filtrates on the permeability of the mouse intestine.J Pathol Bacteriol 1956; 71: 311-23.7. Billington SJ, Wieckowski EU, Sarker MR, Bueschel D, Songer\nJG, McClane BA. \nClostridium perfringens  type E animal ente-\nritis isolates with highly conserved, silent enterotoxin genesequences. Infect Immun 1998; 66: 4531-6.\n8. Borriello SP, Carman RJ. Association of iota-like toxin and\nClostridium spiroforme  with both spontaneous and antibiotic-\nassociated diarrhea and colitis in rabbits. J Clin Microbiol1983; 17: 414-8.\n9. Borriello SP, Larson HE, Welch AR, Barclay F, Stringer MF,\nBartholomew BA. Enterotoxigenic \nClostridium perfringens :\na possible cause of antibiotic-associated diarrhoea. Lancet1984; 8372: 305-7.\n10. Borrmann E, G\u00fcnther H, K\u00f6hler H. Effect of \nClostridium\nperfringens  epsilon toxin on MDCK cells. FEMS Immunol\nMed Microbiol 2001; 31: 85-92.\n11. Brown CC, Baker DC, Barker IK. The alimentary system.\nIn: MG Maxie, editor. Jubb, Kennedy and Palmer\u2019s pathologyof domestic animals. Vol. 2, 5\u00ba ed.; Elsevier, 2007, p. 771.\n12. Brynestad S, Synstad B, Granum PE. The \nClostridium\nperfringens  enterotoxin gene is on a transposable element\nin type A human food poisoning strains. Microbiology 1997;143: 2109-15.\n13. Bullen JJ, Batty I. Experimental enterotoxaemia of sheep:\nthe effect of the permeability of the intestine and thestimulation of antitoxin production in immune animals. JPathol Bacteriol 1957; 73: 511-8.\n14. Cabiaux V, Buckley JT, Wattiez R, Ruysschaert JM, Parker\nMW, van der Goot FG. Conformational changes in aerolysinduring the transition from the water-soluble protoxin to themembrane channel. Biochemistry 1997; 36: 15224-32.\n15. Canard B, Cole ST. Genome organization of the anaerobic\npathogen \nClostridium perfringens . Proc Natl Acad Sci USA\n1989; 86: 6676-80.\n16. Carman RJ, Perelle S, Popoff MR. Binary toxins from\nClostridium spiroforme  and Clostridium perfringens , In: Rood\nJI, McClane BA, Songer JG, Titball RW, editors. Theclostridia: molecular biology and pathogenesis. London, UK,Academic Press, 1997, p. 359-67.\n17. Chakrabarti G, Zhou X, McClane BA. Death pathways\nactivated in CaCo-2 cells by \nClostridium perfringens\nenterotoxin. Infect Immun 2003; 71: 4260-70.\n18. Chassin C, Bens M, de Barry J, Courjaret R, Bossu JL,\nCluzeaud F, et al. Pore-forming epsilon toxin causes\nmembrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am JPhysiol Renal Physiol 2007; 293: 927-37.\n19. Cole AR, Gibert M, Popoff M, Moss DS, Titball RW, Basak\nAK. \nClostridium perfringens  epsilon-toxin shows structural\nsimilarity to the pore-forming toxin aerolysin. Nat Struct MolBiol 2004; 11: 797-8.\n20. Collie RE, McClane BA. Evidence that the enterotoxin gene\ncan be episomal in \nClostridium perfringens  isolates\nassociated with non-food-borne human gastrointestinaldiseases. J Clin Microbiol 1998; 36: 30-6.\n21. Collins JE, Bergeland ME, Bouley D, Ducommun AL, Francis\nDH, Yeske P. Diarrhea associated with \nClostridium\nperfringens  type A enterotoxin in neonatal pigs. J Vet Diagn\nInvest 1989; 1: 351-3.\n22. Cornillot E, Saint-Joanis B, Daube G, Katayama S, Granum\nPE, Canard B, et al. The enterotoxin gene ( cpe) of\nClostridium perfringens  can be chromosomal or plasmid-\nborne. Mol Microbiol 1995; 15: 639-47.\n23. Czeczulin JR, Hanna PC, McClane BA. Cloning, nucleotide\nsequencing, and expression of the Clostridium perfringens\nenterotoxin gene in Escherichia coli . Infect Immun 1993;\n61: 3429-39.\n24. Fern\u00e1ndez Miyakawa ME, Ibarra CA, Uzal FA. In vitro effects\nof Clostridium perfringens  type D epsilon toxin on water\nand ion transport in ovine and caprine intestine. Anaerobe2003; 9: 145-9.258 Revista Argentina de Microbiolog\u00eda (2009) 41: 251-260\n25. Fern\u00e1ndez Miyakawa ME, Uzal FA. Morphologic and\nphysiologic changes induced by Clostridium perfringens  type\nA alpha toxin in the intestine of sheep. Am J Vet Res 2005;66: 251-5.\n26. Fern\u00e1ndez-Miyakawa ME, Marcellino R, Uzal FA.\nClostridium perfringens  type A toxin production in 3\ncommonly used culture media. J Vet Diagn Invest. 2007;19: 184-6.\n27. Ferrarezi MC, Cardoso TC, Dutra IS. Genotyping of\nClostridium perfringens  isolated from calves with neonatal\ndiarrhea. Anaerobe 2008; 14: 328-31.\n28. Finnie JW. Neurological disorders produced by Clostridium\nperfringens  type D epsilon toxin. Anaerobe 2004; 10: 145-50.\n29. Fisher DJ, Miyamoto K, Harrison B, Akimoto S, Sarker MR,\nMcClane BA. Association of beta2 toxin production with\nClostridium perfringens  type A human gastrointestinal\ndisease isolates carrying a plasmid enterotoxin gene. MolMicrobiol 2005; 56: 747-62.\n30. Fisher DJ, Fern\u00e1ndez-Miyakawa ME, Sayeed S, Poon R,\nAdams V, Rood JI, \net al. Dissecting the contributions of\nClostridium perfringens  type C toxins to lethality in the\nmouse intravenous injection model. Infect Immun 2006; 74:5200-10.\n31. Fujii Y, Nomura S, Oshita Y, Sakurai J. Excitatory effect of\nClostridium perfringens alpha toxin on the rat isolated aor-\nta. Br J Pharmacol 1986; 88: 531-9.\n32. Fujii Y, Sakurai J. Contraction of the rat isolated aorta caused\nby Clostridium perfringens  alpha toxin (phospholipase C):\nevidence for the involvement of arachidonic acid metabolism.Br J Pharmacol 1989; 97: 119-24.\n33. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M,\nTsukita S. \nClostridium perfringens  enterotoxin binds to the\nsecond extracellular loop of claudin-3, a tight junction inte-gral membrane protein. FEBS Lett 2000; 476: 258-61.\n34. Fukata T, Hadate Y, Baba E, Arakawa A. Influence of bac-\nteria on \nClostridium  perfringens  infections in young chickens.\nAvian Dis 1991; 35: 224-7.\n35. Gardner DE. Pathology of Clostridium welchii  type D\nenterotoxaemia. II. Structural and ultrastructural alterationsin the tissues of lambs and mice. J Comp Pathol 1973; 83:509-24\n36. Gibert, M.; Jolivet-Renaud, C.; Popoff, M.R. Beta-2 toxin, a\nnovel toxin produced by \nClostridium perfringens . Gene 1997;\n203: 65-73.\n37. Gkiourtzidis K, Frey J, Bourtzi-Hatzopoulou E, Iliadis N,\nSarris K. PCR detection and prevalence of alpha-, beta-,beta 2-, epsilon-, iota- and enterotoxin genes in \nClostridium\nperfringens  isolated from lambs with clostridial dysentery.\nVet Microbiol 2001; 82: 39-43.\n38. Gouaux E. Alpha-hemolysin from Staphylococcus aureus :\nan archetype of beta-barrel, channel-forming toxins. J StructBiol 1998; 121: 110-22.\n39. Hale ML, Marvaud JC, Popoff MR, Stiles BG. Detergent-\nresistant membrane microdomains facilitate Ib oligomerformation and biological activity of \nClostridium perfringens\nIota-toxin. Infect Immun 2004, 72, 4: 2186-93.\n40. Hardy SP, Denmead M, Parekh N, Granum PE. Cationic\ncurrents induced by Clostridium perfringens  type A\nenterotoxin in human intestinal CaCO-2 cells. J MedMicrobiol 1999; 48: 235-43.\n41. Hauschild AH, Hilsheimer R. Purification and characteristics\nof the enterotoxin of \nClostridium perfringens  type A. Can J\nMicrobiol 1971; 17: 1425-33.\n42. Herholz C, Miserez R, Nicolet J, Frey J, Popoff M, Gibert\nM, et al. Prevalence of beta2-toxigenic Clostridium\nperfringens  in horses with intestinal disorders. J Clin\nMicrobiol 1999; 37: 358-61.\n43. Holdsworth RJ, Parratt D. The potential role of Clostridium\nperfringens  alpha toxin in the pathogenesis of acute\npancreatitis. J Clin Pathol 1996; 49: 500-3.44. Hughes ML, Poon R, Adams V, Sayeed S, Saputo J, Uzal\nFA, et al. Epsilon-toxin plasmids of Clostridium perfringens\ntype D are conjugative. J Bacteriol 2007; 189: 7531-8.\n45. Iwanaka T, Kawashima H, Kishimoto H, Kakinuma M, Arai\nK, Sakurai J, et al. Enteritis necroticans caused by\nClostridium perfringens  type A. J Pediatr 2004; 144: 410-4.\n46. Johnson S, Gerding DN. Enterotoxemic infections. In: Rood\nJI, MCClane BA, Songer JG, editors. The Clostridia:Molecular Biology and Pathogenesis. London, UK,Academic Press, 1997, p. 117-40.\n47. Kamaras J, Murrell WG. Intestinal epithelial damage in SIDS\nbabies and its similarity to that caused by bacterial toxins inthe rabbit. Pathology 2001; 33: 197-203\n48. Kanoe M, Inoue S, Abe T, Anzai T, Kamada M, Imagawa\nH, \net al. Isolation of Clostridium perfringens  from foals. Mi-\ncrobios 1990; 64: 153-8.\n49. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N.\nMolecular cloning and functional characterization of thereceptor for \nClostridium perfringens  enterotoxin. J Cell Biol\n1997a. 24; 136: 1239-47.\n50. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M,\nSugimoto N. Clostridium perfringens  enterotoxin utilizes two\nstructurally related membrane proteins as functionalreceptors \nin vivo. J Biol Chem 1997b; 272: 26652-8.\n51. Katayama S, Dupuy B, Daube G, China B, Cole ST.\nGenome mapping of Clostridium perfringens  strains with I-\nCeuI shows many virulence genes to be plasmid-borne.Mol Gen Genet 1996; 251: 720-6.\n52. Keyburn AL, Sheedy SA, Ford ME, Williamson MM, Awad\nMM, Rood JI, \net al. Alpha-toxin of Clostridium perfringens\nis not an essential virulence factor in necrotic enteritis inchickens. Infect Immun 2006; 74: 6496-500.\n53. Keyburn AL, Boyce JD, Vaz P, Bannam TL, Ford ME, Parker\nD, \net al. NetB, a new toxin that is associated with avian\nnecrotic enteritis caused by Clostridium perfringens . PLoS\nPathog 2008; 4: e26, 1-11.\n54. Kokai-Kun JF, McClane BA. Evidence that a region(s) of\nthe Clostridium perfringens  enterotoxin molecule remains\nexposed on the external surface of the mammalian plasmamembrane when the toxin is sequestered in small or largecomplexes. Infect Immun 1996; 64: 1020-5.\n55. Kominsky SL, Tyler B, Sosnowski J, Brady K, Doucet M,\nNell D, \net al. Clostridium perfringens  enterotoxin as a no-\nvel-targeted therapeutic for brain metastasis. Cancer Res2007; 67: 7977-82.\n56. Kruth SA, Prescott JF, Welch MK, Brodsky MH. Nosocomial\ndiarrhea associated with enterotoxigenic \nClostridium\nperfringens  infection in dogs. J Am Vet Med Assoc 1989;\n195: 331-4.\n57. Lawrence G, Walker PD. Pathogenesis of enteritis\nnecroticans in Papua New Guinea. Lancet 1976; 1: 125-6.\n58. Long JR, Truscott RB. Necrotic enteritis in broiler chickens.\nIII. Reproduction of the disease. Can J Comp Med 1976;40: 53-9.\n59. Ludwig A, Bauer S, Benz R, Bergmann B, Goebel W.\nAnalysis of the SlyA-controlled expression, subcellularlocalization and pore-forming activity of a 34 kDa haemolysin(ClyA) from \nEscherichia coli  K-12. Mol Microbiol 1999; 31:\n557-67.\n60. Manteca C, Daube G, Jauniaux T, Linden A, Pirson V,\nDetilleux J, et al. A role for the Clostridium perfringens  beta2\ntoxin in bovine enterotoxaemia? Vet Microbiol 2002; 86:191-202.\n61. Mantis NJ. Vaccines against the category B toxins:\nStaphylococcal enterotoxin B, epsilon toxin and ricin. AdvDrug Deliv Rev 2005; 57: 1424-39.\n62. Marvaud JC, Stiles BG, Chenal A, Gillet D, Gibert M, Smith\nLA, \net al. Clostridium perfringens  iota toxin. Mapping of the\nIa domain involved in docking with Ib and cellularinternalization. J Biol Chem 2002; 277: 43659-66.Toxinas de Clostridium perfringens 259\n63. Matsuda T, Okada Y, Inagi E, Tanabe Y, Shimizu Y,\nNagashima K, et al. Enteritis necroticans \u2018pigbel\u2019 in a\nJapanese diabetic adult. Path Int 2007; 57: 622\u20136.\n64. Matsushita C, Matsushita O, Katayama S, Minami J, Takai\nK, Okabe A. An upstream activating sequence containingcurved DNA involved in activation of the \nClostridium\nperfringens  plc promoter. Microbiology 1996; 142: 2561-6.\n65. McClane BA, McDonel JL. Protective effects of osmotic\nstabilizers on morphological and permeability alterationsinduced in Vero cells by \nClostridium perfringens  enterotoxin.\nBiochim Biophys Acta 1981; 641: 401-9\n66. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins T.\nThe Enterotoxic Clostridia. In: Dworkin M, Falkow S,Rosenburg E, Schleifer KH, Stackebrandt E, editors. TheProkaryotes, Vol. 4. New York, Springer-Verlag, 2006, p.698-752.\n67. McCourt MT, Finlay DA, Laird C, Smyth JA, Bell C, Ball HJ.\nSandwich ELISA detection of \nClostridium perfringens  cells\nand alpha-toxin from field cases of necrotic enteritis ofpoultry. Vet Microbiol 2005; 106: 259-64.\n68. McDonel JL, Duncan CL. Histopathological effect of\nClostridium perfringens  enterotoxin in the rabbit ileum. Infect\nImmun 1975; 12: 1214-8.\n69. Michl P, Gress TM. Bacteria and bacterial toxins as\ntherapeutic agents for solid tumors. Curr Cancer DrugTargets 2004; 4: 689-702.\n70. Minami J, Katayama S, Matsushita O, Matsushita C, Okabe\nA. Lambda-toxin of \nClostridium perfringens  activates the\nprecursor of epsilon-toxin by releasing its N- and C-termi-nal peptides. Microbiol Immunol 1997; 41: 527-35.\n71. Miyamoto O, Minami J, Toyoshima T, Nakamura T, Masa-\nda T, Nagao S, \net al. Neurotoxicity of Clostridium perfringens\nepsilon-toxin for the rat hippocampus via the glutamatergicsystem. Infect Immun 1998; 66: 2501-8.\n72. Miyamoto O, Sumitani K, Nakamura T, Yamagami S, Miyata\nS, Itano T, \net al. Clostridium perfringens  epsilon toxin cau-\nses excessive release of glutamate in the mousehippocampus. FEMS Microbiol Lett 2000; 189: 109-13.\n73. Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto\nS, Okabe A. Cleavage of a C-terminal peptide is essentialfor heptamerization of \nClostridium perfringens  epsilon-toxin\nin the synaptosomal membrane. J Biol Chem 2001; 276:13778-83.\n74. Morgan KT, Kelly BG, Buxton D Vascular leakage produced\nin the brains of mice by \nClostridium welchii  type D toxin. J\nComp Pathol 1975; 85: 461-6\n75. Nabuurs MJ, Haagsma J, Van de Molen EJ, Van der Heijden\nPJ. Diarrhea in one to three week-old piglets associatedwith \nClostridium perfringens  type A. Ann Rech Vet 1983;\n14: 408-11.\n76. Nagahama M, Iida H, Sakurai J. Effect of Clostridium\nperfringens  epsilon toxin on rat isolated aorta. Microbiol\nImmunol 1993; 37: 447-50.\n77. Nagahama M, Nakayama T, Michiue K, Sakurai J. Site-\nspecific mutagenesis of Clostridium perfringens  alpha-toxin:\nreplacement of Asp-56, Asp-130, or Glu-152 causes lossof enzymatic and hemolytic activities. Infect Immun 1997;65: 3489-92.\n78. Niilo L. Mechanism of Action of the enteropathogenic fac-\ntor of \nClostridium perfringens type A. Infect Immun 1971;\n3: 100-6.\n79. Niilo L. Fluid secretory response of bovine Thiry jejunal\nfistula to enterotoxin of Clostridium perfringens . Infect\nImmun 1973; 7: 1-4.\n80. Niilo L. Enterotoxigenic Clostridium perfringens  type A\nisolated from intestinal contents of cattle, sheep andchickens. Can J Comp Med 1978; 42: 357-63.\n81. Niilo L. \nClostridium perfringens  in animal disease: a review\nof current knowledge. Can Vet J 1980; 21: 141-8.82. Otamiri T. Phospholipase C-mediated intestinal mucosal\ndamage is ameliorated by quinacrine. Food Chem Toxicol1989; 27: 399-402.\n83. Parsons JA, Bannam TL, Devenish RJ, Rood JI. TcpA, an\nFtsK/SpoIIIE homolog, is essential for transfer of theconjugative plasmid pCW3 in \nClostridium perfringens . J\nBacteriol 2007; 189: 7782-90.\n84. Patton NM, Holmes HT, Riggs RJ, Cheeke PR.\nEnterotoxemia in rabbits. Lab Anim Sci 1978; 28: 536-40.\n85. Payne DW, Williamson ED, Havard H, Modi N, Brown J.\nEvaluation of a new cytotoxicity assay for Clostridium\nperfringens  type D epsilon toxin. FEMS Microbiol Lett 1994;\n116: 161-7.\n86. Payne D, Williamson ED, Titball RW. The Clostridium\nperfringens  epsilon-toxin. Rev Med Microbiol 1997; 8: 28-30.\n87. Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P,\nPopoff MR. Clostridium perfringens  epsilon-toxin acts on\nMDCK cells by forming a large membrane complex. JBacteriol 1997; 179: 6480-7.\n88. Petit L, Maier E, Gibert M, Popoff MR, Benz R. \nClostridium\nperfringens  epsilon toxin induces a rapid change of cell\nmembrane permeability to ions and forms channels in arti-ficial lipid bilayers. J Biol Chem 2001; 276: 15736-40.\n89. Petrillo TM, Beck-Sagu\u00e9 CM, Songer JG, Abramowsky C,\nFortenberry JD, Meacham L, \net al. Enteritis necroticans\n(pigbel) in a diabetic child. N Engl J Med 2000; 342: 1250-3.\n90. Roeder BL, Chengappa MM, Nagaraja TG, Avery TB,\nKennedy GA. Experimental induction of abdominal tympany,abomasitis, and abomasal ulceration by intraruminalinoculation of \nClostridium perfringens  type A in neonatal\ncalves. Am J Vet Res 1988; 49: 201-7.\n91. Rood JI, Cole ST. Molecular genetics and pathogenesis of\nClostridium perfringens . Microbiol Rev 1991; 55: 621-48.\n92. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM.\nPublic health assessment of potential biological terrorismagents. Emerg Infect Dis 2002; 8: 225-30. Sakurai J, Duncan\nCL. Purification of beta-toxin from \nClostridium perfringens\ntype C. Infect Immun 1977; 18: 741-5.\n93. Sakurai J, Duncan CL. Some properties of beta-toxin\nproduced by Clostridium perfringens  type C. Infect Immun\n1978; 21: 678-80.\n94. Sakurai J, Fujii Y, Matsuura M, Endo K. Pharmacological\neffect of beta toxin of Clostridium perfringens  type C on\nrats. Microbiol Immunol 1981; 25: 423-32.\n95. Sakurai J, Fujii Y, Dezaki K, Endo K. Effect of Clostridium\nperfringens  beta toxin on blood pressure of rats. Microbiol\nImmunol 1984; 28: 23-31.\n96. Sakurai J, Nagahama M. Amino groups in Clostridium\nperfringens  epsilon prototoxin and epsilon toxin. Microb\nPathog 1986; 1: 417-23.\n97. Sakurai J, Nagahama M, Takahashi T. Contraction induced\nby Clostridium perfringens epsilon toxin in the isolated rat\nileum. FEMS Microbiol Lett 1989; 49: 269-72.\n98. Sakurai J, Fujii Y, Shirotani M. Contraction induced by\nClostridium perfringens  alpha toxin in the isolated rat ileum.\nToxicon 1990; 28: 411-8.\n99. Sakurai J, Nagahama M, Oda M. Clostridium perfringens\nalpha-toxin: characterization and mode of action. J Biochem2004; 136: 569-74.\n100.Santin AD, Can\u00e9 S, Bellone S, Palmieri M, Siegel ER,\nThomas M, \net al. Treatment of chemotherapy-resistant\nhuman ovarian cancer xenografts in C.B-17/SCID mice byintraperitoneal administration of \nClostridium perfringens\nenterotoxin. Cancer Res 2005; 65: 4334-42.\n101.Santin AD, Bellone S, Marizzoni M, Palmieri M, Siegel ER,\nMcKenney JK, et al. Overexpression of claudin-3 and claudin-\n4 receptors in uterine serous papillary carcinoma: noveltargets for a type-specific therapy using \nClostridium\nperfringens  enterotoxin (CPE). Cancer 2007; 109: 1312-22.260 Revista Argentina de Microbiolog\u00eda (2009) 41: 251-260\n102. Sarker MR, Carman RJ, McClane BA. Inactivation of the\ngene (cpe) encoding Clostridium perfringens  enterotoxin\neliminates the ability of two cpe-positive C. perfringens  type\nA human gastrointestinal disease isolates to affect rabbitileal loops. Mol Microbiol 1999; 33: 946-58. Erratum in: MolMicrobiol 2000; 35: 249.\n103. Satija KC, Narayan KG. Passive bacteriocin typing of strains\nof \nClostridium perfringens  type A causing food poisoning\nfor epidemiologic studies. J Infect Dis 1980; 142: 899-902.\n104. Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG,\nTweten RK. Clostridium perfringens  beta-toxin forms\npotential-dependent, cation-selective channels in lipidbilayers. Infect Immun 2000; 68: 5546-51.\n105. Sherman S, Klein E, McClane BA. \nClostridium perfringens\ntype A enterotoxin induces tissue damage and fluidaccumulation in rabbit ileum. J Diarrhoeal Dis Res 1994;12: 200-7.\n106. Shortt SJ, Titball RW, Lindsay CD. An assessment of the in\nvitro toxicology of \nClostridium perfringens  type D epsilon-\ntoxin in human and animal cells. Hum Exp Toxicol 2000;19: 108-16.\n107. Sinclair R, Boone SA, Greenberg D, Keim P, Gerba CP.\nPersistence of category A select agents in the environment.Appl Environ Microbiol 2008; 74: 555-63.\n108. Singh U, Mitic LL, Wieckowski EU, Anderson JM, McClane\nBA. Comparative biochemical and immunocytochemicalstudies reveal differences in the effects of \nClostridium\nperfringens  enterotoxin on polarized CaCo-2 cells versus\nVero cells. J Biol Chem 2001; 276: 33402-12.\n109.Smedley JG III, Fisher DG, Sayeed S, Chakrabarti G,\nMcClane BA. The enteric toxins of Clostridium perfringens .\nRev Physiol Biochem Pharmacol 2004; 152: 183-204.\n110. Songer JG. Clostridial enteric diseases of domestic animals.\nClin Microbiol Rev 1996; 9: 2116-34.\n111.Songer JG. Bacterial phospholipases and their role in\nvirulence.Trends Microbiol 1997; 5: 156-61.\n112. Songer JG, Miskimmins DW. Clostridium perfringens  type\nE enteritis in calves: two cases and a brief review of theliterature. Anaerobe. 2004; 10: 239-42.\n113.Songer JG, Miskimmins DW. Clostridial abomasitis in\ncalves: Case report and review of the literature. Anaerobe2005; 11: 290-4.\n114. Stackebrandt E, Sproer C, Rainey FA, Burghardt J, P\u00e4uker\nO, Hippe H. Phylogenetic analysis of the genus\nDesulfotomaculum : evidence for the misclassification of\nDesulfotomaculum guttoideum  and description of\nDesulfotomaculum orientis  as Desulfosporosinus orientis\ngen. nov., comb. nov. Int J Syst Bacteriol 1997; 47: 1134-9.\n115.Stark RL, Duncan CL. Purification and biochemical\nproperties of Clostridium perfringens  type A enterotoxin.\nInfect Immun 1972; 6: 662-73.\n116. Stevens DL, Tweten RK, Awad MM, Rood JI, Bryant AE.\nClostridial gas gangrene: evidence that alpha and thetatoxins differentially modulate the immune response and in-duce acute tissue necrosis. J Infect Dis 1997; 176: 189-95.\n117. Stringer MF. \nClostridium perfringens  type A food poisoning.\nIn: Borriello SP, editor. Clostridia in gastrointestinal disease.Boca Raton, Florida, CRC Press Inc., 1985, p. 117-43.\n118. Thompson DR, Parreira VR, Kulkarni RR, Prescott JF. Live\nattenuated vaccine-based control of necrotic enteritis ofbroiler chickens. Vet Microbiol 2006; 113: 25-34.\n119. Titball RW. Bacterial phospholipases C. Microbiol Rev 1993;\n57: 347-66.\n120. Tironi-Farinati C, Morris WE, Loidl F, Goldstein J, Dunleavy\nM, Uzal F, \net al. La toxina epsilon de Clostridium perfringens\nincrementa la permeabilidad del intestino delgado de roe-dores. LII Reuni\u00f3n Anual de la Sociedad Argentina de In-vestigaci\u00f3n Cl\u00ednica, 2007, Mar del Plata, Argentina.\n121. Uzal FA, Kelly WR. Enterotoxaemia in goats. Veter Res\nCommun 1996; 20:481-92.\n122. Uzal FA, Marcellino RM. \nClostridium perfringens  in clinically\nhealthy sheep of Patagonia, Argentina. The 6th BiennialCongress of the Anaerobe Society of the Americas, 2002,Park City, USA.\n123. Uzal FA, Songer JG. Diagnosis of \nClostridium perfringens\nintestinal infections in sheep and goats. J Vet Diagn Invest2008; 20: 253-65.\n124. Vance HN. \nClostridium perfringens  as a pathogen of cattle:\nA literature review. Can J Comp Med Vet Sci 1967; 31:248-50.\n125. Wallace AJ, Stillman TJ, Atkins A, Jamieson SJ, Bullough\nPA, Green J, \net al. E. coli hemolysin E ( HlyE, ClyA, SheA):\nX-ray crystal structure of the toxin and observation ofmembrane pores by electron microscopy. Cell 2000; 100:265-76.\n126.Wen Q, McClane BA. Detection of enterotoxigenic\nClostridium perfringens  type A isolates in American retail\nfoods. Appl Environ Microbiol 2004; 70: 2685-91.\n127. Wieckowski EU, Wnek AP, McClane BA. Evidence that an\napproximately 50-kDa mammalian plasma membraneprotein with receptor-like properties mediates theamphiphilicity of specifically bound \nClostridium perfringens\nenterotoxin. J Biol Chem 1994; 269: 10838-48.\n128. Wierup M. Equine intestinal clostridiosis. An acute disease\nin horses associated with high intestinal counts of\nClostridium perfringens  type A. Acta Vet Scand Suppl 1977;\n62: 1-182.\n129. Wierup M, DiPietro JA. Bacteriologic examination of equine\nfecal flora as a diagnostic tool for equine intestinalclostridiosis. Am J Vet Res 1981; 42: 2167-9.\n130. Wojdat E, Kwiatek K, Zdrojewski H, Krupa L. Gas gangrene-\ncase diagnosis. Przegl Epidemiol 2005; 59: 859-63.\n131. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and\nnow: use of 16S rDNA gene sequencing for bacterialidentification and discovery of novel bacteria in clinicalmicrobiology laboratories. Clin Microbiol Infect 2008; 14:908-34.\nRecibido: 07/04/09 \u2013 Aceptado: 26/10/09Im\u00e1genes microbiol\u00f3gicas 1 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 261\nCytopathic effect in BHK 21 (C13) cells inoculated with Leptospira  interrogans\nserovar Pomona isolated from a porcine abortionIM\u00c1GENES MICROBIOL\u00d3GICAS\nBHK 21 (C13) cells inoculated with a wild strain of\nLeptospira interrogans  serovar Pomona isolated from a\nporcine abortion exhibited cythopathic effect (CPE)consistent in degenerative morphological alterationswhereas no cell changes or alterations were observed incells infected with a non-pathogenic\n Leptospira biflexa\nserovar Patoc strain.\nBHK 21 (C13) cells were seeded on 24 well cell culture\nplates containing MEM-E medium with 10% fetal bovineserum and no antibiotics; 5 x 10\n4 cells per ml were poured\ninto each well. Cell cultures were infected with one milliliterof a suspension from each separate strain containing 1 x10\n7 leptospires/ml. Cells were subsequently incubated at\n37 \u00b0C in a 5% CO2 atmosphere and fixed with methyl\nalcohol at 24 and 48 h pi. Cell morphology and leptospiralCPE were microscopically assessed in May Gr\u00fcnwald-Giemsa stained smears. In this study, several CPE causedby a wild strain of \nL. interrogans  serovar Pomona were\nobserved at 24 h pi: ballooning, loss of cell structure,vacuolization and lysis (Figures 1 and 2). This factdemonstrated the ability of leptospires to produce celldamage. No changes were observed in BHK 21 (C13)cells infected with a non-pathogenic \nL. biflexa serovar\nPatoc strain (Figure 3). Origin of Leptospira  strains: La-\nB. Brihuega1, A. Venzano1, O. Zabal2, D. Funes1, C. Auteri1, G. Romero1, L. Samartino1.\n1Instituto de Patobiolog\u00eda. 2Instituto de Virolog\u00eda. Centro de Investigaciones\nen Ciencias Veterinarias y Agron\u00f3micas. INTA.\nLas Caba\u00f1as y Los Reseros (1712) Castelar, Buenos Aires, Argentina.\nE-mail: bbrihuega@cnia.inta.gov.arFigure 1.  BHK 21 (C13) cells inoculated with a  wild type L.\ninterrogans serovar Pomona. Arrows show vacuolization. May\nGr\u00fcnwald-Giemsa. 400XFigure 2.  BHK 21 (C13) cells inoculated with a wild type L.\ninterrogans  serovar Pomona.  Arrow shows ballooning and loss\nof cell structure. May Gr\u00fcnwald-Giemsa. 400X\nFigure 3. BHK 21 (C13) cells inoculated with L. biflexa serovar\nPatoc. No cell changes or alterations are observed. MayGr\u00fcnwald-Giemsa. 400X\nboratory of Leptospirosis, Instituto de Patobiolog\u00eda,\nCICVyA-CNIA, Instituto Nacional Tecnolog\u00eda Agrope-cuaria, Castelar, Buenos Aires, Argentina.262 Revista Argentina de Microbiolog\u00eda (2009) 41: 262 ISSN 0325-7541\nRevista Argentina de Microbiolog\u00eda (2009) 41: 262\nBacterial hydrocarbon-degrading consortium from Antarctic soilsIM\u00c1GENES MICROBIOL\u00d3GICAS\nRemoval of contaminants from polluted environments could be improved by taking advantage of the catabolic\ncapacity of some microorganisms in a process called bioremediation . Nowadays, the use of microbial associations\n(also called microbial consortia ) is gaining attention, because they seem to have a wider degradation spectrum\nthan that exhibited by isolated strains. M10 is a bacterial consortium obtained from hydrocarbon-contaminated Antarcticsoils. The members of the M10 consortium have been isolated and identified, being its main components bacteriabelonging to the \nPseudomonas , Sthenotrophomonas  and Sphingobacterium  genera (1). The use of the M10 consortium\nas a bioaugmentation tool proved to enhance phenanthrene removal from Antarctic soils (2). Transmission electronicmicroscopy (TEM) images of M10 revealed the presence of morphological diversity among the cells grown in liquidculture with phenanthrene as sole carbon and energy source (Figure1, A and B). This morphological diversity is inagreement with the idea of M10 as a complex microbial association. Images in Figure 1, C and D are compatible withthe presence of an extracellular matrix around the cells. This matrix, that seems to be forcing or helping bacterial cellsto stay close together is associated to the surface of only some members of the consortium.\nL.A.M. Ruberto1, S.C. V\u00e1zquez1, W.P. Mac Cormack2\n1CONICET - C\u00e1tedra de Microbiolog\u00eda Industrial y Biotecnolog\u00eda, Facultad de Farmacia y Bioqu\u00edmica, UBA,\nJun\u00edn 956 - 6\u00ba P (1113) CABA; 2Instituto Ant\u00e1rtico Argentino, Cerrito 1248 (1010) CABA, Argentina.\nE-mail: lruberto@ffyb.uba.arFigure 1. Transmission electronic micrography of cells from the M10 bacterial consortium. The consortium\nwas cultured using phenanthrene as sole carbon and energy source. A: 10.000X; B: 18.500X; C: 46.000X;D: 70.000X.\nBIBLIOGRAF\u00cdA\n1. Mestre MC, V\u00e1zquez SC, Ruberto L, Mac Cormack WP. Identificaci\u00f3n de los componentes cultivables del consorcio bacteriano\ndegradador de hidrocarburos M10. Actas del VI\u00ba Simposio Argentino sobre Investigaciones Ant\u00e1rticas Disponible en:www.dna.gov.ar/CIENCIA/SANTAR07/CD/PDF/CVRE407.PDF C\u00f3d. CVRE407 2007; p. 5.\n2. Ruberto LAM, V\u00e1zquez SC, Curtosi A, Mestre MC, Pelletier E, Mac Cormack WP. Phenanthrene bioremediation in soils using\nan Antarctic bacterial consortium. Bioremediation J 2006; 10: 191-201.\n\u00cdndice General del Volumen 263Volumen 41 - A\u00f1o 2009\n\u00cdNDICE GENERAL DEL VOLUMEN 41\n1\n4\n11\n 20\n27\n28\n29\n34\n39\n45N\u00famero 1\nEDITORIAL\nC\u00edrculo vicioso vs. c\u00edrculo virtuoso: como mantener a la RAM en el SCIE\nH.R. Morbidoni\nMICROBIOLOG\u00cdA B\u00c1SICA\nCaracterizaci\u00f3n del gen de la citotoxina vacuolizante de Helicobacter pylori  a partir de\nbiopsias g\u00e1stricas de pacientes residentes en Tolima, Colombia\nA.M. L\u00f3pez, M.P. Delgado, C. Jaramillo, A. Am\u00e9zquita, G. Parra, M.M. Echeverry\nCaracterizaci\u00f3n de aislamientos de Vibrio cholerae  no-01, no-0139 asociados a diarrea\nS. Gonz\u00e1lez Fraga, A. Villagra de Trejo, M. Pichel, S. Figueroa, G. Merletti, M.I. Caffer, M. Ce-cilia de Castillo, N. Binsztein\nMICROBIOLOG\u00cdA CL\u00cdNICA Y ENFERMEDADES INFECCIOSAS\nDiagn\u00f3stico molecular de histoplasmosis humana en muestras de sangre entera\nA.I. Toranzo, I.N. Tiraboschi, N. Fern\u00e1ndez, B. Ibarra-Camou, M.C. Rivas, W. Lee, G. Davel,\nC.E. Canteros\nIM\u00c1GENES MICROBIOL\u00d3GICAS\nEsporotricosis en un gato dom\u00e9stico\nR. Iachini\nToxocara canis  bajo la lupa\nM.V. Bojanich\nAGENTES ANTIMICROBIANOS\n*Prevalencia de los genes mef y ermB en aislamientos invasores de Streptococcus pneumoniae\nresistentes a la eritromicina recuperados de pacientes pedi\u00e1tricos en Argentina\nA. Corso, D. Faccone, C. Gali\u00e1, P. Gagetti, M. Rodr\u00edguez, J. Pace, M. Regueira, Grupo de Tra-\nbajo Argentino SIREVA\nUso de linezolid para el tratamiento de reci\u00e9n nacidos con infecciones por Enterococcus\nfaecium resistentes a la vancomicina.\nG. Berberian, G. Castro, S. Fistolera, M. Travaglianti, H. Lopardo, A. Mastroianni, M.T. Rosanova\n*Alteraciones de crecimiento y ramificaci\u00f3n en Neurospora crassa provocadas por con-\ncentraciones sub-inhibitorias de agentes antimic\u00f3ticosR.C. Pereira, S. Said\nART\u00cdCULOS ESPECIALES\n*Micobacteri\u00f3fagos como herramientas vers\u00e1tiles para la manipulaci\u00f3n gen\u00e9tica y el de-\nsarrollo de m\u00e9todos simples para el diagn\u00f3stico de enfermedades micobacterianas\nE.J. Stella, A.I. de la Iglesia, H.R. MorbidoniRevista Argentina de Microbiolog\u00eda (2009) 41: 263-266 264\n63\n65\n73\n79\n86\n92\n97\n102\n105\n112\n117\n118\n119EDITORIAL\nM\u00e9todos r\u00e1pidos: una herramienta \u00fatil y pr\u00e1ctica para el an\u00e1lisis microbiol\u00f3gico de ali-\nmentos\nG.A. Leotta\nMICROBIOLOG\u00cdA B\u00c1SICA\nEfecto de la inoculaci\u00f3n de la cepa Sphingomonas paucimobilis  20006FA sobre la com-\nposici\u00f3n de un consorcio bacteriano degradador de fenantreno\nL. Madue\u00f1o, B.M. Coppotelli, I.S. Morelli\n*Perfil de sensores de qu\u00f3rum en cepas nosocomiales y ambientales de Acinetobacter\nR.H. Gonz\u00e1lez, L. Dijkshoorn, M. van den Barselaar, C. Nudel*Amplificaci\u00f3n\n in vitro de cepas de campo de virus de la diarrea viral bovina (VDVB) ais-\nladas en Argentina: efecto de la l\u00ednea celular y las condiciones de cultivo\nA.C. Ode\u00f3n, M.R. Leunda, C. Faver\u00edn, N. Boynak, M.M. Vena, O. Zabal\n*Evaluaci\u00f3n de vacunas experimentales para la diarrea viral bovina en bovinos, ovinos y\ncobayos.\nF. Fern\u00e1ndez, V. Costantini, M. Barrandeguy, V. Parre\u00f1o, G. Schiappacassi, F. Maliandi, M.\nLeunda, A. Ode\u00f3n\nMICROBIOLOG\u00cdA CL\u00cdNICA Y ENFERMEDADES INFECCIOSAS\nEnterococos resistentes a vancomicina: prevalencia y factores asociados a la coloniza-\nci\u00f3n intestinal en pacientes oncol\u00f3gicos del Hospital de Ni\u00f1os de C\u00f3rdoba\nA.L. Reale, M.L. Depetri, C. Culasso, M. Paviolo, M.L. Cheguiri\u00e1n, M.C. Enrico, E.M. Ledesma,\nC. Vidal, E. Glastein, L. Bertoni\n*Estudio serol\u00f3gico y bacteriol\u00f3gico de brucelosis en perros de Lomas de Zamora, pro-\nvincia de Buenos Aires.\nG. L\u00f3pez, S.M. Ayala, A.M. Efron, C.F. G\u00f3mez, N.E. Lucero\n*Identificaci\u00f3n de la fuente de infecci\u00f3n de histoplasmosis de dos maras ( Dolichotis\npatagonum ) cautivas procedentes de la misma colonia, utilizando ensayos moleculares e\ninmunol\u00f3gicos.\nM.R. Reyes-Montes, G. Rodr\u00edguez-Arellanes, A. P\u00e9rez-Torres, A.G. Rosas-Rosas, A. Par\u00e1s-\nGarc\u00eda, C. Juan-Sall\u00e9s, M.L. Taylor\n*Hidatidosis pedi\u00e1trica en el sudeste de la provincia de Buenos Aires, Argentina\nM.C. Dopchiz, M.C. Elissondo, M.V. Andresiuk, E. Maiorini, A.M. Guti\u00e9rrez, P.M. Muzulin, M.C.\nRosenzvit, C.M. Lavall\u00e9n, G. Denegri\nMICROBIOLOG\u00cdA INDUSTRIAL Y AMBIENTAL\n*Actinomicetos termoalcal\u00f3filos del \u00e1rea subtropical de Jujuy, Argentina\nL. Carrillo,  M.R. Ben\u00edtez Ahrendts, M.J. Maldonado\nIM\u00c1GENES MICROBIOL\u00d3GICAS\nMicroorganismos que afectan diferentes soportes de informaci\u00f3n\nP.S. Guiamet, P. Lavin, P. Schilardi, S.G. G\u00f3mez de Saravia\nInfestaci\u00f3n por Demodex  spp.: un caso cl\u00ednico\nC.L. Gatta, E. Comunale, C.I. Menghi\nFe de erratasN\u00famero 2\u00cdndice General del Volumen 265\nN\u00famero 3\nEDITORIAL\nAnte la predictibilidad de la pandemia, lo impredecible: el virus pand\u00e9mico\nV. Savy\nMICROBIOLOG\u00cdA B\u00c1SICA\nIdentificaci\u00f3n de ant\u00edgenos inmunorreactivos (dobler) de Leptospira interrogans\nA. Carrizo, B. Brihuega, I. Etchechoury, A. Arese, S. Romero, A. Gioffre, M.I. Romano, K. Caimi\nEl virus de la Lengua azul: mecanismos de apoptosis en su infecci\u00f3n\nE. Mortola, A. Larsen\nMICROBIOLOG\u00cdA CL\u00cdNICA Y ENFERMEDADES INFECCIOSAS\n*Caracterizaci\u00f3n fenot\u00edpica de cepas de Clostridium botulinum  aislados de casos de bo-\ntulismo del lactante en Argentina\nM.D. Sagua, C. Luquez, C.P. Barzola, M.I. Bianco, R. A. Fern\u00e1ndez\nTungiosis adquirida en la provincia del Chaco, Argentina\nC.I. Menghi, E. Comunale, C.L. Gatta\nAGENTES ANTIMICROBIANOS\nEvaluaci\u00f3n microbiol\u00f3gica y epidemiol\u00f3gica de los clones de Acinetobacter baumannii  re-\nsistentes a los carbapenemes aislados en la unidad de cuidados intensivos de un Hospi-\ntal Universitario de la ciudad de Buenos Aires\nC.H. Rodr\u00edguez, K. Bombicino, G. Granados, C. Vay, A. Famiglietti\nSerovariedades de Salmonella enterica  subespecie enterica en porcinos de faena y su\nresistencia a los antimicrobianos\nM.P. Ibar, G. Vigo, P. Pi\u00f1eyro, M.I. Caffer, P. Quiroga, C. Perfumo, D. Centr\u00f3n, G. Giacoboni\nMICROBIOLOG\u00cdA DE ALIMENTOS\nMieles del sistema serrano de Ventania: evaluaci\u00f3n de la calidad microbiol\u00f3gica en el cir-\ncuito de la planta de extracci\u00f3n\nL.M. Gallez, L.A. Fern\u00e1ndez\nH\u00e1bitos de consumo de hamburguesas y riesgo de exposici\u00f3n a Escherichia coli  VTEC:\nmodelo de simulaci\u00f3n\nM.L. Signorini, V. Marin, C. Quinteros, H. Tarabla\n*Levaduras contaminantes en vinos patag\u00f3nicos: caracter\u00edsticas moleculares y fisiol\u00f3gi-\ncas de los aislamientos ind\u00edgenas de Pichia guilliermondii\nC.A. Lopes, V. Jofr\u00e9, M.P. Sangorrin\nART\u00cdCULO ESPECIAL\nCriptosporidiosis: una zoonosis emergente\nV.F. Del Coco, M.A. C\u00f3rdoba, J.A. Basualdo\nIM\u00c1GENES MICROBIOL\u00d3GICAS\nThelebolus microsporus\nG.A. Leotta, E.H. Reinoso\nPsorospermium haeckellii: pseudopar\u00e1sito hallado en un vector\nC.L. Gatta, E. Comunale, C.I. Menghi127\n129\n134\n141\n148\n151\n156\n163\n168\n177\n185\n197\n198Revista Argentina de Microbiolog\u00eda (2009) 41: 263-266 266\n*En Ingl\u00e9sN\u00famero 4\nEDITORIAL\nTransferencia e intercambio de conocimiento a trav\u00e9s de reuniones cient\u00edficas. Cerca del\ncoraz\u00f3n de los amigos, lejos de las arcas del Estado\nH.R. Morbidoni\nMICROBIOLOG\u00cdA B\u00c1SICA\n*Amplificaci\u00f3n del genoma completo del subtipo 2 del virus de la influenza equina\nG.H. Sguazza, N.A. Fuentealba, M.A. Tizzano, C.M. Galosi, M.R. Pecoraro\nMICROBIOLOG\u00cdA CL\u00cdNICA Y ENFERMEDADES INFECCIOSAS\nBrote de micoplasmosis cl\u00ednica por Mycoplasma ovis en ovinos de Salta, Argentina. Diag-\nn\u00f3stico cl\u00ednico, microbiol\u00f3gico y molecular\nD.H. Aguirre, C. Thompson, R.D. Neumann, A.O. Salatin,  A.B. Gaido, S. Torioni de Echaide\n*Mycobacterium bovis  en Argentina: aislamientos de gatos tipificados por spoligotyping\nM.J. Zum\u00e1rraga, M. Mart\u00ednez Vivot, D. Marticorena, A. Bernardelli, R. Fas\u00e1n, R. Iachini, A.A. Cataldi\n*Echinococcus granulosus : comparaci\u00f3n biol\u00f3gica de aislados de bovinos de regiones\nend\u00e9micas de Argentina y Espa\u00f1aM.V. Andresiuk, F. Ponce Gordo, C. Cuesta Bandera, M.C. Elissondo, M. Dopchiz, G. Denegri\nAGENTES ANTIMICROBIANOS\n*Actividad antibacteriana y antioxidante del aceite esencial extra\u00eddo de \nArtemisia\nechegarayi  Hieron (Asteraceae).\nA. Laciar, M.L. Vaca Ruiz, R. Carrizo Flores, J.R. Saad\nMICROBIOLOG\u00cdA DE ALIMENTOS\n*El t\u00e9 de tilo como veh\u00edculo potencial de esporas de Clostridium botulinum en la transmi-\nsi\u00f3n del botulismo infantilM.I. Bianco, C. L\u00faquez, L.I.T. de Jong, R.A. Fern\u00e1ndez\nModelo de contaminaci\u00f3n cruzada por \nEscherichia coli  verocitotoxig\u00e9nica durante la ela-\nboraci\u00f3n de hamburguesas caseras y evaluaci\u00f3n cuantitativa de riesgosM.L. Signorini, L.S. Frizzo\nMICROBIOLOG\u00cdA INDUSTRIAL Y AMBIENTAL\n*Evoluci\u00f3n del contenido de ocratoxina A en vinos tintos argentinos durante el proceso\nde vinificaci\u00f3n a escala pilotoM.L. Ponsone, M.L. Chiotta, M. Combina, A.M. Dalcero, S.N. Chulze\nART\u00cdCULO ESPECIAL\nToxinas de \nClostridium perfringens\nW.E. Morris, M.E. Fern\u00e1ndez-Miyakawa\nIM\u00c1GENES MICROBIOL\u00d3GICAS\n*Efecto citop\u00e1tico en c\u00e9lulas BHK 21 (C13) inoculadas con Leptospira  interrogans  serovar\nPomona aislada de un aborto porcinoB. Brihuega, A. Venzano,O. Zabal, D. Funes, C. Auteri, G. Romero, L. Samartino\n*Consorcio bacteriano degradador de hidrocarburos aislado de suelos de Ant\u00e1rtida\nLAM Ruberto, SC V\u00e1zquez, WP Mac Cormack\n\u00cdndice general del volumen 41\n\u00cdndice de temas\u00cdndice de autores\nAgradecimiento a revisores\nFe de erratas\nInstrucciones para los autores\n*Instructions to authors203\n207\n212\n215\n218\n226232\n237\n245\n251\n261\n262\n263\n269\n271\n272272273275Indice de Temas 267\nVolumen 41 - A\u00f1o 2009\n\u00cdNDICE DE TEMAS\nAcinetobacter\nAcinetobacter baumannii 151\nacyl  homoserina lactona 73adherencia 151\ncepas\nambientales 73nosocomiales 73\nclones 151\nresistencia a carbapenemes 151sensores de qu\u00f3rum 73\nunidad de cuidados intensivos 151\nActinomicetos\nbagazo 112\nca\u00f1a de az\u00facar 112\nsuelos subtropicales 112\nAlimentos\nan\u00e1lisis microbiol\u00f3gicos 63\nm\u00e9todos r\u00e1pidos 63\nAntimicrobianos\nAcinetobacter 73,151\nClostridium botulinum 141\nEnterococos resistentes a la vancomicina 34, 92\nEscherichia coli 168\nSalmonella enterica 156\nStreptococcus pneumoniae 29\nArtemisia echegarayi\naceite esencial 226actividad\nantibacteriana 226\nantioxidante 226\nBrucella canis\nbrucelosis canina 97\nClostridium botulinum\n botulismo del  lactante 141, 232\ncaracterizaci\u00f3n fenot\u00edpica 141\nClostridium perfringens\nenterotoxemia 251toxinas 251\nConsorcio bacteriano 262\nCryptosporidium\nciclo evolutivo 185cl\u00ednica 185diagn\u00f3stico 185\nepidemiolog\u00eda 185\ntaxonom\u00eda 185\nDemodex  spp.\ncaso cl\u00ednico 118\nEchinococcus granulosus\nArgentina 105, 218epidemiolog\u00eda 105, 218\nEspa\u00f1a 218hidatidosis 105, 218\nhidatidosis pedi\u00e1trica 105\nmorfolog\u00eda 218genotipos 218\nzoonosis 105\nEnterococos resistentes a la vancomicina\ncolonizaci\u00f3n 92\npacientes oncol\u00f3gicos 92\nEscherichia coli\ncontaminaci\u00f3n cruzada 237evaluaci\u00f3n de riesgos 168, 237\nhamburguesas 168, 237s\u00edndrome ur\u00e9mico hemol\u00edtico 168, 237\nverocitotoxig\u00e9nica 237\nHelicobacter pylori\nColombia 4detecci\u00f3n 4\nTolima 4\nVacA 4\nHistoplasma capsulatum\nDOT-Elisa 102fuente de infecci\u00f3n 102\nhistoplasmosis 20, 102\nmaras 102PCR 20, 102\nRAPD-PCR 102\nsangre entera 20\nLeptospira  interrogans\nant\u00edgenos 129Efecto citop\u00e1tico 261MALDI-TOF 129\nLinezolid\nenterococos resistentes a la vancomicina 34, 92reci\u00e9n nacidos 34\nMicobacteri\u00f3fagos\ngen\u00e9tica de micobacterias 45herramientas diagn\u00f3sticas 45\ntuberculosis 45\nMiel\ncalidad microbiol\u00f3gica 163\nplanta de extracci\u00f3n 163\nSistema de Ventania 163\nMycobacterium bovis\ngatos 215\nspoligotyping 215\ntuberculosis 215\nMycoplasma ovis\nArgentina 105, 212brote 212\novinos 212\nNeurospora crassa\ncrecimiento apical 39drogas antimic\u00f3ticas 39\nOcratoxina  A\nuvas 245\nproceso de vinificaci\u00f3n 245\nvino 245Revista Argentina de Microbiolog\u00eda (2009) 41: 267-268 268\nPichia guilliermondii\nbiotipo killer 177\nfenoles vol\u00e1tiles 177\nlevaduras contaminantes 177\nRAPD 177\nPsorospermium haeckelii\npseudopar\u00e1sito 198\nRAM 1Reuniones cient\u00edficas\ntuberculosis 293\nSalmonella enterica\ncerdos 156integrones de clase 1 156\nmultirresistencia a los antimicrobianos 156salud p\u00fablica 156\nSCIE 1\nSoportes de informaci\u00f3n\nbiodeterioro 117\nSphingomonas  paucimobilis\nconsorcios bacterianos 65DGGE 65\nfenantreno 65\nSporothrix  sp.\nesporotricosis 27\ngato dom\u00e9stico 27\nStreptococcus pneumoniae\nArgentina 29genes  \nerm y mef B2 9\nmacr\u00f3lidos 29\nT\u00e9 de tilobotulismo  del  lactante 141, 232\nesporas botul\u00ednicas 232\nThelebolus  microsporus 197\nToxocara canis\nadultos 28\nTunga penetrans\nArgentina 148Chaco 148\nVibrio cholerae\nfactores de virulencia 11no-01 11no-0139 11\nPFGE 11\nVirus de la diarrea viral bovina (VDVB)\ncepas de campo argentinas 79, 86\ncultivos celulares 79\ninteracci\u00f3n virus-c\u00e9lula 79pestivirus 79\nvacunas inactivadas 86\nVirus de la influenza equina\ndiagn\u00f3stico 207\ngenoma 207\nRT-PCR 207\nVirus de la Lengua azul\napoptosis 134\nBax 134citocromo c 134\nSmac/DIABLO 134\nNF-\u03bab 134\nVirus pand\u00e9mico 127Subject index 269\nVolume 41 - 2009\nSUBJECT INDEX\nAcinetobacter\nAcinetobacter baumannii 151\nacyl  homoserine lactone 73\nadherence 151\ncarbapenem resistance 151clones 151\nenvironmental strains 73\nintensive care unit 151nosocomial strains 73\nquorum sensing 73\nActinomycetes 112\nbagasse 112\nsubtropical soils 112\nsugar cane 112\nAntimicrobial agents\nAcinetobacter 73, 151\nClostridium botulinum 141\nEscherichia coli 168\nSalmonella enterica 156\nStreptococcus pneumoniae 29\nVancomycin-resistant enterococci 34, 92\nArtemisia echegarayi\nantibacterial  activity 226antioxidant  activity 226\nessential oil 226\nBacterial consortium 262Bluetongue virus\napoptosis 134\nBax 134cytochrome c 134\nSmac/DIABLO 134\nNF-\u03bab 134\nBovine viral diarrhea virus (BVDV)\nArgentinean field strains 79, 86\ncell culture 79inactivated virus  vaccine 86\nkinetics of viral replication 79\npestivirus 79\nBrucella canis\ncanine brucellosis 97\nClostridium botulinum\ninfant botulism 141, 232\nphenotypic characterization 141\nClostridium perfringens\nenterotoxemia 251toxines 251\nCryptosporidium\ndiagnosis 185epidemiology 185\nlife cycle 185symptomatology 185\ntaxonomy 185\nDemodex  spp.\nclinical case 118Echinococcus granulosus\nArgentina 105, 218epidemiology 105, 218\ngenotype 218\nmorphology 218pediatric   hydatidosis 105, 218\nSpain 218\nzoonosis 105\nEquine influenza virus\ndiagnosis 207\ngenome 207RT-PCR 207\nEscherichia coli\ncross-contamination 237\nhamburguer 168, 237\nhemolytic uremic syndrome 168, 237\nquantitative risk assessment 168, 237verocitotoxigenic   \nE. coli 237\nSporothrix  sp.\nsporothricosis 27domestic  cat 27\nFood\nmicrobiological analysis 63rapid methods 63\nHelicobacter pylori\nColombia 4detection 4\nTolima 4\nVacA 4\nHistoplasma capsulatum\nDot-ELISA 102\nhistoplasmosis 20, 102infection source 102\nmaras 102\nmolecular diagnosis 20, 102PCR 20, 102\nRAPD-PCR 102\nwhole blood sample 20\nHoney\nhoneyhouse 163\nmicrobiological quality 163Ventania system 163\nLeptospira  interrogans\nantigens 129cytopathic effect 261\nMALDI-TOF 129\nLinden  flower  tea\nbotulinum spores 232\ninfant botulism 141, 232\nLinezolid\nnewborns 34\nvancomycin-resistant enterococci 34\nMedia of information\nbiodeterioration 117Revista Argentina de Microbiolog\u00eda (2008) 41: 269-270 270\nMycobacteriophages\ndiagnostic  tools 45mycobacterial  genetics 45\ntuberculosis 45\nMycobacterium bovis\ncats 215spoligotyping 215\ntuberculosis 215\nMycoplasma ovis\nArgentina 105, 212outbreak 212sheep 212\nNeurospora crassa\nantifungal drugs 39apical growth 39\nOchratoxin  A\ngrapes 245vinification process 245\nwine 245\nPandemic  virus 127\nPichia guilliermondii\nkiller biotype 177RAPD 177spoilage yeasts 177\nvolatile phenols 177\nPsorospermium haeckelii\npseudoparasite 198\nRAM 1\nSalmonella entericaantimicrobial multidrug resistance 156\nclass 1 integrons 156pigs 156\npublic health 156\nSCIE 1\nScientific meetings\ntuberculosis 293\nSphingomonas  paucimobilis\nbacterial  consortium 65\nDGGE 65\nphenanthrene 65\nStreptococcus pneumoniae\nArgentina 29e\nrm  gene 29\nmacrolide 29\nmefB gene 29\nThelebolus  microsporus 197\nToxocara canis\nadults 28\nTunga penetrans\nArgentina 148\nChaco 148\nVancomycin-resistant enterococci\ncolonization 92\noncology  patients 92\nVibrio cholerae\nno-01  isolate 11no-0139  isolate 11\nPFGE 11virulence  factors 11Indice de Autores 271\nVolumen 41 - A\u00f1o 2009\n\u00cdNDICE DE AUTORES\nAguirre DH 212\nAm\u00e9zquita A 4Andresiuk MV 105, 218Arese A 129Auteri C 261Ayala SM 97Barberian G 34Barrandeguy M 86Barzola CP 141Basualdo JA 185Ben\u00edtez Ahrendts MR 112Bernardelli A 215Bertoni L 92Bianco MI 141, 232Binsztein N 11Bojanich MV 28Bombicino K 151Boymak N 79Brihuega B 129, 261Caffer MI 11, 156Caimi K 129Canteros CE 20Carrillo L 112Carrizo A 129Carrizo Flores R 226Castillo MC 11Castro G 34Cataldi A 215Centr\u00f3n  D 156Combina M 245Comunale E 118, 148, 198Constantini V 86Coppotelli BM 65C\u00f3rdoba MA 185Corso A 29Cuesta Bandera C 218Culasso C 92Cheguiri\u00e1n ML 92Chiotta ML 245Chulze SN 245Dalcero AM 245Davel G 20de la Iglesia AI 45Del Coco VF 185Delgado MP 4Denegri G 105, 218Depetri ML 92Dijkshoorn L 73Dopchiz MC 105, 218Echeverry MM 4Efron AM 97Elissondo MC 105, 218Enrico MC 92Etchechoury I 129Faccone D 29Famiglietti A 151Fas\u00e1n R 215Faver\u00edn C 79Fern\u00e1ndez F 86Fern\u00e1ndez LA 163Fern\u00e1ndez-Miyakawa ME 251Fern\u00e1ndez N 20Fern\u00e1ndez RA 141, 232\nFigueroa S 11Fistolera S 34Frizzo LS 237Fuentealba NA 207Funes D 261Gagetti P 29Gaido AB 212Gali\u00e1 C 29Galosi CM 207Gallez LM 163Gatta CL 118, 148, 198Giacobone G 156Gioffre A 129Glastein E 92G\u00f3mez CF 97G\u00f3mez de Saravia SG 117Gonz\u00e1lez Fraga S 11Gonz\u00e1lez RH 73Granados G 151Grupo de Trabajo Argentino SIREVA 29Guiamet PS 117Guti\u00e9rrez AM 105Iachini R 27, 215Ibar MP 156Ibarra Camou B 20Jaramillo C 4Jofr\u00e9 V 177Jong LIT de 232Juan-Sall\u00e9s C 102Laciar A 226Larsen A 134Lavall\u00e9n CM 105Lavin P 117Ledesma EM 92Lee W 20Leotta GA 63, 197Leunda MR 79, 86Lopardo H 34Lopes CA 177L\u00f3pez AM 4L\u00f3pez G 97Lucero NE 97L\u00faquez C 141, 232Mac Cormack WP 262Madue\u00f1o L 65Maldonado MJ 112Maiorini E 105Maliandi F 86Mar\u00edn V 168Marticorena D 215Mart\u00ednez Vivot M 215Mastroianni A 34Menghi CI 118, 148, 198Merletti G 11Morbidoni HR 1, 45, 203Morelli IS 65Morris WE 251Mortola E 134Muzulin PM 105Neumann RD 212Nudel C 73Ode\u00f3n AC 79, 86\nPace J 29Par\u00e1s-Garc\u00eda A 102Parra G 4Parre\u00f1o V 86Paviolo M 92Pecoraro MR 207Pereira RC 39P\u00e9rez-Torres A 102Perfumo C 156Pichel M 11Pi\u00f1eyro P 156Ponce Gordo F 218Ponsone ML 245Quinteros C 168Quiroga P 156Reale AL 92Regueira M 29Reinoso EH 197Reyes-Montes MR 102Rivas ME 20Rodr\u00edguez-Arellanes G 102Rodr\u00edguez CA 151Rodr\u00edguez M 29Romano MI 129Romero G 261Romero S 129Rosanova MT 34Rosas-Rosas AG 102Rosenzvit MC 105Ruberto LAM 262Saad JR 226Said S 39Sagua MD 141Salatin AO 212Samartino L 261Sangorrin MP 177Savi V 127Schiappacassi G 86Schilardi P 117Sguazza GH 207Signorini ML 168, 237Stella EJ 45Tarabla H 168Taylor ML 102Thompson C 212Tiraboschi IN 20Tizzano MA 207Toranzo AI 20Torioni de Echaide S 212Travaglianti M 34Vaca Ruiz ML 226van den Barselaar M 73Vay C 151Vazquez SC 262Vena MM 79Venzano A 261Vidal C 92Vigo G 156Villagra de Trejo A 11Zabal O 79, 261Zum\u00e1rraga MJ 215Revista Argentina de Microbiolog\u00eda (2009) 41: 00 272\nVolumen 41 - A\u00f1o 2009\nAGRADECIMIENTO A REVISORES\nEl Comit\u00e9 Editor de la Revista Argentina de Microbiolog\u00eda agradece a los se\u00f1ores revisores el\ntiempo, esfuerzo y experiencia dedicados a mejorar la calidad de la revista.\nDiagn\u00f3stico molecular de histoplasmosis humana\nen muestras de sangre entera\nA. I. TORANZO1, I. N. TIRABOSCHI2, N. FERN\u00c1NDEZ2, B. IBARRA-CAMOU1,\nM. C. RIVAS1, W. LEE1, G. DAVEL1, C. E. CANTEROS1*\n1Departamento Micolog\u00eda, INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d.  Av. V\u00e9lez Sarsfield 563 (1281) Ciudad Aut\u00f3noma de\nBuenos Aires; 2Divisi\u00f3n Infectolog\u00eda, Hospital de Cl\u00ednicas \u201cJos\u00e9 de San Mart\u00edn\u201d, Universidad de Buenos Aires.\nAv. C\u00f3rdoba 2351 (1120) Ciudad Aut\u00f3noma de Buenos Aires. Argentina.\n*Correspondencia. E-mail: ccanteros@anlis.gov.ar\nVolumen 41, N\u00ba 1, p. 20-26.\nLos autores desean enmendar dos errores en la secuencia de los cebadores  deta-\nllados en la secci\u00f3n MATERIALES Y M\u00c9TODOS\nEn la p\u00e1gina 22. en el item PCR anidada\ndonde dice: Hcl: 5\u2019GCG TTC CGA GCC TTC CAC CTC ACC 3\u2019debe decir: HcI: 5\u2019 GCG TTC CGA GCC TTC CAC CTC AA C 3\u2019\ndonde dice: Hc III: 5\u2019GAC ATC TAG TCG CGG CCA GGT TCA 3\u2019\ndebe decir: Hc III: 5\u2019 GAG ATC TAG TCG CGG CCA GGT TCA 3\u2019Albanesi A\nAlche L\nAmbrosi A\nArabolaza AArakaki C\nBacci M\nBantar CBas\u00edlico JC\nBenintende G\nBianchi TBianchini H\nBinsztein N\nBonofiglio LBorda E\nBouzas MB\nBratanich ABravo A\nCadario E\nCampero CMCandurra N\nCarbone C\nCarrillo ECatalano M\nCataldi A\nCavalito SCavallaro L\nChulze S\nColombato CCombina MCopotelli B\nCorrea O\nCostamagna S\nCravero SCrossa J\nDe Paulis A\nde Villalobos Cde Waard J\ndel Panno MT\nDemo MDionisi H\nEchenique J\nEraso JErijman L\nEscand\u00f3n P\nFaccone DFamiglietti A\nFern\u00e1ndez Canigia L\nFern\u00e1ndez Pinto VForchiassin F\nFossati A\nFrade HGagetti P\nGentile A\nGiri AGodeas A\nGogorza L\nG\u00f3mez Carrillo MGonz\u00e1lez Ayala SGonz\u00e1lez Cappa S\nGuerrero R\nGuiamet P\nKantor I NKaufman S\nKorol S\nKozubsky LLarsen A\nLimansky A\nLi\u00f1ares JLitterio M\nLopardo H\nLujan HMari\u00f1elarena A\nMartino P\nMasana MMasih D\nMattioli G\nMattion NMersich S\nMorcillo N\nMujica MTNicola F\nNikel P\nOteiza JMPadola N\nPecoraro M\nPereda AP\u00e9rez S\nFe de ErratasPerfumo CPerticari A\nPetroni A\nPicconi APi\u00f1eyro P\nRamos L\nRaya RReynaldi F\nRivera M\nSadir ASamartino L\nSangorr\u00edn M\nSantoianni JSmayevsky J\nSosa Estani S\nStanchi NSutich E\nTaboga D\nTakiff HTanaro D\nTerzolo H\nTolmasky MTosello M\nTous M\nTurco MUrcelay C\nVaamonde G\nValverde CWanke MM\nZorreguieta A274 Revista Argentina de Microbiolog\u00eda (2006) 38: 49-52\n INSTRUCCIONES PARA LOS AUTORES\nLa Revista Argentina de Microbiolog\u00eda es una publicaci\u00f3n trimestral editada por la Asociaci\u00f3n Argentina de Microbiolog\u00eda y\ndestinada a la difusi\u00f3n de trabajos cient\u00edficos en las distintas \u00e1reas de la Microbiolog\u00eda. La Asociaci\u00f3n Argentina de Microbio log\u00eda\nse reserva los derechos de propiedad y reproducci\u00f3n del material aceptado y publicado.\nTipos de contribuci\u00f3n. La Revista Argentina de Microbiolog\u00eda acepta: art\u00edculos originales, informes breves, art\u00edculos especia-\nles, im\u00e1genes microbiol\u00f3gicas, editoriales y suplementos.\nLos art\u00edculos originales son trabajos de investigaci\u00f3n completos y deben presentarse respetando las siguientes divisiones:\nIntroducci\u00f3n, Materiales y M\u00e9todos, Resultados, Discusi\u00f3n, Agradecimientos y Bibliograf\u00eda. Se admite la presentaci\u00f3n de Resulta -\ndos y Discusi\u00f3n como una secci\u00f3n conjunta.\nLos informes breves  son trabajos de menor extensi\u00f3n, entre los que se incluyen casu\u00edsticas, casos cl\u00ednicos y descripciones de\nt\u00e9cnicas o dispositivos nuevos avalados por trabajos experimentales concluyentes. Se deber\u00e1 omitir la divisi\u00f3n del texto en sec ciones y\nel manuscrito no podr\u00e1 exceder las ocho p\u00e1ginas, con un m\u00e1ximo de quince citas bibliogr\u00e1ficas y tres tablas o figuras.\nLos art\u00edculos especiales  son actualizaciones o consensos de grupos de trabajo acerca de temas de gran inter\u00e9s en el \u00e1mbito regional\no internacional. Sus autores deben ser especialistas en la materia y el texto debe incluir una amplia y actualizada revisi\u00f3n bi bliogr\u00e1fica.\nRecientemente la Revista Argentina de Microbiolog\u00eda ha incorporado la secci\u00f3n, im\u00e1genes microbiol\u00f3gicas . Las contribuciones\nenviadas para esta secci\u00f3n pueden corresponder a fotos de bacterias, hongos, par\u00e1sitos o virus, tomadas de ex\u00e1menes en fresco o\ncon coloraciones, y observadas bajo microscop\u00eda \u00f3ptica, electr\u00f3nica o de fluorescencia. Tambi\u00e9n se admiten otras im\u00e1genes fotog r\u00e1-\nficas, por ejemplo, microorganismos en medios de cultivo, lesiones ilustrativas en pacientes o en animales de experimentaci\u00f3n;\nim\u00e1genes radiogr\u00e1ficas y ecogr\u00e1ficas, de tomograf\u00edas computadas, de resonancias magn\u00e9ticas nucleares, etc. Estas im\u00e1genes de\ngran valor did\u00e1ctico y no necesariamente excepcionales, deben estar acompa\u00f1adas de un texto explicativo y de flechas indicadora s,\ncuando corresponda. El conjunto no debe exceder una p\u00e1gina impresa.\nEn todos los casos se exigir\u00e1 excelente calidad fotogr\u00e1fica, de modo que sea posible la fiel reproducci\u00f3n de la imagen enviada.  La\nversi\u00f3n electr\u00f3nica (que siempre se deber\u00e1 suministrar, adem\u00e1s de la impresa) se realizar\u00e1 en el formato JPEG, con alta resoluc i\u00f3n.\nLos editoriales  abordan t\u00f3picos de gran actualidad y particular relevancia para la comunidad cient\u00edfica especializada en la\nMicrobiolog\u00eda. La oportunidad y autor\u00eda de los editoriales, as\u00ed como sus lineamientos generales, quedan exclusivamente a criter io\ndel Comit\u00e9 Editor.\nLos suplementos  corresponden a extensas revisiones de un tema espec\u00edfico realizadas por una o varias sociedades cient\u00edficas\no universidades, o a los res\u00famenes de las contribuciones efectuadas en el marco de eventos cient\u00edficos organizados por la Asoci a-\nci\u00f3n Argentina de Microbiolog\u00eda, o alguna de sus Divisiones o Filiales (comunicaciones orales, posters, conferencias, mesas redon-\ndas, etc.), a cargo de editores invitados.\nLas propuestas tem\u00e1ticas de los suplementos y sus lineamientos generales deber\u00e1n ser aceptados por el Comit\u00e9 Editor.\nLa revisi\u00f3n de los manuscritos correspondientes a suplementos estar\u00e1 a cargo de revisores elegidos por el Comit\u00e9 Editor (extens as\nrevisiones) y de los editores invitados (res\u00famenes de eventos). El suplemento deber\u00e1 ser financiado en su totalidad por la enti dad que ha\norganizado la reuni\u00f3n cient\u00edfica, la que tendr\u00e1 en cuenta que el suplemento se deber\u00e1 distribuir entre todos los socios de la A sociaci\u00f3n\nArgentina de Microbiolog\u00eda y todos los participantes del evento. Con respecto a la edici\u00f3n, el suplemento deber\u00e1 respetar exact amente el\nformato y el estilo de la Revista Argentina de Microbiolog\u00eda en todos sus aspectos (tapa, tipo de papel, impresi\u00f3n, tablas, fig uras, fotos,\netc.), tal como se describe en las Instrucciones para los autores. Los suplementos correspondientes a los res\u00famenes de los even tos\ndeben incluir en este orden: n\u00f3mina de los miembros del Comit\u00e9 Editor de la Revista Argentina de Microbiolog\u00eda, datos de presen taci\u00f3n\ndel evento (t\u00edtulo completo, lugar y fecha ), \u00edndice (en espa\u00f1ol y en ingl\u00e9s), agradecimientos, n\u00f3mina de las autoridades del e vento y\nmensaje/s del/los presidente/s. A continuaci\u00f3n se presentar\u00e1n los res\u00famenes numerados desde el uno con n\u00fameros ar\u00e1bigos. Al fin al del\nsuplemento debe incluirse el \u00cdndice alfab\u00e9tico de autores y las Instrucciones para los autores de la Revista Argentina de Micro biolog\u00eda, en\nespa\u00f1ol y en ingl\u00e9s. El programa esquem\u00e1tico del evento s\u00f3lo se podr\u00e1 incluir en forma de tr\u00edptico, suelto en el interior del s uplemento.\nLa Revista Argentina de Microbiolog\u00eda apoya las pol\u00edticas para registro de ensayos cl\u00ednicos de la Organizaci\u00f3n Mundial de la\nSalud (OMS) y del International Committee of Medical Journal Editors (ICMJE), reconociendo la importancia de esas iniciativaspara el registro y divulgaci\u00f3n internacional de informaci\u00f3n sobre estudios cl\u00ednicos, en acceso abierto. En consecuencia, solame nte\nse aceptar\u00e1n para publicaci\u00f3n, a partir de 2007, los art\u00edculos de investigaciones cl\u00ednicas que hayan recibido un n\u00famero de iden tifi-\ncaci\u00f3n en uno de los Registros de Ensayos Cl\u00ednicos validados por los criterios establecidos por OMS e ICMJE, cuyas direccionesest\u00e1n disponibles en el sitio del ICMJE. El n\u00famero de identificaci\u00f3n se deber\u00e1 registrar al final del resumen.\nPresentaci\u00f3n de los originales.  Los manuscritos deber\u00e1n ser enviados al Comit\u00e9 Editor de la Revista Argentina de Microbio-\nlog\u00eda, De\u00e1n Funes 472, (C1214AAD) Ciudad Aut\u00f3noma de Buenos Aires, Argentina.\nEl material ser\u00e1 analizado por el Comit\u00e9 Editor y sometido a la consideraci\u00f3n de dos \u00e1rbitros cient\u00edficos designados para cada caso.\nEl Comit\u00e9 Editor se reserva el derecho de rechazar aquellos manuscritos cuyos contenidos se superponen total o parcialmente con\ntrabajos ya publicados, o aquellos cuya tem\u00e1tica no se corresponde con la de la Revista Argentina de Microbiolog\u00eda. Asimismo, s e reserva\nel derecho de efectuar las modificaciones gramaticales o literarias que considere necesarias.\nLos manuscritos podr\u00e1n ser redactados indistintamente en espa\u00f1ol o en ingl\u00e9s, aunque el Comit\u00e9 Editor estimula a los autores a escribir\nlos trabajos en ingl\u00e9s para favorecer su difusi\u00f3n y lectura a nivel internacional. Los autores cuya primera lengua no sea el es pa\u00f1ol deber\u00e1n\nremitir los manuscritos en ingl\u00e9s. Los art\u00edculos originales, informes breves y art\u00edculos especiales incluir\u00e1n dos res\u00famenes de hasta 200\npalabras. El primero de ellos estar\u00e1 redactado en el idioma empleado en el trabajo, y el segundo, en el otro idioma, estar\u00e1 enc abezado por\nel t\u00edtulo completo del trabajo. Evitar en los res\u00famenes las abreviaturas y las citas bibliogr\u00e1ficas.\nLos manuscritos se presentar\u00e1n impresos por triplicado y en disquete o CD-ROM. Las hojas deber\u00e1n estar numeradas correla-\ntivamente, y el texto se escribir\u00e1 dejando m\u00e1rgenes amplios, a doble espacio, sobre una sola cara del papel, con un tama\u00f1o m\u00edni mo\nde letra de 12 puntos. Las letras en negrita o \nit\u00e1lica se usar\u00e1n s\u00f3lo cuando corresponda.275\nEn la primera p\u00e1gina se indicar\u00e1:  t\u00edtulo del trabajo (s\u00f3lo la primera letra en may\u00fascula, el resto en min\u00fascula),  iniciales de los nombres y\napellidos completos de todos los autores; lugar de trabajo (nombre de la instituci\u00f3n y direcci\u00f3n postal), de haber autores con distintos lugares\nde trabajo, se colocar\u00e1n super\u00edndices num\u00e9ricos (no encerrados entre par\u00e9ntesis) junto a los nombres, de manera de identificar a cada autor\ncon su respectivo lugar de trabajo; fax y/o correo electr\u00f3nico del autor responsable de la correspondencia (que se indicar\u00e1 con  un asterisco\nen posici\u00f3n de super\u00edndice ubicado junto al nombre) y t\u00edtulo abreviado del trabajo,  de hasta 50 letras, para cabeza de p\u00e1gina.\nEn la segunda p\u00e1gina se incluir\u00e1n los dos res\u00famenes , seguido cada uno de ellos de una lista de tres a seis palabras clave, en\nel idioma correspondiente.\nIntroducci\u00f3n.  Incluir\u00e1 antecedentes actualizados acerca del tema en cuesti\u00f3n y los objetivos del trabajo definidos con claridad. Las\ncitas bibliogr\u00e1ficas deber\u00e1n ser elegidas muy cuidadosamente y no se deber\u00e1 realizar una exhaustiva revisi\u00f3n del tema.\nMateriales y M\u00e9todos.  Contendr\u00e1 la descripci\u00f3n de los m\u00e9todos, aparatos, reactivos y procedimientos utilizados, con el detalle\nsuficiente para permitir la reproducci\u00f3n de los experimentos.\nResultados.  Se presentar\u00e1n a trav\u00e9s de una de las siguientes formas: en el texto, o mediante tabla/s y/o figura/s. Se evitar\u00e1n\nrepeticiones y se destacar\u00e1n s\u00f3lo los datos importantes. Se dejar\u00e1 para la secci\u00f3n Discusi\u00f3n la interpretaci\u00f3n m\u00e1s extensa.\nLas tablas se presentar\u00e1n en hoja aparte, numeradas consecutivamente con n\u00fameros ar\u00e1bigos, encabezadas con un t\u00edtulo explica-\ntivo, con las leyendas y/o aclaraciones que correspondan al pie. Las llamadas para las aclaraciones al pie se har\u00e1n empleando n \u00fameros\nar\u00e1bigos entre par\u00e9ntesis y super\u00edndice. S\u00f3lo los bordes externos de la primera y la \u00faltima fila y la separaci\u00f3n entre los t\u00edtu los de las\ncolumnas y los datos se marcar\u00e1n con l\u00ednea continua. No se marcar\u00e1n los bordes de las columnas.\nLas figuras se presentar\u00e1n en hoja aparte, numeradas consecutivamente con n\u00fameros ar\u00e1bigos. Los dibujos deber\u00e1n estar en condicio-\nnes que aseguren una adecuada reproducci\u00f3n. Los gr\u00e1ficos de barras, tortas o estad\u00edsticas deber\u00e1n tener el formato GIF. Los n\u00fam eros,\nletras y signos tendr\u00e1n dimensiones adecuadas para ser legibles cuando se hagan las reducciones necesarias. Las referencias de los\ns\u00edmbolos utilizados en las figuras deber\u00e1n ser incluidas dentro de la misma figura y no en el texto de la leyenda.\nLas fotograf\u00edas  deber\u00e1n ser realizadas en color o en blanco y negro, con buen contraste, en papel brillante y con una calidad\nsuficiente para asegurar una buena reproducci\u00f3n. Los dibujos originales o las fotograf\u00edas tendr\u00e1n al dorso los nombres de los a utores\ny el n\u00famero de orden escritos con l\u00e1piz. Las leyendas de las figuras se presentar\u00e1n reunidas en una hoja aparte, ordenadas num\u00e9 ri-\ncamente. La versi\u00f3n electr\u00f3nica deber\u00e1 ser realizada en el formato JPEG, con alta resoluci\u00f3n.\nTanto las figuras como las fotograf\u00edas deber\u00e1n ser legibles y no deber\u00e1n superar los 580 p\u00edxeles de ancho. Las abreviaturas\ndeber\u00e1n ser explicitadas despu\u00e9s de su primera menci\u00f3n en el texto. Las unidades de medida se expresar\u00e1n siguiendo las normas\ndel Syst\u00e9me International d\u00b4Unit\u00e9s .\nDiscusi\u00f3n.  Se har\u00e1 \u00e9nfasis sobre los aspectos del estudio m\u00e1s importantes y novedosos, y se interpretar\u00e1n los datos experi-\nmentales en relaci\u00f3n con lo ya publicado. Se indicar\u00e1n las conclusiones a las que se arrib\u00f3, evitando la reiteraci\u00f3n de datos y\nconceptos ya vertidos en secciones anteriores.\nAgradecimientos.  Deben presentarse en un tama\u00f1o de letra menor y en un solo p\u00e1rrafo\nBibliograf\u00eda.  Las citas bibliogr\u00e1ficas se escribir\u00e1n en hoja aparte y se presentar\u00e1n en orden alfab\u00e9tico de autores, numeradas\ncorrelativamente empleando n\u00fameros ar\u00e1bigos (no usar el formato lista, opci\u00f3n de Word). En el texto, las citas aparecer\u00e1n con n \u00fameros\nentre par\u00e9ntesis, en correspondencia con el n\u00famero con que aparecen en la bibliograf\u00eda. Las referencias a comentarios personale s y a\ntrabajos in\u00e9ditos deber\u00e1n mencionarse como comunicaci\u00f3n personal , escrito entre par\u00e9ntesis. Cuando el n\u00famero de autores de una\ncita sea superior a seis, se deber\u00e1 indicar los nombres de los seis primeros seguidos por el marcador et al.\nPara las referencias se seguir\u00e1n los siguientes modelos:\na. Publicaciones peri\u00f3dicas\nH\u00e9ritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem\nresistance in Acinetobacter baumannii . Antimicrob Agents Chemother 2005; 49: 3198-202.\nLos t\u00edtulos de las revistas ser\u00e1n abreviados seg\u00fan el Index Medicus (el listado puede obtenerse en http://www.nlm.nih.gov).\nb. Cap\u00edtulos de libros/m\u00f3dulos\nRuoff KL, Whiley RA, Beighton D. Streptococcus . En: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors.\nManual of Clinical Microbiology. Washington D.C., ASM Press, 2003, p. 405-21.\nc. Presentaciones en congresos u otros eventos cient\u00edficos\nAguilar M, Punschke K, Touati D, Pianzzola MJ. Estudios fisiol\u00f3gicos y gen\u00e9ticos en la bacteria sulfato reductora Desulfoarculus\nbaarsii. Terceras Jornadas Rioplatenses de Microbiolog\u00eda, 1997, Resumen J2, p. 102, Ciudad Aut\u00f3noma de Buenos Aires, Argentina.\nd. Presentaciones en congresos u otros eventos cient\u00edficos reproducidas dentro de un suplemento publicado por la\nRevista Argentina de Microbiolog\u00eda\nFellner MD, Correa RM, Durand K, Teyssi\u00e9 AR, Picconi MA. An\u00e1lisis del ADN circulante de virus Epstein-Barr (EBV) en pacien-\ntes inmunosuprimidos con y sin linfomas asociados. VIII Congreso Argentino de Virolog\u00eda, Resumen 10416. Rev Argent Microbiol\n2005; 37 Supl 1: 95.\ne. Institucionales\nClinical and Laboratory Standards Institute. Disk diffusion. Performance standards for antimicrobial susceptibility testing; 15 th\ninformational supplement, 2005; M100-S15. Wayne, Pa, USA.\nPresentaci\u00f3n del disquete / CD-ROM.  El disquete o CD-ROM con la versi\u00f3n electr\u00f3nica de la contribuci\u00f3n enviada deber\u00e1\ntener una etiqueta o r\u00f3tulo que indique: el nombre del trabajo, el programa y la versi\u00f3n usados para confeccionar el texto, las  figuras\ny las fotograf\u00edas; y el nombre de los archivos que contiene.\nRecomendaciones.  Incluir todo el texto del art\u00edculo en un s\u00f3lo archivo; en caso de haber im\u00e1genes, \u00e9stas deben enviarse en\narchivos separados; tipear las may\u00fasculas, los espacios entre palabras, las it\u00e1licas y las negritas tal como se desea que salgan\nluego en el impreso; no dar espacios antes y despu\u00e9s de los subt\u00edtulos; justificar el texto; para encolumnar las tablas, usar l a tecla\nde tabulaci\u00f3n y no la barra espaciadora. Antes de enviar un manuscrito, es recomendable consultar alg\u00fan ejemplar reciente de la\nRAM; de este modo se podr\u00e1 verificar si se han seguido las pautas de formato y estilo requeridas y, eventualmente, efectuar las\nmodificaciones necesarias.\nCosto de la p\u00e1gina. Por cada p\u00e1gina publicada se cobrar\u00e1n $ 50, o $ 150 si \u00e9sta incluye fotos en color (Argentina, socios de la\nAAM), $ 100 o $ 300 (Argentina, no socios de la AAM) y U$S 40 o U$S 120 (otros pa\u00edses).\nSeparatas. Se suministrar\u00e1n 25 separatas sin cargo.276 Revista Argentina de Microbiolog\u00eda (2006) 38: 49-52\nINSTRUCTIONS TO AUTHORS\nThe Revista Argentina de Microbiolog\u00eda  is published by the Asociaci\u00f3n Argentina de Microbiolog\u00eda (AAM) on a quarterly basis.\nIt encourages scientific papers in the field of Microbiology. The Asociaci\u00f3n Argentina de Microbiolog\u00eda reserves the  right to use,\nreproduce and publish the accepted contributions.\nTypes of Publications.  The Revista Argentina de Microbiolog\u00eda will publish: original articles, brief reports, special articles,\nimages in microbiology, editorials and supplements.\nOriginal Articles: they are full research papers having the following sections: Introduction, Materials and Methods, Results,\nDiscussion, Acknowledgements and References. Results and Discussions may be subsumed into one section.\nBrief Reports: they are less extensive than Original Articles. They include case reports and descriptions of new techniques and\nprocedures based on experimental work. Division into sections is omitted; manuscripts must not exceed 8 pages, references will be\nlimited to a maximum of 15, tables and figures to a maximum of 3.\nSpecial Articles: they are updates or workshop results which should be based on subject matter of local and international weight\nand include a new and comprehensive bibliography. Their authors must be specialists in their fields.\nImages in Microbiology:  the Revista Argentina de Microbiolog\u00eda   has just incorporated this new section. Images may include: high\nquality pictures of bacteria, fungi, parasites and viruses using staining or direct observation through optical, electron or fl uorescent microscopy;\nthey may also include photographic images of microorganisms in culture media, lesions in humans and laboratory animals, x-rays and\nultrasound images, tomographies, magnetic resonance, etc. Images having instructional worth, though not necessarily breaking ne w\nground,  should be accompanied by explanatory texts and diagrams if required. The set of images should fit one printed page at most.\nImages should use photographic material of the highest possible quality to ensure very good reproduction. Electronic versions,\nwhich should always accompany the printed version, must use JPEG in a high resolution format.\nEditorials: this section is the sole domain of  the Editing Committee, who will determine editorial policy and authorship. Editorials\nfocus upon the main topics under current discussion in the field of  Microbiology.\nSupplements: they will mainly consist of the reviewing in detail of both specific subjects considered  by scientific organizations\nand universities and abstracts of lectures, round tables and oral and visual communications from scientific meetings sponsored by\nthe Asociaci\u00f3n Argentina de Microbiolog\u00eda, its divisions or branches and presided by invited editors. Subjects and overall outl ines\nshould  be approved by the Editing Committee.\nThe articles under Supplements will be examined by reviewers selected by the Editing Committee in the case of extensive reviewing,\nand by invited editors in the case of abstracts of meetings. Supplements will be wholly financed by the body organizing the meeting,\ntaking into account that copies have to be distributed to all the members of the Asociaci\u00f3n Argentina de Microbiolog\u00eda and all the\npersons taking part.The style and format must conform to the standards of the Revista Argentina de Microbiolog\u00eda set out in the\nInstructions to Authors in all respects: cover design, paper quality, preparation of tables and illustrations and printing, for  example.\nSupplements  of the meetings should  list: the names of the members of  the Editing Committee of the Revista Argentina de Microbio-\nlog\u00eda; title, date and venue of the meeting; contents of the  meeting in Spanish and English; acknowledgements; organizing officers an d\npresidential message; the abstracts, numbered consecutively with Arabic numerals starting from 1, should follow. An alphabetica l\nindex of authors and the Spanish and English versions of  the Instructions to Authors of the  Revista Argentina de Microbiolog\u00eda  must\nbe printed at the end of the Supplement . The meeting schedule will accompany the Supplement  as a separate leaflet.\nThe Revista Argentina de Microbiolog\u00eda follows the policies of the World Health Organization (WHO) and of the International\nCommittee of Medical Journal Editors (ICMJE) for clinical trial registration, recognizing the importance of those initiatives f or international\ndissemination of information on clinical research, in open access. Accordingly, only articles of trials previously registered i n one of the\nClinical Trial Registries that meet WHO and ICMJE requirements will be accepted for publication, starting in 2007. The list of registries\naccepted by WHO and ICMJE is available in ICMJE site. The trial registration number should be published at the end of the abstr act.\nPreparation of Manuscripts. Manuscripts must be addressed  to the Editing Committee of the Revista Argentina de Microbio-\nlog\u00eda, De\u00e1n Funes 472 (C1214AAD) Ciudad Aut\u00f3noma de Buenos Aires, Argentina.\nAll material will be examined by the Editing Committee first and then by two scientific reviewers selected for each work. The\nEditing Committee will exercise the right to refuse manuscripts the subject matter of which falls outside the field covered by the\nRevista Argentina de Microbiolog\u00eda,  or deals partially or fully with topics already discussed in published papers. The  Editing\nCommittee will also correct grammar and style where necessary.\nManuscripts may be written in Spanish or English; nevertheless, the Editing Committee encourages authors to use English so\nthat their work reaches wider international diffusion. Authors whose first language is not Spanish must submit their papers inEnglish. \nOriginal Articles, Brief Reports  and Special Articles must be accompanied by two copies of an abstract not exceeding 200\nwords: one of the copies should be written in the same language  as the paper, the other, in the other language: the full title of the\nmanuscript should be typed in this copy.  Abbreviations and references are discouraged in abstracts.\nThe original manuscript must be  sent in triplicate and on  a diskette/CD-ROM; pages must be numbered, typewritten on one side\nonly using as a minimum size 12 characters, double-spaced and with wide margins. Bold and italics printing types may be used\nwhen necessary.\nTitle page: it should include the title (using capitals only for first letters); authors\u2019 names (initials of first name, full f amily name);\nplace of work: institution  and mailing address. If the place of work is different the institutional affiliation of each author  should be\ngiven  with superscriptions added to their  names to identify each author with his/her affiliation. Fax number  and e-mail addr ess of\nthe corresponding author, whose name should be asterisked, must be given. A short title with up to 50 characters should also be\ngiven for use as a running head.\nSecond page: the Spanish and English versions of the abstract will be printed on the second page, each version listing from 3 t o\n6 keywords.277\nThe Secretary: De\u00e1n Funes 472, (C1214AAD) Ciudad Aut\u00f3noma de Buenos Aires - Argentina; Tel.: (54-11) 4932-8858 and\n(54-11) 4932-8948; mail: info@aam.org.ar; http://www.aam.org.ar\nANNUAL SUBSCRIPTION  (4 issues)\nArgentina $ 150\nLatin America U$S 80\nOther countries U$S 100\nPayment: By check or money order, to the order of Asociaci\u00f3n Argentina de Microbiolog\u00eda. Price includes mail postage. AAM members\nreceive the Revista Argentina de Microbiolog\u00eda free of charge.Introduction.  It should clearly state the antecedents of the study and the purpose in undertaking it. References should be\ncarefully chosen and the problem addressed should not be reviewed in detail.\nMaterials and Methods. Methods, procedures, reagents, and equipment used must be accurately described so that experiments\ncan be replicated.\nResults. Results will be shown in  one of these ways: in the text or in tables and illustrations. Repetition should be avoided by\npresenting only the most important data. In-depth interpretation will be under Discussion.\nTables should be typed on separate pages and numbered consecutively with Arabic numerals; they should have a title above\nand a legend and/or explanation below. Reference marks for explanations should use superscripted Arabic numerals in parentheses .\nLines will only be used for the first and the last row and to separate the headings of the columns from the data; vertical line s between\ncolumns should not be inserted.\nIllustrations should be presented on separate pages and numbered consecutively with Arabic numerals. Drawings must ensure\ngood reproduction. Bar graphs, pie charts and tables should use a GIF format. The size of numbers, letters and signs should belarge enough to remain legible if reductions are required. References of symbols in the figures should be given in the body of the\nfigures and not in the legends.\nPhotographs:  both black and white and color photographs are accepted, their quality must be very high, with good contrast so that\nreproductions are precise; a gloss finish must be used. Original drawings and photographs must have the names of the authors an d the\nsequence number in pencil overleaf. The legends of the illustrations should be typed on a separate page and in numerical order.\nElectronic forms must use a high resolution JPEG format. Illustrations and photographs must not exceed 580 pixels in width. Abb reviations\nshould be defined at their first appearance in the text. Units of measure should be expressed in the \nSyst\u00e8me International d\u2019Unit\u00e9s.\nDiscussion. Emphasis should be laid on the new and most important findings of the study; experimental data should be\nexamined in the light of previously published work. Conclusions should be presented avoiding the repetition of what has alreadybeen stated in the preceding sections.\nAcknowledgements. They must be typed in smaller print in only one paragraph.\nReferences. The names of the authors cited should be listed in alphabetical order and numbered in sequence with Arabic\nnumerals on a separate page. It should be noted that  the Word list format must not be used. A citation in the text must be\naccompanied by the corresponding number in the Reference list in parentheses. Unpublished work and personal comments should\nbe presented as: personal communication . Should the number of authors be more than six, the name of the first six must be\nfollowed by \net al.\nSample references:\na. Periodical publications\nH\u00e9ritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem\nresistance in Acinetobacter baumannii . Antimicrob Agents Chemother 2005; 49: 3198-202.\nThe abbreviated title of the journal must follow the style of the Index Medicus (the list maybe obtained in http://www.nlm.nih. gov).\nb. Chapters of books/modules\nRuoff KL, Whiley RA, Beighton D. Streptococcus . En: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors.\nManual of Clinical Microbiology. Washington D.C., ASM Press, 2003, p. 405-21.\nc. Presentations in meetings\nAguilar M, Punschke K, Touati D, Pianzzola MJ. Estudios fisiol\u00f3gicos y gen\u00e9ticos en la bacteria sulfato reductora Desulfoarculus\nbaarsii. Terceras Jornadas Rioplatenses de Microbiolog\u00eda, 1997, Resumen J2, p. 102, Ciudad Aut\u00f3noma de Buenos Aires, Argentina.\nd. Presentations in meetings in a supplement\nFellner MD, Correa RM, Durand K, Teyssi\u00e9 AR, Picconi MA. An\u00e1lisis del ADN circulante de virus Epstein-Barr (EBV) en pacien-\ntes inmunosuprimidos con y sin linfomas asociados. VIII Congreso Argentino de Virolog\u00eda, Resumen 10416. Rev Argent Microbiol2005; 37 Supl 1: 95.\ne. Institutional publications\nClinical and Laboratory Standards Institute. Disk diffusion. Performance standards for antimicrobial susceptibility testing; 15 th\ninformational supplement, 2005; M100-S15. Wayne, Pa, USA.\nPreparation of the diskette/CD-ROM. The label should show: title of work, program and program version used for the text,\nfigures and photographs, and the title of each of the files on the diskette/CD-ROM.\nRecommendations.  Text format: type the whole text in only one file; images, if any, must be filed separately; capitals, spaces\nbetween words, italics and bold types should be those to be used in the printed version; there should be no spaces before or after\nsubheads; the text should be justified; use tab-settings instead of spacing-bars for tables. Before submitting a manuscript one  of the\nlatest issues of RAM should be consulted in order to  comply with the Instructions to Authors.\nPublishing charges.  Each published page will cost $ 50, or $ 150 (pesos) when the page includes color photographs to AAM\nArgentine members; or $100 or $300 (pesos) to Argentine non-member price; and U$S 40 or US$ 120 to all other contributors.\nReprints. Twenty-five off prints will be provided free of charge.\nEdici\u00f3n realizada por Estudio Sigma S.R.L.  - J. E. Uriburu 1252 - 8\u00ba F - Buenos Aires - Tel.: 4824-9431 / 4821-2702\nE-mail: estsigma@gmail.com - www.estudiosigma.com.ar\nImpreso en el mes de Diciembre de 2009", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}